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Abstract
RNA polymerase II holoenzyme, a form of eukaryotic RNA polymerase II,
had been found to consist of core RNA polymerase II, a subset of general
transcription factors and four Srb proteins. The Srb proteins had been
identified through a selection for Saccharomyces cerevisiae genes involved in
transcription initiation and regulation in vivo. Three genes, SRB7, SRB8 and
SRB9, were isolated and characterized. Along with the prior isolation of 6
otherSRB genes, this completed the characterization of this genetic selection.
All nine gene products were found associated with the RNA polymerase II
holoenzyme. A direct interaction between the holoenzyme and a
transcriptional activator provided the basis for a model whereby activator
recruitment of this apparatus at promoters directs gene expression.
Two yeast cyclin-dependent kinases (CDKs), present in RNA
polymerase II holoenzyme, were found to be biochemically indistinguishable
in their ability to phosphorylate the RNA polymerase II carboxy-terminal
domain (CTD), yet in living cells one acted as a positive regulator and the
other as a negative regulator of transcription. This paradox was resolved by
the observation that the negative regulator, Srb10, was uniquely capable of
phosphorylating the CTD prior to formation of the initiation complex on
promoter DNA, inhibiting transcription. In contrast, the TFIIH CDK, Kin28,
phosphorylated the CTD only after the transcription apparatus was associated
with promoter DNA. Thus, the timing of CTD phosphorylation could
account for the positive and negative functions of the two kinases.
Genome-wide expression analysis was performed to identify the genes
whose transcription depended on the functions of the two yeast cyclin-
dependent CTD kinases. Kin28 function was found to be generally required
throughout the genome, while Srb1O functioned negatively at a small subset
of genes. Analysis of this subset of genes revealed a novel mechanism for
coordinate regulation of specific sets of genes when cells encounter limiting
nutrients. A negative role was found for Srb1O in a yeast developmental
pathway, suggesting that the ultimate targets of signal transduction pathways
could be directly traced to the RNA polymerase II holoenzyme.
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5Chapter 1
Introduction: RNA polymerase II holoenzyme and transcription initiation
6Overview
The genes expressed by a biological organism serve as the dynamic link
between its genome and its phenotype. Thus, it comes as no surprise to find
that organisms invest a significant degree of complexity and energy in their
regulation of gene expression. Protein abundance in a cell is usually related
to the abundance of its mRNA, whose expression is commonly controlled at
the level of transcription initiation. Transcription is initiated by interactions
of the RNA polymerase II holoenzyme and general transcription factors at
common core promoter elements, and is regulated by various gene-specific
activators and repressors bound to adjacent or distal regulatory elements.
Nucleosomes and other chromatin-associated proteins contribute additional
layers to the transcriptional regulation process. The communication between
the regulatory factors and the components of the transcription machinery is
critical for appropriate gene expression.
This chapter aims both to introduce the subject of my studies and to
summarize our current knowledge of the yeast RNA polymerase II
holoenzyme and transcription initiation.
RNA polymerase II holoenzyme.
RNA polymerase II, the enzyme synthesizing mRNA, exists in several forms.
The first form to be isolated was called core RNA polymerase II and is also the
simplest form, made up of 10-12 subunits (reviewed in Young, 1991; Woychik
and Young, 1994). A much larger form of RNA polymerase II, thought to be
the form recruited to promoters in vivo, was discovered twenty years later in
Saccharomyces cerevisiae and is called a RNA polymerase II holoenzyme
(Koleske and Young, 1994; Kim et al., 1994; Thompson and Young, 1995). The
RNA polymerase II holoenzyme is not unique to yeast and has been purified
7from mammalian cells as well (reviewed in Parvin and Young, 1998). Yeast
RNA polymerase II holoenzyme has been reported to contain the hallmark
Srb proteins and near stoichiometric levels of most general components
involved in transcription initiation with the exception of TFIID and TFIIE.
The holoenzyme components can be divided into 3 main groups, which I will
review individually: core RNA polymerase II, the general transcription
factors (GTFs), and the regulatory factors (Srb proteins and others). Table I
lists all yeast RNA polymerase II components identified so far.
RNA polymerase II.
In eukaryotes, three types of DNA-dependent RNA polymerases accomplish
the transcription of nuclear genes, each responsible for the transcription of a
different class of RNA. RNA polymerase I transcribes the ribosomal RNA-
encoding genes, RNA polymerase II transcribes the protein-encoding genes,
and RNA polymerase III transcribes the tRNA- and the 5S ribosomal RNA-
encoding genes (reviewed in Sentenac, 1985; Roeder, 1996).
Yeast Saccharomyces cerevisiae RNA polymerase II is a multisubunit
enzyme comprised of 12 core polypeptides encoded by genes designated RPB1-
RPB12, (reviewed in Young, 1991; Woychik and Young, 1994). All 12 genes
are required for normal growth, and all but RPB4 and RPB9 are essential for
cell viability. Minor differences aside, this enzyme shares many
characteristics in subunit composition with all other eukaryotic nuclear RNA
polymerases. In yeast, five of the RNA polymerase II subunits (Rpb5, Rpb6,
Rpb8, Rpb1O and Rpbl2) are also present in RNA polymerases I and III and are
referred to as "common" subunits. A human counterpart for each of the 12
genes encoding yeast RNA polymerase II has been isolated (Pati and
Weissman, 1989; Pati and Weissman, 1990; Acker et al., 1992; Wintzerith et
Table I. RNA polymerase II Holoenzyme Components in S. cerevisiae
Factor Gene Subunit Essential? Features References
RPB1
RPB2
RPB3
RPB4
RPB5
RPB6
RPB7
RPB8
RPB9
RPBIO
RPB11
RPB12
TFBI
TFB2
TFB3
TFB4
RAD3
SSLI
SSL2/RAD25
KIN28
CCLI
192 kDa
139 kDa
35 kDa
25 kDa
25 kDa
18 kDa
19 kDa
17 kDa
14 kDa
8 kDa
14 kDa
8 kDa
73 kDa
59 kDa
32 kDa
37 kDa
90 kDa
52 kDa
95 kDa
35 kDa
45 kDa
Y
Y
Y
N
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
TFA1 55 kDa Y
TFA2 37 kDa Y
SSUI/TFGI 82 kDa Y
TFG2 47 kDa Y
ANC1/TFG3 27 kDa N
SUA7
SRB2
SRB4
SRB5
SRB6
SRB7
SRB8
SRB9
SRBIO
SRB11
MEDI
MED2
MED4
MED6
MED7
MED8
MEDII
CSE2
GALII
NUT2
PGDI
ROX3
RGRI
SIN4
NUT1
XTC1
Heptapeptide repeat
Shared with Poll, 11, 111
Shared with Poll, II, I
Shared with Poll, II, I1
Shared with Poll, II, III
Shared with Poll, II, I
Nucleotide excision repair
Nucleotide excision repair
Nucleotide excision repair
DNA Helicase
Nucleotide excision repair
DNA Helicase
Cyclin dependant CTD kinase
Kin28 cyclin pair
Shared with TFIID and TFIIH
38 kDa
23 kDa N
78 kDa Y
34 kDa N
14 kDa Y
16 kDa Y
166 kDa
160 kDa
63 kDa
38 kDa
64 kDa
48 kDa
32 kDa
33 kDa
26 kDa
25 kDa
15 kDa
17 kDa
120 kDa
18 kDa
47 kDa
25 kDa
123 kDa
111 kDa
129 kDa
N
N
N
N
N
N
Y
Y
Y
Y
N
N
Y
N
Y
Y
N
N
Cyclin dependant CTD kinase
SrblO cyclin pair
27 kDa N
FCP1 83 kDa
SWII 148 kDa N
SWI2/SNF2 194 kDa N
SWI3 93 kDa N
SNF5 103 kDa N
SNF6 38 kDa N
SNFI 19 kDa N
ARP9 53 kDa Y/N
ARP7 54 kDa Y/N
SNF12 64 kDa N
SWp82p - 82 kDa ?
ANC1/TFG3 27 kDa N
DNA dependant ATPase
Actin related
Actin related
Shared with TFIID and TFIH
RNA Polymerase RI
* These proteins have not yet been formally demonstrated to be stoichiometric subunits of purified RNA polymerase II holoenzyme.
Young and Davis, 1983; Ingles et al, 1984; Allison et al., 1985
Sweetser et al., 1987
Kolodziej and Young, 1989
Woychik and Young, 1989
Woychik et al., 1990
Woychik et al., 1990
Woychik et al., 1993a
Woychik et al., 1990
Woychik et al., 1991
Woychik and Young, 1990
Woychik et al., 1993b
Treich et al., 1992
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1997
Feaver et al., 1994
Feaver et al., 1994
Henry et al, 1994
Henry et al, 1994
Henry et al, 1994
Pinto et al., 1992
Nonet and Young, 1989; Koleske et al., 1992; Koleske and Young, 1994
Thompson et al, 1993; Koleske and Young, 1994
Thompson et al, 1993; Koleske and Young, 1994
Thompson et al, 1993; Koleske and Young, 1994
Hengartner et al., 1995
Hengartner et al., 1995
Hengartner et al., 1995
Liao et al., 1995
Liao et al., 1995
Balciunas et al., 1999
Myers et al., 1998
Myers et al., 1998
Myers et al., 1998
Myers et al., 1998
Myers et al., 1998
Gustafsson et al., 1998
Gustafsson et al., 1998
Li et al., 1996; Barberis et al., 1996
Gustafsson et al., 1998
Myers et al., 1998
Gustafsson et al., 1997
Li et al., 1996
Li et al., 1996
Gustafsson et al., 1998
Emili et al., 1998
Archambault et al., 1997
Cairns et al., 1994; Cote et al., 1995
Cairns et al., 1994; Cote et al., 1995
Cairns et al., 1994; Cote et al., 1995
Cairns et al., 1994; Cote et al., 1995
Cairns et al., 1994; Cote et al., 1995
Treich et al., 1995
Cairns et al., 1994; Cote et al., 1995; Cairns et al., 1998; Peterson et al., 1998
Cairns et al., 1994; Cote et al., 1995; Cairns et al., 1998; Peterson et al., 1998
Cairns et al., 1996A
Cairns et al., 1994; Cote et al., 1995
Cairns et al., 1996B
TFIIH
TFIIE
TFIIF
TFIIB
Srbs
Meds
Cse2
Gall
Nut2
Pgdl
Rox3
Rgr1
Sin4
(Nut1)*
(Xtc1)*
Fcp1
SWI/SNF
9al., 1992; Acker et al., 1993; Acker et al., 1994; Pati, 1994; Khazak et al., 1995;
McKune et al., 1995; Shpakovski et al., 1995; Khazak et al., 1998). They share a
sequence similarity with their yeast orthologs that is accompanied by a
remarkable conservation of function as six out of seven human RNA
polymerase II subunits tested are able to functionally substitute for their yeast
counterparts (McKune and Woychik, 1994; Khazak et al., 1995; McKune et al.,
1995; Shpakovski et al., 1995).
There is a profound similarity between yeast RNA polymerase II and
the bacterial RNA polymerases as well. The bacterial RNA polymerases are
composed of a specificity factor (a), and of a three-component bacterial core
enzyme, structured as a PP'fc 2 tetramer. The two largest subunits, Rpbl and
Rpb2, are homologous to the P' and P bacterial core subunits, respectively.
Rpb3 and Rpb11 share a weaker homology with the a bacterial core subunit
and can form a Rpb3-Rpbll heterodimer in vitro , consistent with the
hypothesis that this heterodimer is the ortholog of the x2 homodimer (Larkin
and Guilfoyle, 1997). As expected, the yeast orthologs of the bacterial core
enzyme, Rpl, Rpb2 and Rpb3, are found to be largely responsible for the
enzymatic RNA catalysis (reviewed in Young, 1991; Woychik and Young,
1994).
Rpb4 and Rpb7 form a dissociable subcomplex that has been implicated
in the stress response and in the initiation of transcription (Dezelee et al.,
1976; Woychik and Young, 1989; Edwards et al., 1991; Choder and Young,
1993). While Rpb4 and Rpb7 are present only in substoichiometric amounts
during the exponential phase of yeast growth, they are found as
stoichiometric subunits of core RNA polymerase II under suboptimal
conditions such as the stationary phase of cell growth (Choder and Young,
1993).
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CTD. Rpbl contains an unusual carboxy-terminal domain CTD) that
consists of tandem repeats of the consensus sequence YSPTSPS (reviewed in
Chao and Young, 1991; Corden, 1990). This repeat is highly conserved among
eukaryotes and is unique to the largest subunit of RNA polymerase II,
suggestive of a role in mRNA biogenesis. The CTD has been found to contain
as few as 26 heptapeptide repeats in yeast, or as many as 52 repeats in mouse
(Allison et al., 1985; Corden et al., 1985; Allison et al., 1988). Deletion studies
have demonstrated that the CTD is essential for cell viability in yeast,
Drosophila, and mammalian cells (Nonet et al., 1987; Allison et al., 1988;
Bartolomei et al., 1988; Zehring et al., 1988).
Partial CTD truncation studies were the first to suggest the domain's
role in transcription initiation. CTD partial truncation mutations cause
growth defects in yeast (Nonet et al., 1987) and impair inducible gene
expression at a subset of promoters in both yeast and mammalian cells
(Allison and Ingles, 1989; Scafe et al., 1990; Gerber et al., 1995). The defects in
gene expression can be mapped in vivo and in vitro to the UAS of the genes
affected, and can be shown to occur at the level of transcription initiation
(Allison and Ingles, 1989; Scafe et al., 1990; Liao et al., 1991). The CTD
provided the focal point for the genetic analysis that led to the discovery of
the Srb proteins and the RNA polymerase II holoenzyme.
The general transcription factors.
While purified RNA polymerase II is sufficient and necessary for template-
dependent RNA synthesis, additional factors are required for accurate and
selective initiation at promoters in vitro (Matsui et al., 1980). These general
transcription factors (GTFs) were originally defined through fractionation and
in vitro transcription reconstitution experiments and include TFIIA, TFIIB,
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TFIID, TFIIE, TFIIF and TFIIH (reviewed in Zawel and Reinberg, 1993;
Orphanides et al., 1996; Roeder, 1996). As seen in many aspects of gene
transcription, the general transcription factors show a high degree of
functional and structural homology between eukaryotes. The yeast genes
coding for the various GTF subunits have now all been cloned (reviewed in
Hampsey, 1998). With the exception of a number of TBP-associated factors
(TAFjjs), the genes are all essential (reviewed in Hampsey, 1998).
Step-wise assembly model of PIC fomation. A decade ago, DNA
footprinting, gel electrophoretic mobility shift assays and kinetic assays had
revealed that the GTFs and core RNA polymerase II could be assembled in a
orderly and step-wise fashion on promoters in vitro to form a pre-initiation
complex (PIC) (reviewed in Conaway and Conaway, 1993; Zawel and
Reinberg, 1993; Buratowski, 1994). In short, core promoter elements were
recognized by TFIID or TBP, followed by the sequential assembly of TFIIA,
TFIIB, RNA polymerase II/TFIIF, TFIIE and TFIIH. The discovery of a form of
RNA polymerase II that already contained a number GTFs suggested that in
vivo, ordered GTF asssembly may be bypassed in favor of direct recruitment
of a preassembled complex consisting of RNA polymerase, GTFs, and
regulatory proteins (Srb, Med, etc.) to TFIID-bound promoters (Koleske and
Young, 1995). Before undertaking a review of the main properties and
function of each GTF, I will introduce the main structural elements found in
the promoters of protein-encoding genes.
Promoter structure.
Promoters of genes transcribed by eukaryotic RNA polymerase II (class II
genes) contain core elements and regulatory elements (reviewed in Struhl,
1995). The core elements encompass the site for assembly of the transcription
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preinitiation complex (PIC) and include the TATA box and the initiator
sequence (Inr). The regulatory elements, located upstream of the core
promoter, are gene-specific sequences that serve to control the rate of
transcription initiation and include upstream activation sequences (UAS),
upstream repression sequences (URS) and poly(dA-dT) tracts.
Core promoter elements: TATA box core element. Most yeast
promoters contain a TATA elements (consensus TATAAA) that is important
for transcriptional initiation (Breathnach and Chambon, 1981; Struhl, 1995).
The TATA-binding protein TBP), a pivotal component of the general
transcription factor TFIID, binds the TATA element and serves to nucleate
the assembly of the PIC. TBP is also required for transcription from
promoters lacking a canonical TATA box (TATA-less promoters), where it is
presumed to function in concert with other components of the TFIID
complex in recognizing a promoter structure other than the TATA to
nucleate PIC assembly (Brandl et al., 1992; Cormack and Struhl, 1992).
Inr core element. In the budding yeast, S. cerevisiae, initiator (Inr)
elements are defined as the DNA sequences surrounding the transcription
start sites where RNA polymerase II initiates mRNA synthesis. The yeast Inr
element is typically located at a variable 40 to 120 bp downstream of the TATA
element, in marked contrast to most eukaryotes where RNA polymerase II
initiates trasncription at a fixed 25-30 bp downstream of the TATA element
(reviewed in Struhl, 1989). This fixed distance between the TATA element
and the transcription start site suggested that, in most eukaryotes, the TATA
element would be sufficient to specify the location of transcription initiation.
Conversely, the variable distance between TATA and Inr elements in yeast,
suggested that specific sequences would exist to direct transcription initiation.
Such Inr sequences have been described (Chen and Struhl, 1985; Hahn et al.,
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1985; Nagawa and Fink, 1985; Healy et al., 1987; Rudolph and Hinnen, 1987).
As opposed to the TATA and the regulatory promoter elements, yeast Inr lack
a strong sequence consensus and their contributions to the overall level of
transcription are relatively modest.
In higher eukaryotes, the Inr element is defined differently from the
yeast Inr: a core promoter element near the transcription start site, that could
nucleate PIC assembly at TATA-less promoters (Smale and Baltimore, 1989).
Besides functional PIC assembly, metazoan TATA and Inr elements share
additional functional similarities: each can, independently or in concert,
direct accurate transcription initiation and activator responsive transcription
(reviewed in Smale, 1997). A number of factors have been demonstrated or
inferred to recognize the Inr element, such as the TBP-associated factor
(TAF1j) subunits of TFIID, RNA polymerase II and novel Inr-binding proteins
(reviewed in Weis and Reinberg, 1992) ; (Smale, 1997). The favored model is
that TFIID, either through direct TAF11s-Inr element recognition or with the
help of other factors, nucleates PIC assembly. Core promoter structures can
contain both TATA and Inr elements (composite promoters), either element
alone (TATA- or Inr-directed promoter) or none (null promoter) (reviewed
in Novina and Roy, 1996). The composite promoters are found primarily in
viral genes (reviewed (Roeder, 1991) while most cellular class II genes contain
TATA-directed promoters and, to a lesser extent, Inr-directed promoters. The
null promoters seem to contain no strong Inr element and usually have
multiple transcription start sites, suggestive of imprecise initiation (Geng and
Johnson, 1993; Lu et al., 1994; Ince and Scotto, 1995). Their frequency is
unknown but they have been proposed to function at "cellular
housekeeping" genes. Several null promoters share an intragenic sequence
element called MED-1 (Ince and Scotto, 1995).
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In Saccharomyces cerevisiae, it is still not known whether Inr elements
are able to nucleate PIC assembly as well, or if there are specific Inr-
recognition factors. One study so far, has shown that the Inr element of
GAL80 was capable of directing transcription initiation in the absence of a
canonical TATA element (Sakurai et al., 1994).
DPE and BRE core elements. Studies in Drosophila have described a
conserved downstream promoter element (DPE) located 30 bp downstream of
the transcription start site in many TATA-less promoters (Burke and
Kadonaga, 1996). The DPE is necessary for efficient transcription in vitro and
can contact TAF1140 and TAF1160, working in concert with the Inr element to
recruit TFIID to the promoter (Burke and Kadonaga, 1996; Burke and
Kadonaga, 1997). A new core promoter element that modulates the binding
of the general transcription factor TFIIB, the TFIIB recognition element (BRE),
has just recently been described (Lagrange et al., 1998). While no conserved
yeast DPE element has been described yet, the strong conservation of the
TFIIB protein among eukaryotes leads to expect that BRE elements will be
generally conserved as well.
Regulatory promoter elements: UAS and URS. While the core
promoter elements serve to direct the accurate transcription initiation of a
gene, positive transcription factors (activators) and negative transcription
factors (repressors) regulate the level of transcription through upstream
activation sequences (UAS) and upstream repressor sequences (URS),
respectively (reviewed in Mitchell and Tjian, 1989; Struhl, 1995). The UAS
and URS elements are typically located within a few hundred bp upstream of
the initiation start site and are specifically and directly bound by activators
and repressors.
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In metazoans, sequences directing transcriptional activation can be
divided into promoter-proximal elements, binding glutamine-rich activators
such as Spi, Oct-1 and Oct-2, and enhancer elements, located many kilobases
from the core promoter in either 5' or 3' direction (Seipel et al., 1992). Yeast
UAS elements are analogous to enhancers in that they function in either
orientation and at variable distances upstream from the core promoter.
However, in marked contrast to enhancers, UAS elements fail to activate
transcription when positioned downstream of the core promoter (Guarente
and Hoar, 1984; Struhl, 1984). UAS-bound activators have been found to
facilitate or stabilize PIC formation through direct or indirect contacts between
their transcriptional activation domain and the transcription initiation
machinery. This activation domain is functionally distinct, and usually
physically separate, from the activator's DNA-binding domain Ptashne, 1988;
Ptashne and Gann, 1990). URS-bound repressors inhibit transcription by a
variety of mechanisms, such as activator-UAS binding interference;
activation domain function interference; or by direct inhibitory contacts with
the transcription initiation machinery (reviewed in Johnson, 1995).
URS and co-represssor complexes. URS-bound proteins can also
mediate repression indirectly by recruiting the Tupl/Ssn6 co-repressor
complex. This general transcription co-repressor complex is recruited to
different promoters via pathway-specific DNA-binding proteins and has been
proposed to inhibit transcription by targeting the transcription machinery
and/or core nucleosomal histones (reviewed in Roth, 1995). Chromatin-
packaged genes present problems of promoter DNA accessibility to general
and regulatory transcription factors. Modulating changes in nucleosomal
structure at promoters is thought to allow or inhibit transcription. What role,
if any, the Tup1/Ssn6 complex plays in regulating nucleosomal structure is
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unknown. However, two classes of factors that facilitate nucleosomal
structure changes have come to the foreground recently: ATP-dependent
chromatin remodelling complexes and enzymatic complexes which control
histone acetylation and deacetylation (reviewed in Grunstein, 1997;
Tsukiyama and Wu, 1997; Armstrong and Emerson, 1998; Ashraf and Ip, 1998;
Davie, 1998; Workman and Kingston, 1998). A general in vivo correlation
between core histone acetylation and gene expression has long been
recognized. Conversely, histone deacetylation has been thought to lead to
transcriptional repression. In yeast, recruitment of the Sin3-Rpd3 histone
deacetylase co-repressor complex by the URS-bound Ume6 repressor, leads to
inhibition of transcription (Kadosh and Struhl, 1997). The Sin3-Rpd3 co-
repressor complex and function are found to be conserved in metazaons,
while the identification of Tupi/Ssn6 homologs also suggest evolutionary
conservation of this co-repressor complex (Grbavec et al., 1999; Pazin and
Kadonaga, 1997).
Poly(dA-dT) tracts regulatory element. As opposed to the protein-
mediated effects of UAS and URS elements, the regulatory properties of yeast
promoters can also be determined by poly(dA-dT) tracts. The Poly(dA-dT)
type of upstream element functions not by interacting with a specific DNA-
binding protein, but by virtue of it's intrinsic DNA structure (Iyer and Struhl,
1995). Poly(dA-dT) elements have distinct structural characteristics that
impair nucleosome assembly and stability (reviewed in Iyer and Struhl, 1995).
The analysis of the complete yeast genome sequence has revealed that these
elements are found frequently one nucleosome DNA length upstream and
downstream of open-reading frames (ORFs), suggestive of a modulatory role
in nucleosome positioning (Raghavan et al., 1997).
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TFIID and TBP-associated factors.
TBP and TFIID. The TATA-binding protein TBP) is a universal
transcription factor that is used for transcription by all three nuclear RNA
polymerases (reviewed in Sharp, 1992; Hernandez, 1993). As befits a protein
central to so many processes, TBP displays an uncommonly strong
evolutionary sequence conservation among eukaryotes. Yeast TBP is encoded
by SPT15 (Hahn et al., 1989). SPT15 was isolated as a suppressor of a
transcription defect that originated from transposon element insertion into
the core promoter region of a class II gene (Eisenmann et al., 1989). As a RNA
polymerase II GTF, the TBP protein is found associates with approximately 10
polypeptides, called TBP-associated factors (TAF11s), to form a large complex
referred to as TFIID (reviewed in Burley and Roeder, 1996). While TBP
functions to specifically recognize the TATA elements present in most
eukaryotic core promoters, the TAF 1 s subunits can interact with initiator and
downstream elements (reviewed in Burley and Roeder, 1996; Verrijzer and
Tjian, 1996; Burke and Kadonaga, 1997). Together, TBP and TAFjjs direct
promoter recognition and the bound TFIID-DNA complex in turn recruits
RNA polymerase II holoenzyme and other factors required for PIC
nucleation.
Crystallography studies of TBP, alone or complexed to promoter DNA
and GTFs, have been instrumental in resolving a number of the protein's
functions at a high level of details (reviewed in Burley, 1996). TBP was found
to resemble a symmetrical molecular saddle (Nikolov et al., 1992; Chasman et
al., 1993). When bound to a promoter, this saddle structure sits atop the
DNA, contacting the minor groove of the TATA element and inducing a
sharp DNA bend accompanied by a partial unwinding of base pairs (Kim et
al., 1993; Kim et al., 1993). Small surfaces on opposite sides of the TBP
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"saddle" are involved in contacting the general transcription factors TFIIA
and TFIIB (Geiger et al., 1996; Nikolov et al., 1995). The TBP-TFIIB interaction
is thought to be the primary connection between TFIID and the RNA
polymerase II holoenzyme although interactions between TBP and the Srb2
holoenzyme component have also been described (Koleske et al., 1992).
While TFIID and TBP have not been found to be bona fide subunits of highly
purified yeast RNA polymerase II holoenzyme, substoichiometric amounts of
TBP have been reported, consistent with a weak interaction between TFIID
and holoenzyme (Thompson et al., 1993; Koleske and Young, 1994). TBP
crystals first suggested that the protein could form homodimers: two TBP
molecules interacting with each other through their DNA binding surfaces
(Nikolov and Burley, 1994). In vitro and in vivo crosslinking studies show
that TBP has the ability to form homodimers in solution, even when part of
the TFIID complex (Coleman et al., 1995; Taggart and Pugh, 1996). It is
unknown what effect, if any, this homodimerization has on RNA
polymerase II transcription regulation.
TAF11s. TFIID complexes have been purified from Drosophila
(Dynlacht et al., 1991), human (Pugh and Tjian, 1991; Tanese et al., 1991;
Takada et al., 1992; Zhou et al., 1992) and yeast (Reese et al., 1994; Poon et al.,
1995) sources, and the genes encoding the major TAFjjs have all been cloned.
The Drosophila TFIID complex (TBP and eight TAFJ1 s) could be entirely
reconstituted from recombinant proteins (Chen et al., 1994). A majority of
yeast TAFjjs are essential for viability (Table II) and a homologous
counterpart for each yeast TAF11 ,except TAF1147 and TAFnJ30, has been found
in higher eukaryotes (reviewed in Burley and Roeder, 1996; Tansey and Herr,
1997).
Table II. TBP-associated regulators in S. cerevisiae
Factor Gene Subunit Essential? Features References
SAGA SPT3
SPT7
SPT8
SPT20/ADA5
ADA2/SW18
ADA3/NGG1
GCN5/ADA4/SWI9
TAF90
TAF61/68
TAF60
TAF25/TAF23
TAF17/TAF20
38 kDa
153 kDa
66 kDa
68 kDa
51 kDa
79 kDa
51 kDa
89 kDa
61 kDa
58 kDa
23 kDa
17 kDa
N
N
N
N
N
N
N
Y
Y
Y
Y
Y
Eisenmann et al., 198927 kDa Y
102 kDa Y
60 kDa Y
59 kDa Y
161 kDa
121 kDa
89 kDa
67 kDa
61 kDa
58 kDa
40 kDa
41 kDa
27 kDa
23 kDa
19 kDa
17 kDa
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
Y
Y
Cell cycle progression role
Histone acetyltransferase
Cell cycle progression role, shared with TFIID, SAGA
Similar to histone H2B, shared with TFIID, SAGA
Similar to histone H4, shared with TFIID, SAGA
Component of TFIF and SWI/SNF
Similar to histone H3, shared with TFIID, SAGA
Homologous to TFIlB
Histone acetyltransferase
Cell cycle progression role, shared with TFIID, SAGA
Similar to histone H2B, shared with TFIID, SAGA
Similar to histone H4, shared with TFIID, SAGA
Similar to histone H3, shared with TFIID, SAGA
Moti MOT1/BUR3/ADI 210 kDa Y Member of SNF2 family of ATPases
NC2 NCBI/BUR6
NCB2/YDRI
Nots NOTI/CDC39
NOT2/CDC36
NOT3
NOT4/MOT2/SIG1
NOT5
16 kDa Y Histone fold motif
17 kDa Y Histone fold motif
240 kDa
22 kDa
94 kDa
65 kDa
66 kDa
Y
N
N
N Zinc finger protein
Regions of homology with NOT3
Keys, et. al., 1994
Keys, et. al., 1994
Lalo, et. al., 1996; Lin, et. al., 1996
TBP TBPI/SPT15
TAFIs RRN6
RRN7
RRN11
TAFls TAF150/TSMI
TAF145/TAF130
TAF90
TAF67
TAF68/FAF61
TAF60
TAF47
TAF40
TAF30/ANC/TFG3
TAF25/TAF23
TAF79/FUN81
TAF17/FAF20
Verrijzer, et. al., 1994; Poon, et. al., 1995
Reese, et. al., 1994; Poon, et. al., 1995
Reese, et. al., 1994; Poon, et. al., 1995
Moqtaderi, et. al., 1996
Moqtaderi, et. al., 1996; Walker, et. al., 1996
Poon, et. al., 1995
Walker, et. al., 1997
Moqtaderi, et. al., 1996; Klebanow, et. al., 1997
Henry, et. al., 1994
Moqtaderi, et. al., 1996; Klebanow, et. al., 1996
Moqtaderi, et. al., 1996
Moqtaderi, et. al., 1996
Buratowski & Zhou, 1992; Colbert & Hahn, 1992; Lopez-de-Leon, et. al., 1992
Kassavetis, et. al., 1995; Ruth, et. al., 1996
Eisenmann, et. al., 1992
Gansheroff, et. al., 1995
Eisenmann, et. al., 1994
Marcus, et. al., 1996; Roberts, et. al., 1996
Berger, et. al., 1992
Brandl, et. al., 1993; Pina, et. al., 1993
Georgakopoulos & Thireos, 1992; Brownell, et. al., 1996; Grant, et. al., 1997
Grant et al., 1998
Grant et al., 1998
Grant et al., 1998
Grant et al., 1998
Grant et al., 1998
Davis, et. al., 1992; Piatti, et. al., 1992; Auble, et. al., 1994
Goppelt & Meisterernst, 1996; Gadbois, et. al., 1997; Prelich, 1997
Goppelt & Meisterernst, 1996; Gadbois, et. al., 1997; Kim, et. al., 1997
Reed, et. al., 1980; Collart & Struhl, 1993
Reed, et. al., 1980; Collart & Struhl, 1994
Collart & Struhl, 1994
Cade, et. al., 1994; Collart & Struhl, 1994; Irie, et. al., 1994; Leberer, et. al., 1994
Oberholzer & Collart, 1998
TAFIIIs BRF1/TDS4/PCF4 67 kDa Y
TFC5/TFC7 68 kDa Y
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Histone-like TAF11s. Sequence analysis has revealed that TAF1161/68 ,
TAF1160 and TAF1117/20 share a similarity to nucleosomal histones H2B, H3
and H4, respectively (reviewed in Burley and Roeder, 1996). The significance
of the sequence alignments is underscored by the crystal structure solution of
Drosophila TAF1160 and TAF1 140 fragments, homologs of yeast TAF1160 and
TAFII17/20, showing that they interact with each other through a "histone
fold" motif (Xie et al., 1996). This type of protein interaction is also seen in
the H3/H4 heterotetramer structure. Furthermore, the human homologs of
the 3 histone-like TAFjjs can associate together in a pattern similar to the one
found in core nucleosomes (Hoffmann et al., 1996). Yeast genetic analysises
strongly support a direct physical interaction between TAF1161/68 , TAF1160
and TAFII17/20 (Michel et al., 1998). It has been speculated that the
nucleosome-like assembly of these TAFjjs might be indicative of a particular
DNA-interacting function for TFIID. The histone-like TAFjis, along with
TAF1190 and TAF,1 25/23 are also found as subunits of another TBP-
interacting complex, called the SAGA complex (Grant et al., 1998). The TFIID
and SAGA complexes both possess histone acetyltransferase activity (Mizzen
et al., 1996; Grant et al., 1997), raising the possibility that they play similar, or
even redundant, chromatin modifying functions at promoters.
TBP and TAF11s in transcriptional activation. In some Drosophila
(Hoey et al., 1990; Pugh and Tjian, 1990; Dynlacht et al., 1991) and human
(Smale et al., 1990) reconstituted in vitro transcription systems, TFIID but not
TBP, was required for a transcriptional response to activators. These findings
inspired many biochemical studies in higher eukaryotes to probe the TAFrjs'
function in activation. A large number of direct and specific contacts between
various TAFjjs and transcriptional activators were identified as a result of
this effort (Hoey et al., 1993; Chen et al., 1994; Gill et al., 1994; Jacq et al., 1994;
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Chiang and Roeder, 1995; Klemm et al., 1995; Lu and Levine, 1995; Thut et al.,
1995; Sauer et al., 1995; Uesugi et al., 1997). The pattern of some of these
activator-TAFI1 contacts was also found to be consistent with the requirement
for a given TAF11 in activated transcription in vitro. A model emerged from
these experiments, where activators would generally increase the rate of
transcription by directly targeting TBP and the TAFjjs, thus enhancing the
recruitment of TFIID to the core promoter.
The first yeast in vivo studies looking at TBP seemed to agree with this
model. In vivo recruitment of TBP to a previously untranscribed promoter
was shown to be a rate-limiting step enhanced by transcriptional activators
(Klein and Struhl, 1994). Furthermore, enhanced recruitment of TBP by
artificial tethering to a promoter-bound factor could activate transcription in
vivo (Klages and Strubin, 1995; Chatterjee and Struhl, 1995; Xiao et al., 1995).
Again, this implied that TBP-binding could be a limiting step in PIC
formation. A similar experiment in human cells showed that artificial
recruitment of TBP activated transcription from TATA-containing but not
from TATA-less promoters (Majello et al., 1998). The strength of acidic
activator-TBP interaction in vitro, was also found to correlate the magnitude
of activation seen both in vitro and in yeast cells (Wu et al., 1996). As
predicted, hybrid fusion proteins tethering yeast TAF11s to promoter DNA in
vivo activated transcription as well (Apone et al., 1996; Gonzalez-Couto et al.,
1997).
However, when these studies where extended further to the in vivo
analysis of TAFjjs function, a different picture emerged. Since most of the
TAFjjs are essential genes, loss of TAF11 function in yeast cells can only be
achieved by using temperature sensitive TAF1 mutants (Moqtaderi et al.,
1996; Walker et al., 1996; Apone et al., 1996) or by TAF11 depletion (Moqtaderi
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et al., 1996; Walker et al., 1996; Apone et al., 1996). Against expectations, loss
of TAF11150/TSM1, TAF11145/130, TAF1190 and TAF1130 function in vivo
showed no global defects in activated transcription, but rather, impaired the
transcription of a small number of genes (Moqtaderi et al., 1996; Walker et al.,
1996; Apone et al., 1996; Walker et al., 1997; Holstege et al., 1998). Furtermore,
cells defective for TAF11150/TSM1 and TAF1190 showed a G2/M cell cycle
arrest (Apone et al., 1996; Walker et al., 1996), while cells defective for
TAF11145/130 showed a G1/S cell cycle arrest (Walker et al., 1996). A more
extensive analysis of a TAF11145/130 showed that it was required for the
transcription of several G1 cyclin genes (Walker et al., 1997), a requirement
conferred by core promoter elements (Shen and Green, 1997). A genome-
wide gene expression analysis further demonstrated that a subset of genes
involved in DNA repair, DNA synthesis and cell cycle progression all had a
direct requirement for TAF1145/130 function (Holstege et al., 1998). These
yeast results echoed earlier findings in ts13 human cells containing a
temperature sensitive mutation in TAF11250, the homolog of yeast
TAF11145/130. At the restrictive temperature, these cells arrested at the G1/S
stage of the cell cycle as well (Wang and Tjian, 1994). This was also correlated
with transcription defects in cell cycle genes (Wang and Tjian, 1994; Suzuki-
Yagawa et al., 1997). The evidence suggests that some of these TAFjjs do not
play the role of general coactivator but rather, function as core promoter
selectivity factors required at a subset of genes involved in cell cycle
progression and other functions.
Loss of the histone-like TAF1js' (TAFI117/20 , TAF1160, TAF1161/68)
function shows they are broadly required for transcription in vivo (Michel et
al., 1998; Natarajan et al., 1998). Different groups disagree on the universality
of the requirement for TAF1117, reflecting differences in methodology or
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mutant severity (Apone et al., 1998; Michel et al., 1998; Moqtaderi et al., 1998).
In marked contrast to the core promoter dependence seen for
TAFjj145/TAFIj130, the gene-dependence on TAF1117 was mapped to the
regulatory UAS elements (Apone et al., 1998). The interpretation of these
results has been complicated by the fact that these histone-like TAFj1 s also
exist in the SAGA complex (Grant et al., 1998). Whether TAF1117 function
reflects the importance of TFIID, SAGA or a combination of both complexes is
unknown.
Recent results in vitro and in vivo suggest that TAFjjs in higher
eukaryotes might not be as generally required for coactivators function as
previously thought. Mammalian TAF11-independent transcription activation
in vitro has been reported recently. In one case the coactivator function for
VP16 or CTF1 activation in nuclear extracts was provided not by TFIID but by
RNA polymerase II holoenzyme (Oelgeschlager et al., 1998). In a highly
purified reconstituted transcription system, TBP could support VP16 activated
transcription in the presence of the coactivator PC4 (Wu et al., 1998).
Mutations in two Drosophila TAFjjs, TAF11110 and TAFJ160/62, were recently
shown to perturb Dorsal activator-dependent transcription in vivo, but their
effect was limited to only a small subset of embryonic cells (Zhou et al., 1998).
It is unknown whether this TAF11110 and TAF1160/62 requirement mapped to
the Dorsal binding site or the core promoter region.
TFIID autoinhibition. Experiments with recombinant TAFjjs
(reviewed in Liu et al., 1998) or reconstituted complexes (Verrijzer et al., 1995;
Guermah et al., 1998), showed that Drosophila and human TAF11250, can
interfere with the formation of a stable TBP-TATA bound complex in vitro.
In the same assay, the yeast homolog TAF11145/130 has proven to be
inhibitory as well (Kokubo et al., 1998; Kotani et al., 1998). NMR analyses
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determined that the Drosophila TAF11250 inhibitory domain binds to the
DNA binding surface of TBP and mimicks the minor groove DNA surface
recognized by TBP (Liu et al., 1998). This incredible protein mimickry of the
TATA element surface clearly establishes the specificity of the negative
regulation of TBP-TATA interactions by TAF11250. These data suggest that
activators also work by antagonizing TFIID autoinhibition. If so, part of the
TFIID coactivator function observed in vitro really is the result of activator-
dependent relief of TFIID autoinhibition (Burley and Roeder, 1998).
Catalytic activities in TFIID. Two catalytic activities can be found in the
largest subunit of human and Drosophila TFIID, TAF11250: a
serine/threonine kinase activity and a histone acetyltransferase activity. A
bipartite (C-terminal and N-terminal) kinase domain is able to
autophosphorylate TAF11250 and transphosphorylate TFIIF in vitro (Dikstein
et al., 1996). Mutations in the N-terminal kinase domain establish a
correlation between kinase activity and the capacity of a transfected TAF11250
to rescue growth defects in a ts13 cell line (TAF11250 ts) (O'Brien and Tjian,
1998). The yeast homolog of hTAF11250, TAF11145/130, lacks both kinase
domains (Dikstein et al., 1996). Human and Drosophila TAF11250 were also
found to possess histone acetyltransferase activity, an activity found to be
conserved in yeast TAF11145/130 (Mizzen et al., 1996). The TFIID histone-
modifying activity would enable itself and the rest of transcription initiation
machinery to access nucleosome-bound promoter sequences.
Multiple TFIID complexes. Several studies have shown that multiple
species of TAF-specific TFIID can be purified from metazoan cells (Timmers
and Sharp, 1991; Brou et al., 1993; Jacq et al., 1994; Bertolotti et al., 1996). This
has been followed with the discovery of a tissue-specific TFIID, isolated from
differentiated B cells, containing a cell type-specific TAF11 subunit replacing a
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more general subunit (Dikstein et al., 1996). Two TBP like factors have also
been reported, the TBP-related factor (TRF) in Drosophila (Crowley et al.,
1993) and a TBP-like factor (TLF) in humans (Wieczorek et al., 1998). TRF
exhibits neural-specific expression and can substitute for TBP to support
transcription (Hansen et al., 1997). TRF is also found associated with other
proteins, called nTAFs, in 500 kD complex (Hansen et al., 1997). In another
striking study, a TBP-free TAF11-containing complex (TFTC) was purified
from human cells and shown to be able to replace TFIID on both TATA-
containing and TATA-less promoters in transcription assays in vitro
(Wieczorek et al., 1998). While many TAFj1 s were shared between TFTC and
TFIID, TFTC was also associated with a number of non-TAF protein species.
While TFTC was found to be devoid of the TBP-like factor, TLF, the presence
of another factor functionally similar to TBP cannot be excluded.
Other TBP-containing complexes. TBP is found as part of a number of other
complexes as well. In a manner analogous to TAFjjs, TAF1 and TAF111 class
proteins also associate with TBP to form promoter selectivity complexes for
RNA polymerase I and III transcription (reviewed in Geiduschek and
Kassavetis, 1995). PTF/SNAPc is a mammalian promoter selectivity factor
made up of TBP and associated proteins. It functions at the promoters of
small nuclear RNA genes, subsets of which are transcribed by either RNA
polymerase II or III (reviewed in Geiduschek and Kassavetis, 1995). No
homologs of the PTF/SNAPc subunits have been found in the yeast genome.
Moti. TBP-Motl complexes have been purified from yeast, human and
Drosophila extract (Timmers et al., 1992; Auble et al., 1994; Poon et al., 1994;
van der Knaap et al., 1997). Genetic evidence from yeast suggests that Moti
serves to influence RNA polymerase II promoter selection by TBP in vivo
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(Collart, 1996; Madison and Winston, 1997). Yeast Moti protein can repress
TBP binding to DNA in an ATP-dependent manner to repress trancription in
vitro (Auble and Hahn, 1993; Auble et al., 1994; Wade and Jaehning, 1996).
TBP-interacting complexes.
Genetic studies in Saccharomyces cerevisiae have suggested the existence of a
functional interaction between TBP and three complexes involved in
regulating the transcription of protein-coding genes: NC2, NOT and SAGA
(reviewed in Lee and Young, 1998). Additionally, a physical interaction
between mammalian topoisomerase I and TBP has been characterized in
vitro. How can one protein, like TBP, be an integral or associated component
of so many complexes ? It turns out that yeast TBP is found to be at least ten
times more abundantly in the cell than its associated regulatory proteins
(TAFlIs, SAGA, Moti, NC2 and NOT proteins) (Lee et al., 1998). Thus a large
pool of TBP interacts with smaller pools of diverse regulators in vivo.
NC2. NC2 and it's mammalian homolog (Dri/DRAP1) is a
heterotetramer composed of two NC2x/ f dimers that can bind directly to TBP
(Goppelt and Meisterernst, 1996; Kim et al., 1996; Gadbois et al., 1997). It acts as
a general negative regulator of transcription by RNA polymerase II and III
(Meisterernst and Roeder, 1991; Inostroza et al., 1992); ; (Goppelt and
Meisterernst, 1996; Mermelstein et al., 1996; Gadbois et al., 1997; Kim et al.,
1997; Prelich, 1997). NC2 can bind directly to TBP on promoter DNA and can
prevent RNA polymerase II holoenzyme, or its TFIIB subunit, from
assembling into a PIC (Meisterernst and Roeder, 1991; Inostroza et al., 1992;
Kim et al., 1995; Goppelt et al., 1996; Mermelstein et al., 1996; Gadbois et al.,
1997).
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Not complex. NOT genes were identified through no less than seven
different yeast genetic screens looking for negative regulators of transcription
(reviewed in Lee and Young, 1998). The 5 NOT encoded proteins, Noti, Not2,
Not3, Not4 and Not5, are found complexed together (Collart and Struhl, 1994)
and can associate with Ccr4 and Cafi (Liu et al., 1998). While their
mechanism of action is not yet solved, biochemical and genetic evidence has
clearly linked these proteins, functionally and physically, to TBP (Collart and
Struhl, 1993; Collart and Struhl, 1994; Lee et al., 1998). Yeast mutant
suppression analysis has also shown them to have a negative function on
RNA polymerase II holoenzyme transcription in vivo (Lee et al., 1998).
Coding sequences for 5 NOT homologs can be found in mammalian genome
databases (T. Lee and R.A. Young, unpubl.).
SAGA complex. The yeast SAGA histone acetyltransferase complex
and it's human counterpart, the PCAF complex, are made up of around 20
different proteins (Grant et al., 1997; Grant et al., 1998; Martinez et al., 1998;
Ogryzko et al., 1998). These include the catalytic component Gcn5, as well as
Spt, Ada and even TAF11 subunits. The SAGA complex has been reported to
stimulate in vitro transcription from preassembled nucleosomal template,
but not from naked DNA (Grant et al., 1998); Steger et al., submitted). While
the SAGA complex does not copurify withTBP, purified SAGA can bind
directly to a TBP-affinity column and SAGA immunoprecipitation in crude
extracts retains TBP (Barlev et al., 1995; Roberts and Winston, 1997; Saleh et
al., 1997; Sterner et al., 1999). This interaction requires Spt3 and to a lesser
extent Spt8, a finding buttressed by genetic evidence of a direct functional
interaction between these two proteins and TBP (Eisenmann et al., 1992;
Eisenmann et al., 1994; Sterner et al., 1999). Another potential relationship
between SAGA and TBP comes from the recent discovery that 5 of the yeast
28
TAFjjs present in TFIID, including the histone-like TAF 1s, are also present in
the SAGA complex (Grant et al., 1998). The TBP interaction with the SAGA
complex has been postulated to facilitate nucleosome disruption at the subset
of promoters requiring SAGA function in vivo. Most recently, Tral, a
protein similar to TRAPP, has been reported to be a subunit of yeast SAGA as
well (Grant et al., 1998). Human TRAPP protein is a member of the
ATM/phosphatidylinositol-3 kinase family and can associate with the c-Myc
and E2F-1 trasncription factors (McMahon et al., 1998).
Topoisomerase I. In mammalian systems, topoisomerase I has been
found to physically interact with TBP to depress basal (i.e. without activator
proteins) transcription and stimulate activated transcription (Merino et al.,
1993; Kretzschmar et al., 1993; Shykind et al., 1997). The DNA relaxation
activity of topoisomerase I is dispensable for repression of basal transcription
(Merino et al., 1993) and stimulation of activated transcription (Shykind et al.,
1997). The latter activity is also dependent on the presence of TAF1js
(Shykind et al., 1997). No genetic evidence of topoisomerase I involvement
in transcription has been found yet.
TFIIB.
TFIIB is an essential protein that can bind core RNA polymerase II (Pinto et
al., 1992; Tschochner et al., 1992; Bushnell et al., 1996), an interaction
supported by genetic interactions between the genes coding for TFIIB and
Rpb9, a core RNA polymerase II subunit (Sun et al., 1996). Not surprisingly,
TFIIB can be found as a component in some yeast RNA polymerase II
holoenzyme preparations (Koleske and Young, 1994; Koleske et al., 1996;
Wilson et al., 1996). Besides TBP and core RNA polymerase II, TFIIB binds
TFIIF as well. In humans, TFIIB interacts biochemically with the human
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homologs of the Tfg1 (Fang and Burton, 1996) and Tfg2 (Ha et al., 1993)
subunits of TFIIF, while in yeast, SUA7 (TFIIB) interacts genetically with
TFG1 (Sun and Hampsey, 1995) in transcriptional start site selection.
Drosophila TFIIB has also been reported to bind dTAF1140, homologue of the
yeast TAF1117 (Goodrich et al., 1993). TFIIB possesses a limited DNA binding
ability (Lagrange et al., 1998) that could partly explain its role in start site
selection (Pinto et al., 1992; Pinto et al., 1994; Berroteran et al., 1994).
In the sequential assembly model of PIC formation, TFIIB enters the
PIC after TFIID and as a prerequisite for the recruitment of the TFIIF bound
RNA polymerase II (reviewed in Conaway and Conaway, 1993; Zawel and
Reinberg, 1993; Buratowski, 1994). TFIIB entry into PIC was considered to be
another possible rate-limiting step that could be modulated by transcriptional
activators. Again, a number of biochemical studies have supported this view.
TFIIB binds to diverse classes of activation domains and its recruitment to the
TBP-TATA complex is enhanced by the acidic activator VP16 and the proline-
rich activator CTF1 (Kim and Roeder, 1994; Lin and Green, 1991). The use of
VP16 and GAL4 acidic activation domain mutants shows that their TFIIB
binding correlates with the strength of their activation domain Lin et al., 1991;
Wu et al., 1996). Conversely, TFIIB point mutants failing to interact with the
activation domain of VP16 support basal but not activated transcription
(Roberts et al., 1993; Roberts et al., 1995). Aside from enhanced TFIIB
recruitment into PIC, acidic activators have also been shown to induce a
conformational change in TFIIB (Roberts and Green, 1994). However, a yeast
in vivo experiment has cast some doubts on the model of direct TFIIB
recruitment by activators. A number of TFIIB mutants had been
characterized in vitro and shown to be unable to form a stable TFIIB-TBP-
TATA complex and/or to bind the VP16 activation domain Chou and Struhl,
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1997). Contrary to the prediction, introduction of these mutants into yeast
cells did not result in any loss of transcriptional activation in response to
VP16 in vivo (Chou and Struhl, 1997). Additionally, TBP mutants defective
in direct TFIIB interaction in vitro show no defect in transcriptional
activation in vivo either (Lee and Struhl, 1997). These data do not preclude
the more complex model where TFIIB, as a holoenzyme component, still
provides a vital link to the TFIID-promoter DNA complex in an activator-
regulated step in vivo. Consistent with this view, recruitment of TFIIB by
artificial tethering to a promoter-bound factor is sufficient to activate
transcription in yeast cells (Gonzalez-Couto et al., 1997).
TFIIF.
While mammalian TFIIF is composed of two subunits, called RAP74 and
RAP30 (Flores et al., 1990), yeast TFIIF contains three subunits (Henry et al.,
1992). Tfg1 and Tfg2 subunits are respectively homologs of RAP74 and RAP30
(Henry et al., 1994), while Tfg3 is a weakly associated component. Tfg3 is
unique to yeast and is a subunit also found in TFIID and Swi/Snf complexes
(Henry et al., 1994; Cairns et al., 1996). This shared component could be
symptomatic of a larger complex tying together the three different
subcomplexes. The mammalian TFIIF subunits were first identified as RNA
polymerase II associated proteins (RAP) and both yeast and human TFIIF
have been found tightly associated with RNA polymerase II (Sopta et al., 1985;
Flores et al., 1989; Henry et al., 1992). Not surprisingly, TFIIF is a component
of all yeast (Koleske and Young, 1994; Kim et al., 1994; Koleske et al., 1996) and
mammalian (reviewed in Parvin and Young, 1998) RNA polymerase II
holoenzymes isolated to date.
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In higher eukaryotes TFIIF appears to exist as c2@2 hetertetramer
(Conaway and Conaway, 1989; Flores et al., 1990) and binds to TFIIB (Ha et al.,
1993; Fang and Burton, 1996), TFIID (Ruppert and Tjian, 1995; Dubrovskaya et
al., 1996; Tang et al., 1996) and TFIIE (Maxon et al., 1994). As described in the
TFIIB section, yeast genetic evidence supports a TFIIF-TFIIB interaction. TFIIF
shows a high degree of structural and functional similarity to the prokaryotic
sigma (a) factors (Sopta et al., 1989; Conaway and Conaway, 1990; McCracken
and Greenblatt, 1991; Garrett et al., 1992; Killeen et al., 1992; Tan et al., 1994).
TFIIF can suppress nonspecific RNA polymerase II DNA binding and can also
stabilize PIC formation (Conaway and Conaway, 1993; Greenblatt, 1991). In
addition to its role in transcription initiation, TFIIF also stimulates the rate of
RNA polymerase II RNA chain elongation ( (Flores et al., 1989; Bengal et al.,
1991). An intriguing TFIIF function has emerged recently from in vitro
DNA-protein crosslinking studies with purified GTFs. TFIIF has been shown
to be responsible for the isomerization of a promoter DNA-TBP-TFIIB-core
RNA polymerase II-TFIIF-TFIIE complex (Robert et al., 1998). This
isomerization is accompanied by tight wrapping of the promoter DNA
around the complex for almost a full turn (Robert et al., 1998). TFIIF subunits
have also been suggested to be a direct target for activators, such as the Serum
Response Factor (Joliot et al., 1995) and Fos/Jun (Martin et al., 1996). Yeast
and human TFIIF have also been shown to interact with Fcpl, a component
of a TFIIF associated CTD phosphatase activity (Chambers and Kane, 1996;
Archambault et al., 1997; Archambault et al., 1998). Fcp1 has been detected in
crude yeast and human RNA polymerase II holoenzyme fractions
(Archambault et al., 1997; Archambault et al., 1998). Little else is known of
Fcpl's function except that it carries out an essential function in yeast
(Archambault et al., 1997).
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TFIIH.
With nine subunits, TFIIH is a complex factor possessing three enzymatic
subunits with either ATP-dependent DNA helicases (Schaeffer et al., 1993;
Serizawa et al., 1993) or CTD kinase (Feaver et al., 1991; Lu et al., 1992;
Serizawa et al., 1992) activities. TFIIH purified from yeast (Feaver et al., 1991),
rat liver (Conaway and Conaway, 1989) and human (Flores et al., 1992; Gerard
et al., 1991) cells share conserved polypeptides and common subunit activities
(reviewed in Svejstrup et al., 1996; Feaver et al., 1997). TFIIH has also been
found as a component in some RNA polymerase II holoenzyme preparations
(Koleske and Young, 1994; Koleske et al., 1996) but not in others (Kim et al.,
1994).
Human TFIIH has been shown to perform critical roles at early and late
stages of transcription initiation. The transcription initiation process can be
thought of as three broad steps: PIC formation, open complex formation and
promoter clearance (reviewed in Gralla, 1996). Open complex formation is a
required intermediate in which 12-15 p of promoter DNA are in the form of a
single-stranded bubble. Initiation is then completed by a series of reactions
coverting the open complex to an activately elongating complex, a transition
called promoter clearance. Open promoter complex formation by RNA
polymerase II requires the ATP-dependent DNA helicase activity of TFIIH
(Wang et al., 1992; Jiang et al., 1994). TFIIE, TFIIH and ATP hydrolysis are
dispensable for in vitro transcription initiation from supercoiled (Parvin and
Sharp, 1993; Parvin et al., 1994; Tyree et al., 1993) or pre-melted promoter
DNA (Holstege et al., 1995; Pan and Greenblatt, 1994; Tantin and Carey, 1994).
Additional detailed biochemical analysis strongly support a role for TFIIE,
TFIIH and ATP hydrolysis in open complex formation (Dvir et al., 1996;
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Holstege et al., 1996; Holstege et al., 1997) and promoter clearance (Holstege et
al., 1997; Shilatifard, 1998; Kumar et al., 1998).
Yeast (Feaver et al., 1991) and mammalian TFIIH (Lu et al., 1992) can
both phosphorylate the CTD in vitro, an activity stimulated by TFIIE (Lu et al.,
1992; Ohkuma and Roeder, 1994). The TFIIH CTD kinase activity has also
been suggested to regulate promoter clearance by phosphorylating the CTD of
core RNA polymerase II. A role for TFIIH in transcriptional elongation has
been suggested by anti-TFIIH antibody microinjection experiments in
Xenopus oocytes (Yankulov et al., 1996) and in vitro transcription
experiments (Dvir et al., 1996; Dvir et al., 1997). Mammalian TFIIH can also
phosphorylate TBP and both TFIIE subunits (Ohkuma and Roeder, 1994).
Yeast TFIIH is a holoenzyme that can be dissociated into three
subcomplexes: a core TFIIH complex, the Ss12 protein and the TFIIK
subcomplex (Svejstrup et al., 1995). The core TFIIH complex contains six
subunits: Tfbl, Tfb2, Tfb3, Tfb4, Rad3 and Ssll (Svejstrup et al., 1995; Wang et
al., 1995; Feaver et al., 1997). Core TFIIH subcomplex exists in multiple forms,
functioning as a fundamental RNA polymerase II GTF in one form (TFIIH)
and as an essential component in nucleotide excision repair (NER) in the
other (repairosome) (Feaver et al., 1991; Wang et al., 1994; Svejstrup et al.,
1995). While both complexes share the same core TFIIH subcomplex and the
Ss12 protein, the repairosome contains the repair proteins Radi, Rad2, Rad4,
RadiO, and Rad14, instead of the TFIIK subcomplex found in the TFIIH GTF.
The dual role of core TFIIH subcomplex in DNA repair and transcription
could account for previous observations of a link between gene transcription
and preferential repair (Bohr et al., 1985; Mellon and Hanawalt, 1989). The
TFIIK subcomplex contains a cyclin homolog, Ccli (Svejstrup and Feaver,
1996), and an associated kinase, Kin28 (Feaver et al., 1994). Kin28 is a cyclin-
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dependent kinase (CDK) homologous to Cdk7/MO15, the catalytic subunit in
human TFIIH (Roy et al., 1994). Biochemical studies have shown that the
human TFIIK kinase, Cdk7, plays a dual role; it serves as a CTD kinase to
control transcription, and as a CDK activating kinase to control cell cycle
progression (Fesquet et al., 1993; Poon et al., 1994); ; (Solomon et al., 1993;
Fisher and Morgan, 1994; Makela et al., 1994; Roy et al., 1994; Serizawa et al.,
1995; Shiekhattar et al., 1995). In yeast however, Kin28 only exhibits CTD
kinase activity and its in vivo role seems restricted to transcription
(Cismowski et al., 1995; Valay et al., 1995). Kin28 does not phosphorylate
Cdc28, the CDK involved in yeast cell cycle progression. Yeast cells with a
temperature sensitive KIN28 mutant show no cell cycle progression defects,
but rather, suffer a rapid loss of class II gene transcription (Cismowski et al.,
1995; Valay et al., 1995). The yeast CDK activating kinase function is found to
be executed by a monomeric kinase with no involvement in transcription:
Caki/Civi (Espinoza et al., 1996; Kaldis et al., 1996; Thuret et al., 1996). Thus
yeast seems to have evolved two protein kinases, Kin28 and Caki, to carry out
the same functions as Cdk7 in vertebrate cells.
As with other transcription factors, TFIIH has also been reported to
interact with activators, such as VP16 and p53 (Xiao et al., 1994). Certain
activators stimulate transcriptional elongation (Yankulov et al., 1996) and the
strength of these activators correlates with their abilities to bind TFIIH (Blau
et al., 1996). Most significantly, the transcriptional activator HIV Tat can
stimulate transcriptional elongation and CTD phosphorylation by human
TFIIH in vitro (Parada and Roeder, 1996; Garcia-Martinez et al., 1997). The use
of a specific TFIIH kinase inhibitor shows that CTD phosphorylation by TFIIH
is necessary for stimulation of elongation by Tat (Cujec et al., 1997).
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TFIIE.
TFIIE contains 2 subunits which have been conserved from yeast to humans
(Feaver et al., 1994; Ohkuma et al., 1991; Peterson et al., 1991; Sumimoto et al.,
1991). TFIIE is physically (Bushnell et al., 1996) and functionally (Li et al.,
1994) linked to TFIIH, stimulating CTD phosphorylation by TFIIH (Lu et al.,
1992; Ohkuma and Roeder, 1994). TFIIE can also interact with the TFIIF and
the unphosphorylated form of RNA polymerase II (Flores et al., 1989; Maxon
et al., 1994). TFIIE can bind to single-stranded DNA (Kuldell and Buratowski,
1997), a result consistent with its requirement in open complex formation.
This GTF is not present in yeast RNA polymerase II holoenzymes (Koleske
and Young, 1994; Kim et al., 1994; Koleske et al., 1996). In Drosophila, TFIIE
has been implicated as the direct target of homeodomain class of activators
(Zhu and Kuziora, 1996) and the KrUppel repressor (Sauer et al., 1995).
The largest TFIIE subunit, Tfal, contains a zinc-binding motif of the
C2C2 class. The TFIIE zinc-binding motif was necessary for reconstituted in
vitro transcription of the Ad2 MLP template in yeast and human systems
(Tijerina and Sayre, 1998; Maxon and Tjian, 1994), but not for TFIIE's ability to
bind single-stranded DNA (Kuldell and Buratowski, 1997). Mutants in this
motif were shown to cause thermosensitive growth in yeast (Kuldell and
Buratowski, 1997; Tijerina and Sayre, 1998). At the restrictive temperature,
bulk mRNA was found to decrease substantially (Kuldell and Buratowski,
1997), yet a subset of genes showed no defects when assayed individually
(Tijerina and Sayre, 1998). A tight TFIIE ts mutant in a region other than the
zinc-binding motif was also used to probe the GTF's function (Sakurai and
Fukasawa, 1997). Such a mutant failed to show a strict and obligatory
requirement for TFIIE at all promoters (Sakurai and Fukasawa, 1997; Holstege
et al., 1998). This promoter variability in TFIIE requirement matches in vitro
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findings that the dependence of promoters on human TFIIE is determined by
a DNA region around the transcription start site (Tijerina and Sayre, 1998;
Holstege et al., 1995).
TFIIA.
Yeast TFIIA is not a component of the RNA polymerase II holoenzyme
(Koleske and Young, 1994; Kim et al., 1994; Koleske et al., 1996) and its activity
copurifies with two polypeptides encoded by TOA and TOA2 (Ranish and
Hahn, 1991; Ranish et al., 1992). Mammalian TFIIA is encoded by two genes
homologous to TOA and TOA2(De Jong and Roeder, 1993; Ma et al., 1993).
The human TOA product is modified post-translationally to yield two
different polypeptides, which, when assembled with the human TOA2
product, yield a TFIIA factor with 3 subunits (Reinberg et al., 1987).
Mammalian TFIIA was originally identified as a general transcription
factor, i.e. required for promoter-specific in vitro transcription in a
reconstituted system (Reinberg et al., 1987). Since then, TFIIA has been found
to be dispensable for this role, acting rather to stimulate transcription in
TFIID-directed systems at TATA-containing and TATA-less promoters (Cortes
et al., 1992; De Jong et al., 1995; Ozer et al., 1994; Sun et al., 1994; Martinez et al.,
1998; Emami et al., 1997). TFIIA joins the PIC through interactions with TBP
(Buratowski et al., 1989) and stabilizes the promoter-TBP interaction
(Imbalzano et al., 1994). TFIIA acts as a transcriptional coactivator or anti-
repressor (Kang et al., 1995; Ma et al., 1996), presumably by antagonizing TBP-
interacting repressors such as NC2 (Inostroza et al., 1992), topoisomerase I
(Meisterernst et al., 1991; Merino et al., 1993), HMG1 (Ge and Roeder, 1994),
Moti (Auble et al., 1994) and even TAFI1s themselves (Ozer et al., 1998).
Drosophila or human TFIIA also interact with activators such as Zta, Spi,
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VP16 and NTF-1 (Ozer et al., 1994; Yokomori et al., 1994), with a TAF11
subunit (Yokomori et al., 1993), with coactivators PC4 and HMG2 (Ge and
Roeder, 1994; Shykind et al., 1995) and with the repressor RBP (Olave et al.,
1998).
Yeast TFIIA stimulates basal and activated in vitro transcription in a
nuclear extract but is dispensable for these same functions when purified
general transcription factors are used (Sayre et al., 1992; Kang et al., 1995).
These results are consistent with an anti-repressor function for TFIIA. In
vivo, yeast mutants of TBP or TFIIA defective in TBP-TFIIA interaction fail to
respond to a number of transcriptional activators and show transcriptional
defects at a subset of promoters (Stargell and Struhl, 1995; Ozer et al., 1998). In
one study, the defects associated with a TBP defective for TFIIA binding was
rescued by fusing the smallest TFIIA subunit (Toa2) to TBP (Stargell and
Struhl, 1995). This argues that an efficient TBP-TFIIA interaction is required
for transcriptional activation at a subset of promoters.
The crystal structure of a yeast promoter DNA-TBP-TFIIA crystal has
been solved and confirms a number of functions assigned to TFIIA:
TBP/TFIIA has extended contacts with DNA and may explain the stabilizing
effect on TBP binding (Geiger et al., 1996; Tan et al., 1996). TFIIA offers a wide
surface for activator contacts and requires only a limited contact surface with
TBP, relying upon relative spatial constraints to achieve specificity. This
suggests that limited contacts between multiple factors may be sufficient to
assemble a large number of proteins into the PIC complex (Jacobson and
Tjian, 1996).
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Suppressors of RNA polymerase B (II) (SRBs).
Genetic selection. The CTD of yeast core RNA polymerase II consists of
26 repeats of a seven amino acid consensus sequence and is involved in
transcription initiation and the response to activators (See core RNA
polymerase II). Yeast cells containing RNA polymerase II mutants that are
progressively more truncated for their CTD, exhibit increasingly more severe
phenotypes (Nonet et al., 1987): with a CTD from 26 (full length) to 13 repeats,
cells grow normally; from 12 to 10 repeats, cells show conditional growth
defects; with 9 repeats or less, cells are inviable. The conditional growth
defects include cold sensitivity (Nonet et al., 1987), temperature sensitivity
(Nonet et al., 1987), inositol auxotrophy (Nonet and Young, 1989) and an
inability to use pyruvate as a sole carbon source (Thompson et al., 1993). This
set of pleiotropic phenotypes is virtually identical to the set seen when RNA
polymerase II is underproduced, consistent with a strong transcription defect
for CTD truncations (Archambault et al., 1992).
A genetic selection for factors likely to be involved in transcription
initiation and regulation was initiated by looking for suppressor mutations
that allowed CTD truncation mutant (rpblAl04) cells to grow under
restrictive conditions (Nonet and Young, 1989; Thompson et al., 1993). Both
intragenic (in rpblA104) and extragenic (in a gene other than rpblAI04)
suppressors were found (Nonet and Young, 1989). Intragenic suppressors fell
in either of two classes: 1) CTD heptapeptide repeat duplications that
increased the number of repeats from to 13 or more ; 2) a specific valine to
phenylalanine amino acid substitution in the homology box H region of
RPB1 (Nonet and Young, 1989). This suggests that the H box region, a region
outside of the CTD that is conserved among RNA polymerases II, could
function with the CTD in transcription initiation. The extragenic suppressor
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mutants, called SRBs (suppressors of RNA polymerase B or II ), were
classified as dominant and recessive on the basis of their ability to suppress
the CTD truncation mutants in the presence of the wild-type suppressor gene
(Nonet and Young, 1989; Thompson et al., 1993; Hengartner et al., 1995). The
dominant SRBs were postulated to be positive (necessary) transcription
factors that had gained or strengthened a function, while the recessive
suppressors were postulated to be negative (inhibitory) transcription factors
that would have lost their repressive function. Both types of mutants, when
combined with a partly defective RNA polymerase II, would partially restore
transcription function. Since the positive factors were deemed more
interesting, initial cloning efforts focused on the dominant SRBs.
In a first small scale SRB genetic selection, two different extragenic
suppressors were analyzed and classified as SRB2-1 and srb3-1, respectively
(Nonet and Young, 1989). Note that the SRB I/KEX2 protease gene is
unrelated to all the other SRB designates and was found as a suppressor of
rpbl-1, a tight RNA polymerase II ts mutant different from the CTD
truncation mutants (Nonet et al., 1987; Martin and Young, 1989). srb3-1 was
found to be a weak recessive suppressor and was not characterized further.
The dominant suppressor SRB2-1 was isolated (Nonet and Young, 1989) and
sequenced (Koleske et al., 1992). A larger genetic selection for suppressors
yielded the isolates from which all other Srb genes were cloned (Thompson et
al., 1993): the dominant suppressor genes SRB4, SRB5 and SRB6 first
(Thompson et al., 1993),the recessive suppressor genes SRB7 (Hengartner et
al., 1995), SRB8 (Hengartner et al., 1995), SRB9 (Hengartner et al., 1995), SRB1O
(Liao et al., 1995), and SRB11 (Liao et al., 1995) later. Mutant alleles of RPB2,
the second largest subunit of core RNA polymerase II, were also isolated as
recessive suppressors of CTD truncation mutants (Hengartner et al., 1995).
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This demonstrated that this genetic selection could find factors physically
linked to Rpbl. All 9 SRB genes encoded for novel proteins and, with the
exception of SRB1O and SRB11 , showed no homology to previously
characterized proteins.
Genetic analysis. SRB deletion analysis showed SRB4, SRB6 and SRB7
to be essential genes, with all other SRBs showing cold sensitive (cs) and
temperature sensitive (ts) phenotypes (Nonet and Young, 1989; Thompson et
al., 1993; Hengartner et al., 1995; Liao et al., 1995). These phenotypes are
characteristic of CTD truncation, and srb2A even caused inositol auxotrophy
(Nonet and Young, 1989). The deletions of SRB8, SRB9, SRB1O or SRB11 were
also shown to suppress some of the CTD defects such as the inability to use
pyruvate as sole carbon source, arguing that the recessive suppressor alleles
were indeed loss-of-function mutants (Hengartner et al., 1995; Liao et al.,
1995). Further genetic characterization of the SRBs clearly showed that they
were functionally interacting with the RNA polymerase II CTD.
First, the original suppressor alleles of all nine SRB genes suppressed
only the conditional growth defects associated with CTD truncation mutants.
Similar conditional phenotypes by six or seven other RPB1 mutations
unrelated to the CTD, were not rescued (Nonet and Young, 1989; Thompson
et al., 1993; Hengartner et al., 1995; Liao et al., 1995). One exception of
unknown significance was noted: the cs phenotype of rpbl-14 could be
suppressed by the dominant suppressor alleles (SRB2-1, SRB4-1, SRB5-1 and
SRB6-1) (Nonet and Young, 1989; Thompson et al., 1993).
Second, the genetic interaction of the CTD with SRB2 (Koleske et al.,
1992)and SRB1O (Hengartner et al., 1998) alleles came to examplify how
dominant and recessive suppressors were indeed acting positively and
negatively on transcription in vivo. Yeast cells containing a spectrum of
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different length of CTD truncation mutants, and a mutant or wild type SRB
allele were assayed for growth. It was shown that the dominant SRB2-1 allele
restored full viability to conditionally growing cells and even allowed cells
with only 9 heptapeptide repeats to grow conditionally. On the other hand, a
SRB2A allele acted to render most CTD truncations lethals, and even full
length CTD remained only conditionally viable. This is consistent with SRB2
encoding a positive transcription factor and the dominant suppressor being a
gain-of-function mutant. In sharp contrast, recessive srblO-1 and srb10A
alleles had the same effect as SRB2-1. That is, they all rescued conditionally
viable cells and both allowed conditional growth of cells with only 9
heptapeptide repeat CTD. Thus, the loss of SRB10 function mimicks the loss
of a repressor protein.
Third, the SRBs were also linked to the CTD using a different genetic
approach. In vivo, substitution of the second heptapeptide Ser
(Y1S2P3T4S5P6S7) for Ala or Glu, was lethal when enough repeats where
altered (Yuryev and Corden, 1996). SRB9 loss-of-function mutations as well
as the dominant SRB alleles tested (SRB2-1, SRB4-1, SRB5-1, SRB6-1)
suppressed these mutants.
Yeast RNA polymerase II holoenzyme discovery.
The attempt to purify the dominant Srb2, Srb4, Srb5 and Srb6 proteins by
conventional chromatography led to the discovery of the RNA polymerase II
holoenzyme (Thompson et al., 1993; Koleske and Young, 1994), a large protein
complex containing a subset of the GTFs, core RNA polymerase II, the
dominant Srb proteins and other regulatory proteins (Koleske and Young,
1994; Kim et al., 1994). The other Srb proteins were later found to be
holoenzyme components as well (Liao et al., 1995; Hengartner et al., 1995).
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Incubating the holoenzyme with anti-CTD antibodies could break apart the
holoenzyme into core RNA polymerase II, general transcription factors and a
CTD-associated subcomplex (Kim et al., 1994; Hengartner et al., 1995). This
CTD-associated subcomplex, called the Srb/mediator complex, was found to
contain the Srb and other holoenzyme-associated regulatory proteins (Kim et
al., 1994; Hengartner et al., 1995).
When supplemented with the missing GTFs, the RNA polymerase II
holoenzyme was able to initiate transcription and respond to an activator in
vitro (Koleske and Young, 1994; Kim et al., 1994). This response to activator
could also be reproduced by adding the Srb/mediator complex to the purified
GTFs and core RNA polymerase II (Kim et al., 1994). The transcriptional
activation witnessed was remarkable because, as opposed to crude yeast
extracts, transcription reconstituted with purified yeast GTFs and core RNA
polymerase II had been found to be unresponsive to activators (Sayre et al.,
1992; Sayre and Kornberg, 1993; Flanagan et al., 1991). Furthermore, neither
TFIIA nor TAFjjs were required as coactivators. Analysis of temperature-
sensitive mutants of two of the Srb components, Srb4 and Srb6, demonstrated
that they were globally required for transcription in yeast cells (Thompson
and Young, 1995). Since these Srb proteins had been found to be tightly and
exclusively associated with the RNA polymerase II holoenzyme, it was
argued that this is likely to be the form of RNA polymerase II recruited to
promoters in vivo.
Heterogeneity in holoenzyme subunit composition.
A protein is considered to be a holoenzyme subunit, if it is found present in
stoichiometric amounts in highly pure holoenzyme preparations (Koleske
and Young, 1994). This is usually determined by quantitative Western
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blotting of purified RNA polymerase II holoenzyme alongside recombinant
protein standards. The amount of query protein found is compared to the
amounts of a known holoenzyme subunit such as Srb5 or Rpbl (Koleske and
Young, 1994; Rubin et al., 1996; Gadbois et al., 1997). In one case, the
erroneous report of Sugi as a holoenzyme component was corrected through
the application of this stringent standard (Rubin et al., 1996).
Even when this standard is applied, the exact polypeptide composition
of yeast and especially mammalian RNA polymerase II holoenzymes is found
to vary from study to study. This is a direct consequence of the inherent
difficulties in purifying intact megadalton-sized complexes (Parvin and
Young, 1998). In yeast, these variations can be traced to a small number of
possible causes (strain background, growth conditions, extract and purification
procedures) combined with a relative holoenzyme instability. From the very
start, quite different yeast strains have been used as holoenzyme sources: the
protease-deficient BJ926 Saccharomyces cerevisiae laboratory strain S288C
derived), (used in Koleske and Young, 1994; Hengartner et al., 1995; Li et al.,
1996) ; (Koleske et al., 1996; Wilson et al., 1996); the closely related laboratory
strains (S288C derived) for studying mutant holoenzymes (used in Liao et al.,
1995; Li et al., 1995; Koleske et al., 1996; Hengartner et al., 1998; Myers et al.,
1999); and finally the less defined commercial yeast (Fleischmann or Red Star
brand) (used in Kim et al., 1994; Hengartner et al., 1995; Koleske et al., 1996;
Myers et al., 1998). As a rule of thumb, all Srb/mediator complex preparations
(Kim et al., 1994; Hengartner et al., 1995; Myers et al., 1998) originate from
commercial yeast, while all RNA polymerase II holoenzyme preparations,
with a few exceptions described in Kim et al., 1994; Li et al., 1995; Koleske et
al., 1996; Wilson et al., 1996; Myers et al., 1999), originate from S288C derived
strains. The second difference is growth condition and time of cell collection:
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laboratory strains have been grown under aerobic conditions in rich (YPD) or
minimal (YNB) media (Sherman, 1991) and collected at mid-log or late
logarythmic growth phase while commercial baking yeast strains are grown
in fermentors and collected when cell density nears saturation. The point on
the growth curve at which cells are harvested is known to dramatically affect
the composition of at least two holoenzyme subcomplexes: the Rpb4/Rpb7
core RNA polymerase II subcomplex is only found as a stoichiometric subunit
near stationary phase (Choder and Young, 1993) while the amount of the
catalytic component of the Srb1O CDK subcomplex is found to decrease several
fold upon diauxic shift (Hengartner et al., 1998). The extract preparation and
chromatographic purification are also likely to cause partial fragmentation of
a larger RNA polymerase II holoenzyme into different isoforms lacking one
or more subcomplexes. Indeed, the differences between the smallest (Li et al.,
1996) and largest (Koleske and Young, 1994) yeast holoenzyme preparations
described, involve a discrete and small number of genuine subcomplexes.
Furthermore, a holoenzyme that seems to be an intermediate between these
two forms has also been reported (Koleske et al., 1996). Importantly, no single
purification attempt has ever resulted in the purification of two different
holoenzyme preparations from the same cells. The existence of a radically
different form of yeast RNA polymerase II holoenzyme, devoid of Srb
proteins, has also been postulated but not demonstrated (Shi et al., 1997). The
physiological importance of this so-called holoenzyme is questionable, since
in vivo disruptions of the function of two purported components, Pafi and
Cdc73, showed little if any effect on gene transcription (Shi et al., 1996; Shi et
al., 1997).
Despite all the differences in purification procedures, the yeast RNA
polymerase II holoenzymes described show discrepancies in subunit
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composition limited to TFIIH, TFIIB, Srb1O CDK subcomplex and Swi-Snf
subcomplex. In this review, it will be assumed that the more complex RNA
polymerase II holoenzyme is closer to the physiological form of holoenzyme.
The combination of yeast genetic and biochemical criteria is of great help in
deducing the nature of the holoenzyme components, and seems to support
this assumption. Thus, the regulatory proteins found in the RNA
polymerase II holoenzyme can be divided into three subcomplexes, the
multifunctional core SRB-mediator complex, and the less tightly associated
Srb1O CDK and Swi-Snf chromatin-remodeling subcomplexes.
The core SRB-mediator complex
In vitro transcription reactions reconstituted with highly pure core RNA
polymerase II and GTFs are not responsive to activators (Sayre et al., 1992;
Sayre and Kornberg, 1993). This formed the basis for the purification of
factors that could act as a "mediator of activation" (Flanagan et al., 1991). It
was recognized that the CTD-associated subcomplex of regulatory proteins
associated with the RNA polymerase II holoenzyme was just such a mediator
(Kim et al., 1994; Hengartner et al., 1995). By far the largest of all holoenzyme
subcomplexes, it has now been fractionated to high purity from commercial
yeast using only conventional chromatography and thus bypassing the need
for a CTD affinity column step (Myers et al., 1998). This yields a simpler
"core" Srb/mediator complex composed of around 20 polypeptides: Srb2, Srb4,
Srb5, Srb6, Srb7, Medi, Med2, Med4, Med6, Med7, Med8, Med1l, Cse2, Gaull,
Pgdl, Rgrl, Rox3, Sin4, Nut2.
In addition to supporting activated transcription in vitro, the
Srb/mediator complex stimulates basal transcription and CTD
phosphorylation by TFIIH in vitro (Kim et al., 1994). As predicted by the SRB
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genetic analysis, all three in vitro effects required the RNA polymerase II CTD
(Myers et al., 1998). The Srb/mediator complex was found to bind tightly and
specifically to recombinant CTD (Myers et al., 1998). The stimulation of basal
transcription is probably a direct consequence of the stable association of GTFs
in a RNA polymerase II holoenzyme. This stable GTF association is also
supported by a role for Srb proteins in holoenzyme stability (Farrell et al.,
1996). Analysis of DNA-bound and free forms of RNA polymerase II in crude
cell extracts suggests that the Srb/mediator complex is not associated with
elongating RNA polymerase II, but rather, is limited to the initiating form of
RNA polymerase II (Svejstrup et al., 1997). On the basis of their genetic and
biochemical properties, the Srb/mediator complex factors can be classified
into a minimum of 4 functional categories: Dominant Srbs subcomplex, Srb7,
Med proteins, and Cse2, Galil, Pgdl, Rgrl, Rox3, Sin4, Nut2.
Dominant Srbs subcomplex (Srb2, Srb4, Srb5, Srb6, Med6 and Rox3
subcomplex). The dominant group of SRB genes code for Srb2, Srb4, Srb5 and
Srb6. As suppressors of RNA polymerase II CTD truncation mutants, they are
functionally linked to the CTD. While CTD truncation does not seem to alter
core RNA polymerase II stability (Nonet et al., 1987), it reduces the ability of
the holoenzyme to respond to activators (Allison and Ingles, 1989; Scafe et al.,
1990; Liao et al., 1991). The SRB gain-of-function mutations compensate for
CTD truncation by affecting the ability of activators to interact with the
holoenzyme, such as with SRB4-1 (Koh et al., 1998), or by stabilizing the
holoenzyme, such as SRB2-1 (Farrell et al., 1996).
The holoenzyme stabilizing role of Srb2 is also consistent with in vitro
assays showing that Srb2 and Srb5 were required for transcription and
assembly of a stable PIC in nuclear extracts (Koleske et al., 1992; Thompson et
al., 1993). Srb2 and Srb5 are likely to be both involved in the same
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holoenzyme stabilization function as they are biochemically and genetically
similar. A strain deleted for SRB5 shows severely reduced levels of Srb2, and
the rescue of the in vitro defects of a srb5A nuclear extract requires addition of
both Srb2 and Srb5 proteins (Thompson et al., 1993). Both proteins are
encoded by non-essential genes whose deletions have nearly identical
phenotypes (Koleske et al., 1992; Thompson et al., 1993).
Biochemical and genetic assays convincingly show that Srb4 is the
direct physiological target of the Gal4 activator (Koh et al., 1998). This
activator interacting role of Srb4 is likely to be shared by Srb6 as well, since
they are both encoded by essential genes that affect transcription of virtually
all protein-coding genes in vivo (Thompson et al., 1993; Thompson and
Young, 1995; Holstege et al., 1998). A temperature-sensitive SRB4 mutant that
produced a rapid and general shutdown of mRNA synthesis (Thompson and
Young, 1995; Holstege et al., 1998), could be suppressed by a dominant (gain-
of-function) mutation in SRB6 orMED6 (Lee et al., 1998). Conversely, a
med6-ts mutation can be suppressed by a dominant allele of SRB4 (Lee and
Kim, 1998). In this case, suppression of the med6-ts growth defects is
correlated with a partial rescue of the transcriptional defects in vivo (Lee and
Kim, 1998). All these genetic suppression interactions have been shown to
occur in an allele specific fashion, strongly suggesting that direct physical
contacts link Srb4 to Srb6 and Med6.
Med6 has been shown to contribute to the mediation of activation
function of the Srb/mediator subcomplex. It is found required for the full
induction of a subset of genes in vivo (Lee et al., 1997), and a genome-wide
analysis of genes requiring Med6 function showed that it plays an essential
role in at least 10% of all yeast promoters (Holstege et al., 1998). Furthermore,
in vitro trancription experiments with RNA polymerase II holoenzymes
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impaired for Med6 function showed that Med6 was required for activated
transcription by the VP16 acidic activator, a requirement limited to the
initiation of transcription step (Lee et al., 1997).
As predicted, recombinant Srb2, Srb4, Srb5, Srb6 and Med6 can form a
stable complex in vitro, where Srb2 associates with Srb5, and Srb4 associates
with Srb6 and Med6 (Koh et al., 1998; Lee et al., 1998). A bridging interaction
between Srb2 and Srb4 brings them together in a single complex. A purified
yeast Srb/mediator subcomplex can also be disrupted into two small stable
subcomplexes after denaturing urea treatment (Lee and Kim, 1998). The first
subcomplex has been reported to contain Srb2, Srb4, Srb5, Srb6 Med6 and
Rox3. The other was reported to contain Srb7, Medi, Med4, Med7, Med8,
Med9, Galil, Pgdl, Rgrl and Sin4. While no mammalian homologs of
dominant Srbs have been found yet, Med6 homologs have been described in
humans and C. elegans (Lee and Kim, 1998) ;(Sun et al., 1998).
Srb7. Srb7 has characteristics that straddle those of both dominant and
recessive Srb proteins. The gene for Srb7 was first isolated as a recessive
suppressor of CTD truncation, yet like SRB4 and SRB6, it is essential for
viability (Hengartner et al., 1995). Unlike the other recessive Srbs (Srb8, Srb9,
Srb1O and Srb11), it is tightly associated with the core Srb/mediator complex
(Myers et al., 1998). A possible explanation for these phenotypes is that Srb7 is
a Srb4- and Srb6-like protein that anchors the recessive Srb subcomplex (SrblO
CDK subcomplex). A mutation impairing the interaction with the Srb1O CDK
subcomplex would appear as a recessive suppressor, while the other functions
of Srb7 would be more akin to Srb4 and Srb6. This predicts that conditional
mutants in Srb7 will show that it is generally required for transcription in
vivo. The human homolog of SRB7 has been cloned and shown to function
in yeast when in the form of a human-yeast chimera (Chao et al., 1996).
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Med proteins. The Med proteins represent the set of polypeptides
found in the core Srb/mediator subcomplex that had not previously been
identified through genetic analysis: Medi, Med2, Med4, Med6, Med7, Med8,
Med11 (Myers et al., 1998; Gustafsson et al., 1998). Med4 and Med5 turned out
to be a single protein migrating as a doublet (Myers et al., 1998) and the
corresponding gene has been named MED4. Med3, Med9 and MedlO were
found to be encoded by PGD1, CSE2 and NUT2, respectively, and will be
discussed in the next section (Myers et al., 1998; Gustafsson et al., 1998).
Aside from Med2 and Med6, the function of most Med proteins is still
unknown. A mouse and human homolog of MED7 have been described
recently (Jiang et al., 1998; Myers et al., 1998).
Genetics of CSE2, GAL11, PGD1, RGR1, ROX3, SIN4 and NUT2. With
the exception of CSE2 and PGD1, the genes in this category were identified in
a variety of genetic selections and screens as a result of their positive or
negative influence on the transcription of genes of interest (CYC7, HO, IMEI,
GALU, GALIO, SUC2, etc.) (reviewed in Carlson, 1997; Tabtiang and
Herskowitz, 1998; Piruat et al., 1997). Depending on the promoter studied,
many of these genes show signs of positive or negative regulation. The
elucidation of each protein's role is complicated by the fact that the bulk of
our knowledge about them derives from genetic observations. It is hard to
determine whether these factors truly possess both positive and negative
functions in the trancription of different genes, or whether the various effects
observed are the indirect consequence of a simpler function. This apparent
dual role in transcription in vivo has also been seen for some Med proteins.
Yeast whole genome analysis of transcription in a med2A strain has also
failed to clarify its role in vivo: of the 6000 genes analyzed, approximately 200
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increased two-fold or more while a similar number decreased two-fold or
more (Myers et al., 1999).
Galil, Pgdl, Rgrl, Sin4 and Med2 subcomplex. A careful analysis of
phenotype similarities and genetic suppression analysises suggest a functional
link between Gal1l, Pgdl, Rgrl and Sin4 (discussed in Li et al., 1995; Carlson,
1997; Piruat et al., 1997). A direct physical interaction between Gall, Pgdl,
Rgrl, Sin4 and Med2 has been inferred from the biochemical analysis of RNA
polymerase II holoenzymes purified from strains deleted for MED2, PGD1 and
SIN4 or partially deleted for RGR1 (Li et al., 1995; Myers et al., 1999). The first
analysis to be conducted concerned the subunit composition of these purified
holoenzymes (Li et al., 1995; Myers et al., 1999). From the pattern of the
subunits missing after the deletion of a given gene, one can model an ordered
arrangement of subunits that tether each other to the RNA polymerase II
holoenzyme complex. This modeling predicts a Med2/Pgd1 subcomplex and
Gal bound to Sin4, and Sin4 in turn anchored to RNA polymerase II
holoenzyme by Rgrl. To attribute a function to these proteins, these same
holoenzymes were assayed in vitro for basal transcription, activated
transcription by VP16 and Gcn4, and TFIIH CTD phosphorylation.
Stimulation of basal transcription and TFIIH-dependent CTD
phosphorylation was relatively constant, while activated transcription by
VP16 required the Med2/Pgdl (/Galll ?) subcomplex and GCN4 activation
required Sin4 (/Galll ?).
Cse2, Nuti and Nut2. Protein sequencing of polypeptides found in the
purified Srb/mediator complex, recently identified Cse2 and Nut2 as
holoenzyme subunits (Gustafsson et al., 1998). CSE2 deletion causes
pleiotropic defects, and the gene was originally isolated for its role in
chromosome segregation (Xiao et al., 1993). NUT2 was isolated in a selection
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for factors responsible for the transcription inhibition of the HO gene by URS2
(Tabtiang and Herskowitz, 1998). This same screen also found inhibitory
holoenzyme components (SIN4, ROX3, SRB8, SRB9, SRB1O and SRB11), a
negative TBP-associated factor (CCR4) and a novel factor (NUTI).
Microsequencing of polypeptides around the expected size of Nuti yielded
matching peptide sequences (Gustafsson et al., 1998). Combined with the
genetic similarity to Nut2, this data makes a strong case for Nuti being a
Srb/mediator complex subunit. However, the stoichiometry and stable
association of Nuti within RNA polymerase II holoenzyme remain to be
shown. Mouse and C. elegans homologs of RGR1 (Jiang et al., 1998), as well as
human and C. elegans homologs of NUT2 (Tabtiang and Herskowitz, 1998;
Gustafsson et al., 1998) have been reported.
SrblO CDK subcomplex.
The recessive SRB genes (SRB8, SRB9, SRB10 and SRB11) behave in a
manner opposite to the dominant SRB genes (SRB2, SRB4, SRB5 and SRB6),
suggesting they encode negative transcription factors (Koleske et al., 1992;
Hengartner et al., 1998). Loss of function in these genes suppresses CTD
truncation mutations, suggesting that they negatively affect the stability or the
activity of the RNA polymerase II holoenzyme (Hengartner et al., 1995; Liao
et al., 1995). Indeed, a large number of genetic screens and selections have
found that SRB8, SRB9, SRB1O and SRB11 were all required for complete
repression of transcription at a variety of genes, consistent with their role as
inhibitors of transcription ( (Kuchin et al., 1995; Song et al., 1996; Balciunas
and Ronne, 1995; Hengartner et al., 1995; Liao et al., 1995; Wahi and Johnson,
1995; Tabtiang and Herskowitz, 1998; Cooper et al., 1997); reviewed in Carlson,
1997). In all of these genetic tests, all four genes behave the same.
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Furthermore, cells mutated for any of these four SRBs share the same
pleiotropic phenotypes of flocculence, cold sensitivity and temperature
sensitivity (Hengartner et al., 1995; Liao et al., 1995).
These genetic data make a strong case for a common function for these
gene products. A direct biochemical evidence for a Srb8-Srb9-SrblO-Srb1l
subcomplex is lacking and reconstitution assays with recombinant proteins
have failed to get a complex larger than the Srb10/Srb11 heterodimer
(Hengartner et al., 1998); S.S. Koh and R.A. Young, unpublished
observations). On the other hand, the yeast RNA polymerase II holoenzymes
described, either contain all four or lack all four of these Srb proteins,
suggesting that the tight genetic association is also indicative of their tight
physical association (Kim et al., 1994; Myers et al., 1998; Koleske and Young,
1994; Liao et al., 1995; Hengartner et al., 1995). RNA polymerase II
holoenzyme purified from a srb8A strain is also shown to lack Srb10 and
Srb11 (Myer and Young, 1998).
Srb10/Srb11: a cyclin-dependent kinase pair. Sequencing of SRB10 and
SRB11 revealed that they were homologous to cyclin-dependent kinase (CDK)
and cyclin C genes, respectively. As opposed to cyclins involved in cell cycle
control and progression, Srb11 mRNA and protein levels do not vary with
the cell cycle (Cooper et al., 1997). Instead Srb11 protein levels have been
found to decrease at the onset of meosis and possibly, after heat shock. Srb10
protein levels can also be found to vary, depending on the yeast cell growth
state (Hengartner et al., 1998). No cell cycle arrest phenotypes have been
found in SRB10 or SRB11 mutants. In this respect, Srb10 and Srb11 are
similar to Kin28 CDK and Ccli cyclin, a yeast CDK-cyclin pair found in TFIIH
that appears also to function exclusively in transcription. In higher
eukaryotes, Cdk8 and cyclin C share sequence and functional homology with
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Srb1O and Srbll, respectively. Furthermore, Cdk8-cyclin C are almost always
found in purified preparations of mammalian holoenzymes (reviewed in
Parvin and Young, 1998). Both Srb1O and Kin28 kinases possess the ability to
phosphorylate the CTD of RNA polymerase II in vitro (Feaver et al., 1994;
Liao et al., 1995; Hengartner et al., 1995).
A negative function for Srb1O kinase in vivo. A point mutation in a
highly conserved catalytic domain of Srb10, can abolish the proteins' kinase
activity (Liao et al., 1995; Hengartner et al., 1995). This mutant allele (srblO-3)
can suppress the in vivo defects associated with CTD truncation mutants as
well as a deletion (srblOA) or a recessive suppressor allele (srbl0-1)
(Hengartner et al., 1998). Cells with srblO-3 show similar, if not more severe,
pleiotropic phenotypes to those found in cells deleted for SRB8, SRB9, SRB10
or SRB1I (Liao et al., 1995); Liao et al., unpublished observation). The SrblO-3
mutant protein is still incorporated in the RNA polymerase II holoenzyme in
vivo, since holoenzymes purified from SRB10 and srblO-3 strains contain
similar anounts of Srb1O and other proteins (Liao et al., 1995; Hengartner et
al., 1998). This suggests that the non-kinase functions of SrblO, if any, remain
unperturbed in the Srb1O-3 mutant. It follows then, that the inhibitory effect
of SRB1O on transcription in vivo must be due to its' kinase activity. Taking
this logic further, this also implies that Srb8, Srb9 and Srb11 function either as
direct kinase substrates or as positive contributors to Srb1O's kinase activity.
CTD phosphorylation and transcription. The RNA polymerase II CTD,
consisting of multiple repeats of the heptapeptide YSPTSPS, contains an
uncommonly high density of potential phosphorylation sites ( reviewed in
Dahmus, 1995; Dahmus, 1996). In vitro transcription experiments have led to
the hypothesis that the CTD is reversibly phosphorylated with each
transcription cycle: RNA polymerase II with hypophosphorylated CTD
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assembles into preinitiation complexes and, as RNA polymerase II shifts to
productive mRNA elongation, the CTD becomes hyperphosphorylated.
Consistent with its role in transcription initiation, yeast RNA
polymerase holoenzymes contains the unphosphorylated form of CTD
(Koleske and Young, 1994; Kim et al., 1994). When reconstituted with
purified GTFs, core RNA polymerase II with the unphosphorylated form of
CTD preferentially assembles into a PIC (Laybourn and Dahmus, 1990; Lu et
al., 1991; Chesnut et al., 1992; Usheva et al., 1992; Kang et al., 1993; Maxon et
al., 1994). Since the phosphorylated CTD has a role in recruiting the mRNA
capping enzyme to the nascent transcript, and mRNA capping occurs soon
after promoter clearance (Coppola et al., 1983; Cho et al., 1997; McCracken et
al., 1997a; McCracken et al., 1997b; Yue et al., 1997), CTD phosphorylation most
likely occurs during the transition from transcription initiation to elongation.
Pol II molecules in the midst of elongation contain CTDs which are highly
phosphorylated (Bartholomew et al., 1986; Cadena and Dahmus, 1987; Weeks
et al., 1993; O'Brien et al., 1994). The CTD has also been found to be required
for 3' mRNA processing in vitro (Hirose and Manley, 1998).
The TFIIH kinase is apparently responsible for CTD phosphorylation
subsequent to PIC formation (Laybourn and Dahmus, 1990; Ohkuma and
Roeder, 1994; Akoulitchev et al., 1995; reviewed in Dahmus, 1996). Loss-of-
function mutations in the yeast TFIIH kinase subunit also cause a general
defect on class II transcription in vivo (Cismowski et al., 1995; Valay et al.,
1995; (Holstege et al., 1998), confirming the positive role in transcription
inferred from in vitro studies.
A role for CTD phosphorylation in transcription elongation is
reinforced by evidence that the HIV-1 transcriptional activator Tat, enhances
transcription elongation by interacting with two CTD kinases, TFIIH and P-
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TEFb, to stimulate or direct CTD phosphorylation (reviewed in Jones, 1997;
Yankulov and Bentley, 1998). P-TEFb (positive transcription elongation factor
b), first identified as a Drosophila factor that could stimulate transcription
elongation in vitro (Marshall and Price, 1992), contains a CDK/cyclin pair,
named Cdk9 and cyclin T (Zhu et al., 1997; Peng et al., 1998). Human cyclin T
has been shown to directly interact with the Tat activator (Wei et al., 1998) in
species-specific manner (Gerber et al., 1998). HumanTFIIH has also been
reported to bind the activation domain of Tat, although the reports differ on
which subunits make contact (Parada and Roeder, 1996; Cujec et al., 1997;
Garcia-Martinez et al., 1997). Tat stimulates the CTD phosphorylation activity
of TFIIH. Both TFIIH and P-TEFb CTD kinases seem to be required for the
Tat-dependent activation in vitro (Parada and Roeder, 1996; Cujec et al., 1997;
Garcia-Martinez et al., 1997; Mancebo et al., 1997; Zhu et al., 1997). Whether
the two kinases act sequentially or simultaneously to phosphorylate the CTD
is unknown.
A large number of kinases have been found to be able to
phosphorylate the CTD in vitro (reviewed in Trigon et al., 1998). However of
all these kinases, only the TFIIH subunit Kin28, and Srb1O have been found
closely associated or complexed with the yeast transcription initiation
machinery (Feaver et al., 1994; Liao et al., 1995). Another yeast CDK, Ctkl,
associates with a cyclin, Ctk2, and is also able to phosphorylate the CTD in
vitro (Sterner et al., 1995). While, to date, there is no evidence that Ctk1 and
Ctk2 play any role in transcription, they have been suggested as possible yeast
homologs of Cdk9 and cyclin T.
Recombinant Srb1O /Srbll, and recombinant Kin28/Ccll can form a
CDK/cyclin pair that is able to specifically phosphorylate the serines in the
heptapeptide repeats found in the CTD (Hengartner et al., 1998). Both
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CDK/cyclin pairs preferentially phosphorylate the same residues, possessing
virtually indistinguishable CTD kinase activities (Hengartner et al., 1998).
This is rather surprising, because these two kinases seem to have opposite
function in vivo, yet phosphorylate the CTD the same way.
A negative function for Srb1O kinase in vitro. The function of the
Srb1O kinase can be assayed in vitro by purifying yeast RNA polymerase II
holoenzyme from wild-type and srblO-3 cells. An SrblO-3 holoenzyme is
severely deficient for CTD phosphorylation (Liao et al., 1995). The SrblO-
dependent CTD phosphorylation shows that the CTD can be efficiently and
extensively phosphorylated by Srb1O in the holoenzyme context. In vitro
transcription assays showed that the Srb1O kinase played an inhibitory role in
transcription (Hengartner et al., 1998). As opposed to the TFIIH kinase
(Kin28), Srb1O is uniquely capable of phosphorylating the CTD prior to
template binding to inhibit holoenzyme transcription. CTD phosphorylation
was accompanied by an inhibition of transcription. If the phosphorylation of
holoenzyme CTD by Srb1O is left to ocur after PIC formation, transcription is
unaffected. This suggests that the RNA polymerase II holoenzyme can be
regulated positively and negatively, with the appropriate timing of CTD
phosphorylation. In this model, Srb1O/Srb11 CTD kinase activity occurs
before competent PIC formation to inhibit transcription activity or PIC
assembly, while Kin28/Ccl1 CTD kinase activity occurs after stable PIC
formation to establish the elongating form of polymerase (Hengartner et al.,
1998).
Swi-Snf subcomplex
The convergence of two yeast genetic screens led to the discovery of the
Swi-Snf complex: SWI genes were isolated thanks to a screen for mating type
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switching defects (Stern et al., 1984), whereas SNF genes where identified
through a screen for defects in sucrose utilization (Neigeborn and Carlson,
1984). The SWI/SNF genes were genetically found to be acting opposite to the
SPT/SIN genes, previously found to encode either histone or chromatin
related factors. (Winston and Carlson, 1992). This lead to a model wherein
the Spt-Sin factors repressed transcription by promoting a transcriptionally
inactive form of chromatin, while the Swi-Snf factors would function to help
transcription overcome chromatin-mediated repression (Winston and
Carlson, 1992; Peterson and Tamkun, 1995). A Swi-Snf complex has been
purified from yeast and found to consist of 11 subunits (Cairns et al., 1994;
Cote et al., 1994; Treich et al., 1995). The complex exhibited a DNA-dependent
ATPase activity that could result in nucleosome destabilization, an activity
catalyzed by the Swi2/Snf2 subunit.(Cote et al., 1994). The Swi-Snf complex
has been found to be an accessory subcomplex of the RNA polymerase II
holoenzyme (Wilson et al., 1996). This is thought to allow direct targeting of
nucleosome disruption activity to the appropriate promoter regions,
facilitating PIC assembly.
A Human SWI/SNF-like complex has been isolated and shown to
possess proteins homlogous to yeast Swi-Snf, as well as nucleosome
remodeling activity (Imbalzano et al., 1994; Kwon et al., 1994; Wang et al.,
1996; Wang et al., 1996).
RSC complex. A Swi-Snf related complex has been purified from yeast
and shown to possess chromatin remodeling activity as well (Cairns et al.,
1996). This 15 subunit complex, called RSC complex, shares common (Cairns
et al., 1998) and related (Cairns et al., 1996) subunits with the Swi-Snf complex.
So far, no role in transcription has been found for RSC, instead the complex is
favored to play a role in cell cycle progression (Du et al., 1998; Cao et al., 1997).
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Yeast holoenzyme component candidates.
In yeast and humans, Fcpl, a presumptive subunit of a CTD phosphatase
activity, was detected in partially purified preparations of RNA polymerase II
holoenzyme (Chambers and Kane, 1996; Archambault et al., 1997;
Archambault et al., 1998). Fcpl was shown to bind TFIIF but exhibited no CTD
phosphatase activity on its own.
A recent study has identified a novel yeast protein, Xtcl, that could
interact physically with the cell-cycle regulated mammalian transcriptional
activator E2F-1 (Emili et al., 1998). Yeast cells deleted for XTC1 exhibit
temperature sensitivity, galactose auxotrophy and a heightened activator
response to GAL4. While Xtcl can be detected in partially purified RNA
polymerase II holoenzyme, it has not yet been shown to be a stoichiometric
component of a highly purified holoenzyme fraction.
RNA polymerase II holoenzyme in higher eukaryotes
As mentioned earlier, the detailed make-up of human RNA polymerase II
holoenzymes in different reports varies greatly. Nonetheless, mammalian
RNA polymerase II holoenzyme and related subcomplexes have been
purified and consistently found to contain hSrb7 and hSrblO/hSrbll
(Cdk8/Cyclin C), in addition to GTFs (reviewed in Parvin and Young, 1998)
Subcomplexes of RNA polymerase II holoenzyme, reminiscent of
those found in yeast, have also been described (Sun et al., 1998; Jiang et al.,
1998). A purified mouse "Srb/mediator" complex, containing mMed7,
mMed6, mRgrl, mRing-3 (nuclear kinase), mTrf-proximal and a dozen more
13 polypeptides, has been shown to bind to the RNA polymerase II CTD and
stimulate CTD phosphorylation (Jiang et al., 1998). However, no stimulation
of activated transcription was reported. A human "SrblO CDK" subcomplex
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that repressed activated transcription in vitro was also purified and included
hRGR1, hSrb7, hMed6 and hSrb11 (Sun et al., 1998). This complex, called
NAT for negative regulator of activated transcription, was able to inhibit
activated transcription in a system reconstituted with RNA polymerase II and
GTFs. NAT could also interact directly with RNA polymerase II. NAT's
RNA polymerase II interaction and repression were independent of the CTD,
yet precluded by phosphorylated CTD. NAT could not inhibit transcription
after stable preinitiation complex formation. Because the study always
included ATP along with NAT in the transcription reactions, it is unknown if
this inhibitory activity required ATP.
Perspective.
Regardless of the technical difficulties associated with yeast RNA polymerase
II holoenzyme purification, it is clear that the task of identifying its
components has reached near completion. With all the initiation
components in hand, we are now in a better position to look at the
biochemical steps after initiation that lead to a fully elongated and processed
mRNA, and at how activators might regulate them. Some studies have
already also suggested that there are different RNA polymerase II
holoenzymes for different stages of transcription besides initiation (mRNA
elongation, mRNA capping, mRNA polyadenylation, mRNA splicing, etc.).
It will be interesting to see how all these functions are coordinated. It is
increasingly clear that the holoenzyme has the capacity to integrate and
respond to intra- and extracellular signals leading to activation or repression
of gene expression. Since some holoenzyme components can be shown to
have an activity at just a subset of promoters, how is this gene-specificity
achieved ? Another relatively unexplored area is the biochemical analysis of
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the role of posttranslational modifications of RNA polymerase II holoenzyme
components in the coordinated control of gene expression. The use of
genome-wide analysis of gene expression to dissect how the different
regulatory pathways feed into the transcription initiation complex, should
also produce interesting results.
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Personal contributions to these projects
Genetic analysis and cloning of SRB genes. When I joined the
laboratory of Dr. Richard Young in 1991, Mike Nonet and Craig Thompson
had already identified a set of novel transcription factors through a selection
for genes involved in transcription initiation by RNA polymerase II in vivo:
Srb2, Srb4, Srb5 and Srb6 (Nonet and Young, 1989; Thompson et al., 1993).
This selection had yielded a large collection of suppressors of CTD truncation
mutation. I perfomed a genetic analysis on the remainder of these
suppressors to define five complementation groups among the recessive
suppressors, suggestive of the existence of at least five more SRB genes (SRB7,
SRB8, SRB9, SRB1O, and SRB11). While I proceeded to clone and characterize
two of these genes, SRB7 and SRB9, Sha-Mei Liao and Jiang-Hua Zhang
focused on the remaining three genes (Liao et al., 1995; Hengartner et al.,
1995).
Characterization of SRB proteins. In 1994, biochemical analysis of the
first SRB genes cloned by Tony Koleske and Craig Thompson led to the
discovery of the RNA polymerase II holoenzyme that consisted of RNA
polymerase II, a subset of general transcription factors and the Srb2, Srb4, Srb5
and Srb6 proteins (Thompson et al., 1993; Koleske and Young, 1994). Young-
Joon Kim from the lab of Roger Kornberg subsequently confirmed Tony
Koleske's holoenzyme finding, and showed that a subcomplex, named the
mediator of activation, could be dissociated from the holoenzyme (Kim et al.,
1994). This mediator contained Srb2, Srb4, Srb5 and Srb6. The clones of the
remainder of the SRB genes allowed us (Sha-Mei Liao, Jiang-Hua Zhang and
I) to purify recombinant protein and to produce antibodies. These antibodies
were then use to demonstrate that all nine Srb proteins found in our genetic
screen were found as components of the RNA polymerase II holoenzyme
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(Liao et al., 1995; Hengartner et al., 1995). I extended this finding further by
purifying the mediator of activation subcomplex according to (Kim et al.,
1994), and showing that all nine Srb proteins are present (Hengartner et al.,
1995).
Association of an activator with the RNA polymerase II holoenzyme.
Tony Koleske had shown that the RNA polymerase II holoenzyme was
capable of responding to a transcriptional activator (Koleske and Young, 1994),
suggesting a model in which activators function, in part, through direct
interactions with the holoenzyme. I validated this model by first showing a
biochemical interaction between the potent trans-activator VP16 and the
RNA polymerase II holoenzyme. I then proceeded to show a specific and
direct interaction of this activator with the mediator subcomplex. These
results provided the first evidence that this form of the transcription
apparatus may be recruited to promoters via direct interactions with
activators (Hengartner et al., 1995).
Temporal model of cyclin-dependent kinases (CDKs) in the RNA
polymerase II holoenzyme. Two cyclin-dependent kinases (CDK) had been
identified in yeast and mammalian RNA polymerase II transcription
initiation complexes: the yeast kinase Kin28, a subunit of the general
transcription factor TFIIH, and the yeast kinase SrblO, a subunit of the RNA
polymerase II holoenzyme. While characterizing SRB10, Sha-Mei Liao had
accumulated genetic evidence that this kinase was a negative regulator of
transcription in vivo while other investigators had provided evidence that
the kinase Kin28 was a positive regulator of transcription in vivo (Cismowski
et al., 1995; Valay et al., 1995). The CTD of RNA polymerase II has been
proposed to be a substrate of both kinases. In order to find the biochemical
basis for their different activities in vivo, I purified epitope-tagged
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recombinants of these two CDKs, with the help of Sang Seok Koh. My first
objective was to compare and contrast the kinase activity of Kin28 and SrblO: I
demonstrated that the two yeast kinases were biochemically indistinguishable
in their ability to phosphorylate the RNA polymerase II CTD. The paradox of
two CDKs with opposite in vivo function but similar kinase activity in vitro
was resolved with the help of Vic Myer. Vic Myer had set up a reconstituted
in vitro transcription assay using purified RNA polymerase II holoenzyme
and general transcription factors. We observed that the negative regulator,
Srb10, was uniquely capable of phosphorylating the CTD prior to formation of
the initiation complex on promoter DNA, with consequent inhibition of
transcription. In contrast, the TFIIH kinase phosphorylated the CTD only
after the transcription apparatus was associated with promoter DNA. These
results revealed that the timing of CTD phosphorylation was able to account
for the positive and negative functions of the two kinases and provided a
model for SrblO-dependent repression of genes involved in cell type
specificity, meiosis, and sugar utilization (Hengartner et al., 1998).
Genome-wide survey of genes regulated by transcriptional cyclin-
dependent kinases SRB1O and KIN28. In 1997, Frank Holstege and John
Wyrick embarked on an ambitious project to analyze the genome-wide of
requirements for key components of the general transcription factors for yeast
gene expression. Using technology that had only recently become available,
they compared the mRNA profile of strains that were impaired in the
function of components of the RNA polymerase II holoenzyme, the general
transcription factor TFIID, and the SAGA chromatin modification complex. I
helped analyze the results obtained with strains defective in Srb1O and Kin28.
The collection of genes affected by both CDKs not only buttressed the
conclusions of my earlier studies (Hengartner et al., 1998), but also provided
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new insights in SrblO function and regulation. I tested these new predictions
and found the following. Diminution of SrblOp levels correlated with the
loss of negative control of a coordinated set of genes during the diauxic shift.
Furthermore, Srb1O negatively regulates the yeast developmental pathway of
pseudohyphal growth, a new important function heretofore unknown.
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Chapter 2
Association of an activator with an RNA polymerase II holoenzyme
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Summary
RNA polymerase II holoenzymes have been described that consist of RNA
polymerase II, a subset of general transcription factors and four SRB proteins.
The SRB proteins, which were identified through a selection for genes
involved in transcription initiation by RNA polymerase II in vivo, are a
hallmark of the holoenzyme. We report here the isolation and
characterization of additional SRB genes. We show that the products of all
nine SRB genes identified thus far are components of the RNA polymerase II
holoenzyme and are associated with a holoenzyme subcomplex termed the
mediator of activation. The holoenzyme is capable of responding to a
transcriptional activator, suggesting a model in which activators function, in
part, through direct interactions with the holoenzyme. Indeed,
immunoprecipitation experiments with anti-Srb5 antibodies demonstrate
that the acidic activating domain of VP16 specifically binds to the
holoenzyme. Furthermore, the holoenzyme, and the mediator subcomplex,
bind to a VP16 affinity column. These results provide a more complete
description of the RNA polymerase II holoenzyme and suggest that this form
of the transcription apparatus can be recruited to promoters via direct
interactions with activators.
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Introduction
Large multisubunit complexes containing RNA polymerase II, a subset of the
general transcription factors, and additional factors implicated in regulation
of transcription initiation in vivo, can assemble independently of promoter
DNA (Koleske and Young, 1994; Kim et al., 1994). These complexes, termed
RNA polymerase II holoenzymes, have been purified from Saccharomyces
cerevisiae. The larger form of holoenzyme contains RNA polymerase II,
TFIIB, TFIIF, TFIIH, and SRB proteins (Koleske and Young, 1994). Another
form of holoenzyme has been described which contains RNA polymerase II,
TFIF, and SRB proteins but lacks TFIIB and TFIIH (Kim et al., 1994). The two
holoenzyme forms may exist simultaneously in vivo or the isolation of the
smaller complex may be a consequence of the instability of the RNA
polymerase II holoenzyme during purification.
Selective transcription initiation in vitro by the twelve subunit core
RNA polymerase II was previously shown to require the action of at least five
general initiation factors: TATA-binding protein (TBP), TFIIB, TFIIE, TFIIF,
and TFIIH (reviewed in Conaway and Conaway, 1993; Zawel and Reinberg,
1993). Consistent with these data, selective transcription initiation in vitro
with the larger form of RNA polymerase II holoenzyme required TBP and
TFIIE (Koleske and Young, 1994), and initiation with the smaller form
required TBP, TFIIB, TFIIE and TFIIH (Kim et al., 1994).
The holoenzymes were discovered by virtue of their association with
SRB proteins. SRB (Suppressor of RNA Polymerase B) genes were obtained
through a genetic selection designed to identify genes involved in RNA
polymerase II carboxy-terminal domain (CTD) function (Nonet and Young,
1989; Thompson et al., 1993). The CTD had been implicated in the response to
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various transcriptional regulatory signals (Allison and Ingles, 1989; Scafe et
al., 1990; Liao et al., 1991; Peterson et al., 1991), and the SRB alleles were
isolated by virtue of their ability to suppress the cold-sensitive phenotype of
cells containing CTD truncation mutations. Purification of the products of
the SRB2, SRB4, SRB5 and SRB6 genes led to the observation that the vast
majority of these SRB proteins in cell lysates are tightly associated with a
portion of the RNA polymerase II and general factor molecules (Thompson et
al., 1993; Koleske and Young, 1994). These results, and evidence that the SRB
proteins have essential roles in transcription in vivo, suggested that the
holoenzyme may be the form of RNA polymerase II that initiates
transcription at promoters in vivo. The results also suggested that the
isolation of more SRB genes might lead to the identification of additional
components of the holoenzyme, and we show here that this is indeed the
case.
The RNA polymerase II holoenzymes are responsive to activators
(Koleske and Young, 1994; Kim et al., 1994), a feature not observed with
purified RNA polymerase II and general transcription factors alone (Flanagan
et al., 1991; Flanagan et al., 1992). Thus, these holoenzymes contain
components necessary and sufficient for some level of response to
transcriptional activators. A subcomplex, called the mediator of activation,
can be dissociated from the RNA polymerase II holoenzyme by using
monoclonal anti-CTD antibodies (Kim et al., 1994). The purified mediator
contains SRB2, SRB4, SRB5, SRB6, SUG1, GAL11, TFIIF, and as yet
unidentified polypeptides, and is capable of reconstituting the ability of
purified RNA polymerase II and general factors to respond to transcriptional
activators. Genetic studies previously suggested that GAL11, SUG1 and the
SRB proteins are involved in transcriptional regulation (Suzuki et al., 1988;
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Fassler and Winston, 1989; Himmelfarb et al., 1990; Nishizawa et al., 1990;
Vallier and Carlson, 1991; Swaffield et al., 1992; Yu and Fassler, 1993).
The mechanisms involved in transcriptional activation are not yet
clear. Transcriptional activators generally contain separable DNA binding
and activation domains (Ptashne, 1988; Mitchell and Tjian, 1989). It is
believed that transcriptional activators function in part by binding to
promoter elements and to components of the transcription initiation
apparatus, thereby contributing to their stable binding to the promoter
(reviewed in Struhl, 1989; Ptashne and Gahn, 1990; Roeder, 1991; Drapkin et
al., 1993). Some of the most compelling evidence for interactions between
transcriptional activators and general factors comes from the analysis of
TFIID, where physical and functional interactions have been reconstituted
with recombinant TBP and TAFs (Dynlacht et al., 1991; Tanese et al., 1991; Gill
and Tjian, 1992; Goodrich et al., 1993; Hoey et al., 1993; Chen et al., 1994; Gill et
al., 1994; Jacq et al., 1994).
Transcriptional activators have been reported to interact with
additional general factors. For instance, the herpes simplex virus
transactivator VP16 (Triezenberg et al., 1988) has been shown to interact with
TFIIB (Lin et al., 1991; Goodrich et al., 1993) and TFIIH (Xiao et al., 1994). This
raises the possibility that some transcriptional activators can interact
simultaneously or sequentially with multiple components of the
transcription initiation apparatus. These results have generally been
interpreted in the context of a model in which each of the general
transcription factors and RNA polymerase II assemble onto the promoter in a
stepwise fashion (Buratowski et al., 1989; Flores et al., 1991; Conaway and
Conaway, 1993; Zawel and Reinberg, 1993; Buratowski, 1994).
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The identification of RNA polymerase II holoenzymes that contain a
subset of the general factors and are capable of responding to activators
suggests a different model for transcriptional activation. In this model,
transcriptional activator proteins first contribute to the establishment of a
promoter-bound TFIID complex. The activators then interact with the
holoenzyme to facilitate its association with the TFIID/promoter complex.
In this report, we describe the isolation and characterization of
additional SRB genes and show that the products of all nine SRB genes
identified thus far are components of the RNA polymerase II holoenzyme
and the mediator of activation subcomplex. We also show that the
transcriptional activator VP16 binds to the holoenzyme and the mediator
subcomplex in vitro, thus providing evidence consistent with the model that
transcriptional activators interact with the holoenzyme.
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Results
Extragenic suppressors of RNA polymerase II CTD truncation mutations
Extragenic suppressors of a S. cerevisiae RNA polymerase II CTD truncation
mutant were isolated to identify components of the transcription apparatus
involved in initiation. The cold-sensitive phenotype of rpblA104 cells
containing RNA polymerase II CTDs with 11 intact heptapeptide repeats was
used to obtain 75 independent suppressing isolates. Genetic analysis revealed
that mutations in a total of nine SRB genes suppress growth defects of cells
containing a truncated CTD (Table I). We previously described the isolation
and characterization of SRB2, SRB4, SRB5, SRB6, SRB1O and SRB11 (Koleske
et al., 1992; Thompson et al., 1993; Liao et al., 1995). Thorough genetic analysis
of the 75 independent suppressing isolates led to the identification of three
additional genes: SRB7, SRB8, and SRB9.
The suppressing alleles of SRB2, SRB4. SRB5, SRB6, SRB10 and SRB 171
were found to suppress the conditional phenotypes associated with the CTD
truncation mutation rpblAl04, but did not suppress similar conditional
phenotypes caused by other mutations in RPB1 (Koleske et al., 1992;
Thompson et al., 1993; Liao et al., 1995). Similarly, the mutations srb7-1,
srb8-1, and srb9-1 were also specific in suppressing conditional phenotypes
due to CTD truncation mutations (not shown). This specificity of suppression
suggests that the SRB gene products and the CTD are involved in the same
process in transcription initiation.
Genomic DNA clones containing SRB7, SRB8, and SRB9 were isolated
by genetic complementation. Sequence analysis revealed that SRB7, SRB8,
and SRB9 are all newly identified genes. The predicted SRB7 protein is 140
amino acids long and has a molecular mass of 16 kd (Figure 1). Physical
Table 1. SRB Gene Summary
Gene Dominant Recessive Deletion Chromosomal Protein mass SDS-PAGE mobility pi References*
alleles alleles viability location (kDa) (kDa)
SRB2 3 0 conditional Vill 23 27 5.2 1,2,3,4
SRB4 14 7 inviable V 78 98 5.1 3, 4
SRB5 7 0 conditional Vil 34 38 4.7 3, 4
SRB6 4 2 inviable II 14 15 4.6 3,4
SRB7 0 3 inviable IV 16 19 4.8 5
SRB8 0 4 conditional 1I1 144 160 5.7 5
SRB9 0 26 conditional IV 160 180 5.5 5
SRB10 0 4 conditional XVI 61 68 9.6 6
SRB1 1 0 1 conditional XIV 38 33 7.0 6
1) Nonet and Young 1989, 2) Koleske et al. 1992, 3) Thompson et al. 1993, 4) Koleske and Young 1994, 5) this publication,
6) Liao et al. 1995
AXhol Afill Hindill /Spel Sphl Hindil Aill EcoRV
0.5 kb
srb7Al::URA3hisG hisG URA3 Kan r hisG
0.5 kb
B
-648 TCGATGATGTTCTTTATTCTTTCAACCAGCTCGAGCCCCTGCAAACTTAAGCTAAGGACAGAAAATGAAAAAAAA
-573 AAAAAAAAAAAATTCAAAGAATCAGCTTATAAAACATATTCAAGGACCATCTGAAGTATCATTCATTCGTTTTTT
-498 ACTCGTTAATCTCATTCATTCGTTTCCTCATTCTTTTTTCTTTGTTCTTTATTTCGGCTATTTTTTCACTATTAA
-423 AATAACTAGAGCTAACAATATTATTTCTTCTGCTTTAGTTACAAAACAAGGACATTCATTTAACTTGGCGTTATC
-348 CCATACATTCGTTTATTATATCTTCTTTTAAAACACAATTTCTTTTACAGTTAAACTTTTCTGATTTATTATATA
-273 TTACTTAAGATTGTTCATATAACTAACATTTATATGCTTATATGCGTGAAGTGCGCTTTTGTAGAACATGTGGCT
-198 GTTTCTGTAGAAGCCTTGTCTTTCTCTGTAATCCTTTAAAGGCCAACCGTACGTGCTTAATTACAGCTTTGTTC
-123 GCATTGCAAGAAAGTTAGAAAAAAAATCAATTCTGAAAGATAATTATAATTCAAACGGTAAACCATTGGTTAAAA
-48 GAGGGACATAACATTTCACTAGTTCAATACATTATATGCTCTTTAACAATGACAGATAGATTAACACAATTGCAG
M T D R L T Q L Q
A(srb7-1)
28 ATATGTTTAGACCAAATGACGGAGCAATTCTGTGCTACTTTAAACTACATAGATAAGAACCATGGTTTTGAACGA
I C L D Q M T E Q F C A T L N Y I D K N H G. F E R
103 TTGACCGTAAATGAACCTCAGATGTCCGATAAGCATGCCACAGTAGTACCTCCTGAGGAATTTTCTAACACGATA
L T V N E P Q N S D K H A T V V P P E E F S N T I
178 GATGAGCTATCCACGGACATTATACTTAAAACAAGACAGATAAACAAGCTTATTGACTCGTTACCTGGTGTTGAC
D E L S T D I I L K T R Q I N K L I D S L P G V D
253 GTTTCAGCTGAAGAGCAATTAAGGAAGATTGATATGTTGCAGAAAAAGCTAGTTGAAGTGGAAGACGAAAAAATT
V S A E E Q L R K I D M L Q K X L V E V E D E K I
328 GAGGCCATCAAAAAGAAGGAGAAACTTTTAAGGCACGTTGATTCTTTAATTGAAGATTTTGTAGATGGCATTGCA
E A I KK K E K L L R H V D S L I E D F V D G I A
403 AACTCAAAAAAGAGC&CATAAACTTAAGTTTTACAAAGAAATTTGCGAACAGAGGACAGAAAATGTACTATAGTT
N S K K S T *
478 ATATGGCAGAGTTAAGCGTATGTATGTTATTCTTATAAATAATTGTGCTACTCTATTTGTACCGGAGAATTATT
553 AAGCAATGGGAGAAAAATCATAATGGAGAAAATCTTTCTACGAGTTACTTTGCAAGGCAATCTAACGATTCTAAA
628 AGACACAATACACTAAAGAAAAAACTTTGGAAGTACAGTTTTTTCCCCAAGTTGAAGTGTGGACTCATTGTGAAG
703 ATGTAAAAATGTAAAAACCAACCGACAATGCACTCCCAGCCAAATTCATTGTAGACCTCCCATTTGATAGAAAAG
778 GAAGGTTCAGCAGTTGTCCACGGATTCCAAGATATCATTCTCTTACATTGCACGCACATGAAAATGATC 846
103
Figure 1. Map and sequence of the SRB7 gene.
(A) Restriction map of a 2.0 kb DNA fragment from pCH7 containing the
SRB7 gene. The entire coding region of SRB7 was replaced with a 5.5 kb DNA
fragment containing the URA3 and kanamycin genes flanked by direct repeats
of Salmonella hisG DNA to create the deletion allele srb7Al::URA3hisG.
(B) Sequence of the SRB7 gene and adjacent DNA. The predicted 140 aa
sequence of the SRB7 protein is shown below the sequence of the gene.
Positive numbering of the nucleotides begins with the predicted start site of
translation. The srb7-1 mutation is a G to A transition (nt 61) that changes aa
21 from Ala to Thr.
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mapping showed that SRB7 is located on the right arm of chromosome IV,
approximately 45 kb distal to GCN2 (% clone 6118). Partial sequence analysis of
the SRB8 coding sequence revealed that it is identical to ORF YCR81W on
chromosome III (Oliver et al., 1992). The SRB8 protein is predicted to be 1226
amino acids in length with a molecular mass of 144 kd (Figure 2). The
predicted SRB9 protein is 1420 amino acids long and has a molecular mass of
160 kd (Figure 3). SRB9 maps to the right arm of chromosome IV,
approximately 35 kb centromere distal to ADE8 (X clone 5513). A search of the
sequence data banks revealed that SRB7, SRB8, and SRB9 do not have
significant sequence similarity to previously identified proteins.
To determine whether the SRB genes are essential for cell viability,
most or all of the coding regions were deleted, producing srb7Al (Figure 1A),
srb8Al (Figure 2A), and srb9Al (Figure 3A). Heterozygous diploid cells
containing these deletion alleles were sporulated and tetrad analysis was
carried out. The results revealed that SRB7 is essential for cell viability. In
contrast, cells lacking either SRB8 or SRB9 are viable, but flocculate and
exhibit mild cold-sensitive and temperature-sensitive phenotypes.
All nine SRBs are components of an RNA polymerase II holoenzyme
An RNA polymerase II holoenzyme has been purified and shown to consist
of RNA polymerase II, the general transcription factors TFIIB, TFIIF and
TFIIH, and the SRB proteins SRB2, SRB4, SRB5, SRB6, SRB10 and SRB11
(Nonet and Young, 1989; Thompson et al., 1993; Koleske and Young, 1994;
Liao et al., 1995). We investigated whether SRB7, SRB8, and SRB9 are also
components of this holoenzyme. Rabbit polyclonal antibodies were generated
against recombinant SRB7, SRB8, and SRB9. Column fractions from the final
purification step of the RNA polymerase II holoenzyme were tested in
A
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-375 TCAATCCAACATTCTTTCCCAGCAATTCGACAAAATTATCAAGATTAGAGAAGACCACATTAATAAGATCCCCTC
-300 AAATTCCACGACGACATTACACGGGCCTGGTTTTCAGTTGCCTAATAGAATAACCCTTACTGATCATAGAAAGGA
-225 AACGTGGTTGCATGAATTGAGATTCGTCTCACACTTCGACTGGTCAAAATTGGCAAGTTTATACCTCACGGCTTG
-150 AAAAGAAGGCAAGTCATCGAGCAGTGCTATTTAAAATTTATACCATTGAAAAGGGCGATTTGGTTGATAAAGTGC
-75 TGCTATTTTATCGAATGGAAATCGAACCAGAAAAAGAAGAGGTCAAATGCTGCTGGGGCAGATGATGCCATTTCC
1 ATGCACCTGCTAAAGGACTGGACGGATACCTTTGTATACATCCTGGAAAAGCTCATCTTTGATATGACAAATCACM H L L K D W T D T F V Y I L K L I F D M T N R
76 TATAACGATTCTCAACAACTGCGTACGTGGAAGAGGCAGATTTCTTATTTTTTAAAACTTTTGGGGAATTOCTAC
Y N D S Q 0 L R T W K R Q I S Y F L K L L G N C Y
151 TCACTAAGATTGATCAATAAGGAAATCTTTCATCATTGGCTTGTAGAGTTTATAAATAAGATGGAAAACTTCGAA
S L R L I N K E I F N R W L V E F I N K M E N F E
226 TTTTTGCCATTATCTTTACATATTTTGATGATTTTTTGGAACGACATCTGCCAAATTGATACAAATGCTCCTGTT
F L P L S L H I L X I E W N D I C Q I D T N A P V
301 GCGGCTACAATAACATCAAGTCAAAAAGAGCCCTTCTTTCTGGTAACAAAAATCACTGATATGCTATTGCACAAA
A A T I T SB Q K P FPF L V T K I T D M L L H K
376 TATTATATTGTTTCCAGCAGCAAATCAATGATAAATGACGAGAACTACATCATCAATGATATAAAGAAAAACAAC
Y Y I V S S S K S X I N D E N Y I I N D I K K N N
451 AAGATAAAGTTGAATATTCTCAAAATATTATCCAGTTTAATTTTGAAAATTTTTCAAGAACAATCTTTAGAGGTG
K I K L N I L K I L S S L I L K I F Q E Q S L E V
526 TTTATATTTCCCACATCTAACTGGGAAATTTACAAGCCCTTACTTTTTGAAATAGTCTCAAACGCCGACACTAAT
F I F P T S N W E I Y K P L L F E I V S N A D T N
601 CAAAATTCTGATATGAAGAAAAAATTAGAGTTAATTAGTTACAGAAACGAGTCATTGAAGAATAATTCTTCTATAQ N S D M K K L E L I S Y R N E S L I N N S S 1
676 CGAAACGTAATAATGTCTGCCAGCAACGCAAATGACTTTCAATTAACTATCGTCACCTGTAAACAATTTCCAAAA
R N V I N S A S N A N D F Q L T I V T C K Q F P K
751 CTATCATGCATTCAATTAAATTGTATAGATACTCAGTTCACCAAGCTACTGGACGATAACCCTACAGAATTCGAT
L S C I Q L N C I D T Q F T K L L D D N P T E F D
826 TGGCCCACTTACGTTGACCAAAATCCCCTTACAATGCATAAAATTATTCAATTAATTCTCTGGTCCATACATCCA
W P T Y V D Q N P L T N H X I I Q L I L W S I H P
901 TCAAGGCAATTTGATCACTATGAATCTAATCAACTGGTAGCGAAATTATTACTATTGCGAATAAATTCAACAGAT
S R Q F D H Y E S N Q L V A K L L L L R I N S T D
976 GAGGATTTGCACGAATTCCAGATAGAAGATGCCATTTGGTCATTGGTTTTCCAATTAGCCAAAAATTTTTCGGCC
E D L H E F Q I E D A I W S L V F Q L A K N F S A
1051 CAAAAGAGGGTGGTATCATATATGATGCCTTCTTTGTATCGCCTGCTTAATATACTAATTACTTATGGCATCATTQ K R V V S Y M M P S L Y R L L N I L I T Y G II
1126 AAGGTCCCTACGTATATCAGAAAGCTAATCAGTTCCGGCCTACTTTATCTCCAAGATTCCAATGATAAGTTTGTG
K V P T Y I R K L I S S G L L Y L Q D S N D K F V
1201 CATGTCCAGCTGTTAATTAACTTGAAAATTTCACCGTTGATGAAAAGTCAATACAATATGGTATTGAGGAACGTT
H V Q L L I N L K I S P L M K S Y N M V L R N V
1276 ATGGAATATGACGTTAAATTTTATGAAATTTTTAATTTCGACCAACTCGTGGAAATCACAGAACAAATCAAAATG
M E Y D V K F Y E I F N E D Q L V E I T E Q I K M
1351 CGAATACTCTCCAATGATATAACTAATTTGCAACTGTCGAAAACTCCTCTGAGCATTAAAATCATGGTTGCAGAAR I L S N D I T N L Q L S K T P L S I K I N V A E
1426 TGGTACTTATCACATTTATGTTCCGGTATTTTATCTAGTGTTAACCoCACAGTGTTGCTAAAAATATTCAAGATT
W Y L S N L C S G I L S S V N R T V L L I I F X I
1501 TTTTGTATCGATCTGGAGGTTTTCCACCACTTTTTTAAGTGGATCGAGTTTATTGTCTACCATCAATTGCTAAGT
F C I D L E V F H H F F K W I E F I V Y H Q L L S
B (Continued)
1576 GATATAGAATCTCTGGAGGCATTGATGGACATCTTGCTATGCTACCAAAAATTGTTCTCACAATTCATTAATGAC
D I E S L E A L M D I L L C Y Q K L F S Q FI N D
1651 CATATTCTTTTTACGAAGACGTTCATATTCATTTACAAGAAAGTTTTGAAAGAAAAAGACGTGCCTGCTTATAAT
H I L F T K T F I F I Y K X V L X E K D V P A Y N
1726 GTGACTTCATTTATGCCATTCTGGAAATTTTTTATGAAAAACTTCCCTTTTGTTTTAAAGGTGGATAACGATTTA
V T S F P F W K F FM R N I P F V L K V D N D L
1801 AGGATTGAGTTACAATCTGTTTACAATAGAGAAATTGAAAACTGAGAAGCTGAAGAATGATAAATCAGAAGTC
R I E L Q S V Y N D E K L K T ER K L K N D S E V
1876 TTGAAGGTGTATTCCATGATCAATAATTCAAACCAAGCTGTTGGACAGACTTGGAATTTTCCCGAGGTGTTTCAA
L X V Y S M I N N S N Q A V G Q T W N F P E V I Q
1951 GTAAACATCAGGTTTCTACTACACAACTCCAATCATTGAACAAATACAACAAACAGTTCCAGAAAGCACGA
V N I R F L L H N S E I I D T N T S R Q F Q K A R
2026 AACAATGTCATGCITTTGATTGCCACTAACTTGA&GGAGTACAATAAATTTATGTCCATTTCTTGAAAAGGAAA
N N V M L L I A T N L K E Y N K F M S I F L K R K
2101 GACTTTACTAACAAAAATTTAATTCAATTGATCTCTCTAAAACTTCTAACTTTTGAAGTGACGCAGAATGTGTTG
D F T N X N L I Q L I S L X L L T F E V T Q N V L
2176 GGGCTCGAGTAIAITATTCGATTATTACCAATAAACTTGGAAAATAATGACGGCTCATATGGTCTGTTTTTGAAG
G L E Y I I R L L P I N L E N N D G S Y G L F L K
2251 TATCATAAAGAACAATTCATAAAGTCAAATTTTGAGAAAATTTTACTTACATGTTATGAATTAGAAAAAAAATAT
Y K E Q F I K S N F E K I L L T C Y E L E K K Y
2326 CATGGCAACGAATGTGAAATAAATTATTATGAGATCCTATTGAAAATTTTAATAACTTATGGGTCATCTCCCAAA
H G N E C E I N TY E I L L X I L I T Y G S S P K
2401 TTACTTGCAACATCTACAAAAATCATTATGTTGTTATTGAATGATAGCGTGGAAAACTCATCTAATATTTTGAG
L L A T S T K I I M L L L N D S V E N S S N I L E
2476 GATATTTTGTACTACTCAACTTGTCCGTCGGAAACCGATCTTAACGATATTCCATTGGGTAGTGGACAACCAGAC
D I L Y Y S T C P S E T D L N D I P L G S G 0 P D
2551 AATGACACTGTTGTAACCAACGATGATAAAAGTGACGATGATGATCACACAGTCGACGAAATTGATCATGTAGAA
N D T V V T N D D X S D D D D H T V D E I D H V E
2626 TATTACGTTATGATGGACTTTGCCAATCTTTGGGTTTTCCAAGCGTTTACCTGTTTCTGCATCAAAAAAATCATG
Y Y V M D F A N L W V F Q A F T C F C I K K I M
2701 GAGAATAATGAGCCAGCAATGGCAATGGAAGACTTGAAGAACTTCATATTCCAAATTATCGAAATAACTAATTCT
E N N E P A M A M E D L K N F I F Q I I E I T N S
2776 AATGATTTATGTTCACAAATATTTGACCAACTGAAGGATATGCAGACCATTGAGATGATAACCCAAATAGTGGAG
N D L C S Q I F D Q L X D M Q T I E N I T Q I V E
2851 AAAGATTTCTGCACTTCTTGTTTGCAAAACAAC.ACCAAAAGATAGATGATAATTACATCGTTGTGGTGATCGAG
K D F C T S C L Q N N N Q K I D D N Y I V V V I E
2926 ATTATAACGTCATTATCAIGAGGTTTCAAAGAGAAACTTCTGGTATGATAGTTATTTCCATGGAGAACTATCAT
I I T S L S M R F Q R E T S G M I V I S M E N Y H
3001 TTACTAATAAAGATCATAAGACAATTAAGTGAACTGAACGAAGGAAATTATCTAAGAGAGAAATCCAAATAGAT
L L I K I I R Q L S E L N E G N L S K R E I Q I D
3076 GCCGTCTTGAAAATTTTTAGCTTTCATCAGGATTCCATTTTCCACGCATCATCGCTGATTTATCAGCTGATAAA
A V L K I F S F H Q D S I F Q R I I A D L S A D K
3151 CCCACAAGTCCATTCTTGAT&AGCATATGCAAGCTGTTTGATAAAATATCATTTAATTTAAGATTGAAGCTGTTC
P T S P F I D S I C K L F D K I S F N L R L K L F
3226 TTGTACGAAATTTTGTCTTCATTGAAATCATTCGCCATCTATTCATCCACAATTGATGCCCCAGCATTCCACACA
L Y E I L S S L K S F A I Y S S T I D A P A F H T
3301 AGCGGTAAGGTCGAACTACCGAAGAAATTGCTGAACTTACCACCATTCCAAGTGTCCTCTTTCGTTAAGGAAACA
S G K V E L P R X L L N L P P F Q V S S F V K E T
3376 AAACTTCATAGTGGCGACTACGGGGAAGAAGAAGATGCAGACCAAGAAGAATCGTTTAGTTTAAATTTAGGAATC
X L H S G D Y G E E D A D Q E E S F S L N L G 1
3451 GGCATAGTTGAAATAGCGCACGAAAACGAACAGAAATGGCTCATTTATGACAAGAAAGATCATAAATATGTCTGC
G I V E I A H E N E Q K W L I Y D X K D N K Y V C
3526 ACATTTTCCATGGAGCCGTACCACTTCATCTCCAACTATAATACCAAGTACACAGATGACATGGCTACAGGCAGT
T F S M E P Y H F I S N Y N T K Y T D D M A T G S
3601 AATGATACGACTGCGTTTAACGATTCCTGTGTAAACCTGAGTCTTTTTGATGCTCGGTTTGAGAGGAAAAATCCA
N D T T A F N D S C V N L S L F D A R F E R K N P
3676 CATTGATCTCAGAATATATCCAAATGGATAAATTATAAATTTACCAATAACAGTAATTATGTGTCAGTTTTAATA
H *
3751 CCCAACCAATTGATTCCTCTAAATGATACCGTACCAAATGACATGTTTGCCACCGATTATAAAACTGOGTTTAT
3826 GAGCGATGGTTAAGGAGGATTAAGACAAAGTGCTCATCCGCTTACAAGATCAGTACTAGCGTGTACCAGTCTATT
3901 TAAACTGGAATGATCACCCCAAAGGGAACGCACGATGCTGTGGCCAAGTTTCAAAAAACTGACCTGCATCAAGAT
3976 CTCGAT 3971
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Figure 2. Map and sequence of the SRB8 gene.
(A) Restriction map of a 6.0 kb DNA fragment from pSL311 containing the
SRB8 gene. The entire coding region of SRB8 was replaced with a 5.5 kb DNA
fragment containing the URA3 and kanamycin genes flanked by direct repeats
of Salmonella hisG DNA to create the deletion allele srb8AI::URA3hisG.
(B) Sequence of the SRB8 DNA and adjacent DNA. The predicted 1226 aa
sequence of the SRB8 protein is shown below the sequence of the gene.
Positive numbering of the nucleotides begins with the predicted start site of
translation. The SRB8 coding sequence is identical to ORF YCR81W (Oliver
et al., 1992).
AEcoR SphI EcoR EcoR EcoR Bal Sail Xhol
0.5 kb
hisG URA3 Kan hisG srb9Al::URA3hisG
0.5 kb
B
-147 GATCAAGTAGTGTAGTATTTATTGTAGTACACTCTTACAACAACCCTTTAAGACGAATGGTGTGAAATCGGAAAT
-72 TACTTTGTTGAAGTAAGGTGTAACTATATTTTAAGAACGTTTAAGCTGGATATCAAGATCTGAGGAGGTAGTATG
4 AGTTCTGACGCTTCCACGTACAGACTTGAGGATGTTTTATCCAGCTTCTATAGAGTGGAGAAAATCAAAAAGATC
S S D A S T Y R L E D V L S S F Y R V E K I K I
79 AACTATCATCAGTACATTTCTAAAGCCCAAAACGATCAATGGTCTATCCAAATGGAATTCATGCTACGAAGCAG
N Y E Q Y I S K A Q N D Q W S I Q M E F M L R K Q
154 GATCCAAAGACTCTAGTTGCGCTGCTTTCAAGGGATTTATGGTGTTTCAGTATAAATGATGATCCGGTACCGACA
D P K T L V A L L S R D L W C F S I N D D P V P T
229 CCTCCTGCGATAGAACATAAACCAGTGAGCCCAGATAAAATCGGAACTTTCACTGCCGATTATTCAAAGCCAAAC
P P A I E H K P V S P D K I G T F T A D Y S K P N
304 TTACCGCCACACTATGCTCTTTTTTTAAAAGCTTTAAGAAGGAAAATTTACATTAATTTGGCATTAGGTTCACAC
L P P H Y A L F L K A L R R K I Y I N L A L G S 
379 AATAAGCTAATACAATTTGGGAATGCCTGCATATCATTAAGCGGAGTGCCAAATTATCTCGTACAGCTAGAACCA
N K L I Q F G N A C I S L S G V P N Y L V Q L E P
454 CACCTTTTTGTAAACGGAGATCTCACAGTGTCGTTATGTGCCAAGAACATGGGATTAGTACCAATGAAGGAGGAA
H L F V N G D L T V S L C A K N M G L V P N K E E
529 AATTTGGAAGAATCTTTCCTTTCAAAGCATGCGCTTTATTTAGCACCATCTGGAATAAGATGCATTTGGCCCCT
N L E Z S F L S K H A L Y L A P S G I R M E L A P
604 GCTTCCAAGCAAGGATACTTGATAACGCCACCAAAACATACAGAACTTCTCTTGACGACGTTAAGTGTATCTCAT
A S K Q G Y L I T P P K H T E L L L T T L S V S S
679 GGTATAALCTTACAAAATAAAAAAAATTTGAAATGGGTTGCTGTTGTTCCTGACTTAGGACATCTCAACGGCCAC
G I N L Q N K K N L K W V A V V P D L G E L N G S
754 ACACCTACTATAGCTTCGTATTTAACTCCCTTACTTGAAGCAAAGAAGCTAOTATGGCCGCTOCATTTAATCTTC
T P T I A S Y L T P L L E A K X L V W P L H L I F
829 GCCCAACCAGTAGCTGATATAGAAAATTCTACTTCCGGAGATCCATCAGAATTTCACTGTTTOCAAGATGCTCTG
A Q P V A D I E N S T S G D P S E F H C L Q D A L
904 GATGCCATTGATGATTTCATACAATTAAAGCAAACAGCTGCCTATAGGACTCCAGGAAGTTCCGGCGTATTGAGC
D A I D D F I Q L K Q T A A Y R T P G S S G V L S
979 AGTAATATTGCTGGTACAAATCCCTTAAGCTCAGATGGAGCATATACAGAACAGTTTCAACATTATAAGAACAACS N Z A G T N P L S D G A Y T E Q F Q H Y K N N
1054 TCAATTAGTTCTCAACCCGCTTCTTATCATTCTGTCCAAGAAACTAATAAGATATCTCCGAAAGATTTCTCCCCT
S I S S Q P A S Y S V Q E T N K I S P K D F S P
1129 AATTTCACAGGCATTGATAAATTAATGCTGTCGCCCAGCGATCAATTTGCTCCAGCTTTCTTAAATACCCCTAAT
N F T G I D K L 4 L S P S D Q F A P A F L N T P N
1204 AATAACATCAATGAGAATGAATTATTTAATGATAGGAAACAAACTACAGTATCAAATGACTTAGAGAACAGCCCA
N N I N E N E L F N D R K Q T T V S N D L E N S P
1279 CTGAAAACGGAACTGGAGGCAAATGGTAGATCACTCGAAAAGGTAAATAATTCCOTGAGCAAGACAGGAAGCGTA
L A T E L EANG E V N N S V B K T G S V
1354 GACACACTTICATAATAAAGAGGGAACACTGGAACAACGAGAACAGAACGAAAATCTGCCAAGTGATAAAAGTGAC
D T L H N K E G T L E Q R E Q N E N L P S D K 8 D
1429 TCTATGGTAGACAAGGAATTGTTTGGTGAGGATGAGGATGAGGATTTATTTGGCGATAGCAATAAATCGAATTCT
S M V D K E L F G E D E D E D L F G D S N K S N S
1504 ACAAACGAATCGAACAAAAGTATATCGGACGAAATTACCGAGGATATGTTCGAAATGTCTGATGAAGAAGAAAAT
T N E S N A S I S D E I T E D M F E M S D E l E N
1579 AATAACAATAAAAGCATTAATAAAAATAACAAGGAAATGCATACTGATCTTGGTAAAGATATTCCATTTTTTCCC
N EN A S I N K EN Al E M N T D L G K D I P F F P
B (Continued 1/2)
1654 TCATCTGAAAAACCGAATATCCGTACGATGAGCGGAACTACEAAAAGATTAAATGGAAAGAGGAAATATTTGGAT
S S E K P N I R T M S G T T K R L N G K R K Y L D
1729 ATTCCGATAGATGAAATGACCTTGCCAACGAGTCCATTATATATGGACCCAGGTGCGCCACTCCCTGTGGAAACA
I P I D E N T L P T S P L Y E D P G A P L P V E T
1804 CCCCGCGATAGACGCAAAAGTGTGTTCGCTCCACTGAATTTTAACCCCATAATAGAAAACAATGTTGATAACAAA
P R D R R K S V F A P L N F N P I I E N N V D N K
1879 TACAAATCTGGAGGGAAATTTTCCTTCAGTCCGTTGCAAAAGGAGGAAGCATTAAACTTTGATATTTCTATGGCG
Y K S G G K F S F S P L Q K E E A L N F D I S M A
1954 GATCTTTCTAGCTCTGAAGAGGAAGAGGATGAAGAAGAACGGTAGCAGCGATGAGGATCTAAAGTCATTGAAC
D L S S S E E E E D E E E N G S S D E D L K S L N
2029 GTACGCGACGACATGAAACCTTCTGATAAATCAGTACTAATACTAATATTCATGAGCCTCAATACATAAATTAC
V R D D M K P S D N I S T N T N I H E P Q Y I N Y
2104 TCTTCGATCCCAAGTCTACAAGACTCTATTATAAAGCAAGAAAATTTCAATTCAGTAAACGATGCTAATATCACT
S S I P S L Q D S I I K Q E N F N S V N D A N I T
2179 AGCAATAAGGAAGGCTTCAACTCTATTTGGAAAATTCCTCAAAATGATATACCACAGACCGAGTCACCACTGAAG
S N KR G F N S I W K I P Q N D I P Q T E S P L K
2254 ACCGTTGATTCATCTATTCAACCCATAGAATCCAATATAAAGATGACCTTGGAAGATAATAATGTTACCAGTAAT
T V D S S I Q P I E S N I K N T L E D N N V T S N
2329 CCGTCCGAATTTACGCCGAATATGGTAAATTCTGAAATTTCTAACCTACCAAAGGACAAGAGTGGTATCCCCGAA
P S E F T P N M V N S EI S N L P K D K S G I P E
2404 TTCACACCGGCGGACCCCAATTTATCTTTTGAATCATCAAGTAGTCTACCGTTTCTATTGAGACACATGCCGCTA
F T P A D P N L S F E S S S S L P F L L R H W P L
2479 GCATCTATACCGGACATTTTCATCACGCCTACTCCCGTTGTTACAATTTCAGAAAAAGAACAAGACATCTTAGAT
A S I P D I F I T P T P V V T I S E K E Q D I L D
2554 TTAATTGCAGAACAAGTCGTCACTGATTATAATATCTTAGGAAACCTCGGTATTCCAAAGATCGCCTATAGGGGA
L I A E Q V V T D Y N I L G N L G I P K I A Y R G
2629 GTTAAAGATTGCCAAGAAGGTTTAATAACAACCACAATGTTACAGTTATTTTCCACTTCGGATAGATTAAATGGC
V R D C Q E G L I T T T X L Q L F S T F D R L N G
2704 AATGATACGATCTCCAAATTCTATAACATGAAGCAGCCGTACGTTTTTGTAAAGAAACATCACGAACTAATCAAA
N D T I S K F Y N M K Q P Y V F V K K N H E L I K
2779 GTCAAACACGACTCTCAGCCATTTATTAAGTTCCTCAATTTTCGCCCTCCAAATGGAATAAAAAACTTCAAATCC
V K H D S Q P F I K F L N F R P P N G I K N F K S
2854 TTATTATTAAGTTCATCTTTCAAAGAAGATTGTCTGTCATTTGCGCCAACTCTATCTCAAACATATATTAATCAA
L L L S S S F K E D C L S F A P T L S Q T Y I N Q
2929 GAGTTAGGGTTTTGTGAGTTGCTTAAACTAACTAATGAAGACCCGCCCGGACTGATGTACTTGAAGGCATTTGAT
E L G P C E L L K L T N E D P P G L N Y L K A F D
3004 AAAAACAAGTTACTGTTGTTAGCTGCGCAGATTGTTTCATACTGTTCTAATAATAAGAACTCCATCAAAAACGTG
K N K L L L L A A Q I V S Y C S N N K N S I K N V
3079 CCACCAATATTAATAATTTTACCCTTGGATAATGCAACTCTGACTGAATTAGTAGACAAGGCGAATATTTTTCAG
P P I L I I L P L D N A T L T E L V D K A N I W Q
3154 GTGATCAAGAACGAAGTTTGTGCCAAGATGCCTAACATTGAACTATATTTGAAAGTTATTCCTATGGATTTCATT
V I K N E V C A K M P N I E L Y L K V I P M D F I
3229 AGAAACGTACTGGTGACAGTGGATCAGTACGTCAACGTAGCAATTTCTATATATAACATGCTGCCGCCAAAATCT
R N V L V T V D Q Y V N V A I S I Y N E L P P K S
3304 GTAAAGTTCACCCACATTGCGCATACGCTGCCGGAGAAAAGTGAATTTCAGACCTGCThArtrrLaw'rl
V K F T H I A N T L P E R V N F R T M Q Q Q Q M Q
3379 CAGCAACAGCAACAGCAACAGCAGCAGCAGALTAACAGTACAGGATCATCTTCTATATATATTATGACTCGTAC
Q Q Q Q Q Q Q Q Q N N S T G S S S I I Y D S Y
3454 ATCCACCTGGCATACTCGCGTAGTGTAGATAAAGAGTGGGTTTTTGCAGCTCTTTCAGATAGCTATGGACAAGGC
I E L A Y S R S V D K E W V F A A L S D S Y G Q G
3529 AGCATGACGAAAACGTGGTACGTCGGGAATTCCAGAGGAAAATTTGACGACGCATGTAATCAAATATGGAATATC
S E T K T W Y V G N S R G F D D A C N Q I W N I
3604 GCCCTAAATTTAGCGTCTAAAAAATTCGGAAAAATATGTCTAATTTTAACTAGATTGAATGGCATACTGCCGGAT
A L N L A S K K F G K I C L I L T R L N G I L P D
3679 GATGAATTGATGAATTGGAGGAGACTTTCTGGTAGGAATATACATCTTGCTGTGGTGTGTGTGGATGACAACTCT
D E L N N W R R L S G R N I H L A V V C V D D N S
3754 AAAATCTCCTTCATAGATGAGGACAAATTGTACCCTAGTTTCAAGCCGATCTACAAAGACACTAGGTTTGAGGA
K I S F I D E D R L Y P S F K P I Y R D T R F G G
3829 CGCATGGATATGACCAGATTATACGACTATGAAATAAGGGATATAGACCAGGACATCCATGGAATAGTATTTCAG
R M D N T R L Y D Y E I R D I D Q D I H G I V F Q
B (Continued 2/2)
3904 CACCCGTTCCCACTGGCACACTCACAGCATCGCTGTGCTATTAGGAGTGGTGCTTTGATCAAATTCAAAAAATGC
H P F P L A H S Q H R C A I R S G A L I K F K K C
3979 GACGGTGATACGGTTTGGGACAAATTCGCAGTCAACCTTTTAAACTGTCCACATTCTGATAGTACACAATTGCTG
D G D T V W D K F A V N L L N C P H S D S T Q L L
4054 GAAACCATCTTAGAAGAGTTTCGCAACCTGGCTGCTCTAAACGTGTGGTACGGTCTCTCTGATGGCGAAGATGGC
E T I L E E F R N L A A L N V W Y G L S D G E D G
4129 CATATTCCATGGCATATCCTAGCCGTGAAAAAAATGkTGAACACTCTTGTGCACACCAGAGTAAAAATTGCTAAT
H I P W H I L A V K K M M N T L V H T R V X I A N
4204 ACTTCCGCCGCTACTGTGCATACCGCTACTTCTTCATCAATTATTCTCTCGGTAAATAAACTTTTTCCGGCAAC
T S A A T V H T A T S 8 S I I L S D K
4279 GTTTTCCTGCTCATCTGTAGCCCTATTTACCAGTTTTGGTTTTAGTATTATTCCGGGGTGTAAACCCAGAAGTCT
4354 ATTTCTCCAGTCGGATTTATAAAAACAAAACCGGAAGCGGGGCGGTACGGCATTTTCACTGGTGATGCACGCCCA
4429 GCGTGTAGTCCGAGACAATTTCCACAGAACGCGAATGAGATTGCGTTTAAGGCTGTATTTTCAAGGCACACGAAG
4504 CGGCCACGTGGGTCTGCGATGGTGTGTTGATGATGTCAAGAATGGTATCATACTCCGTATAAGGTTATGTAATCG
4579 GAAGTCGCGATTCTTTTTCAATTTTTTCTTTTTATTTTTTTCCAGTTTTTTCGTCTCTGCGATGGAAAATTGTTG
4654 AAGTTCTCTTGATTAGCAAGTAGTTCTTACATCGCAGGAATCTTATGTT 4702
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Figure 3. Map and sequence of the SRB9 gene.
(A) Restriction map of a 7.3 kb DNA fragment from pCH47 containing the
SRB9 gene. Most of the coding region of SRB9 was replaced with a 5.5 kb
DNA fragment containing the URA3 and kanamycin genes flanked by direct
repeats of Salmonella hisG DNA to create the deletion allele
srb9 A1::URA3hisG.
(B) Sequence of the SRB9 DNA and adjacent DNA. The predicted 1420 aa
sequence of the SRB9 protein is shown below the sequence of the gene.
Positive numbering of the nucleotides begins with the predicted start site of
translation. A polyglutamine repeat, a motif found in several transcription
factors (e.g. Spi, dTAFI 1 1 0, OCT2), is underlined (Courey and Tjian, 1988;
Hoey et al., 1993; Clerc et al., 1988). In yeast, a BLAST search (Altschul et al.,
1990) reveals that nearly 3% percent of all open-reading frames (ORFs) are
found to contain one or more glutamine-rich domains. These include many
positive and negative transcription factors such as: Adr6, Cafi, Ccr4, Dati,
Gall, Hapi, Hap2, Mcml, Noti, Pho2, Pgdl, Rox1, Snf5, Snf6, Ssn6 and Tupi.
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reconstituted transcription reactions and subjected to Western blot analysis
with antisera specific to RNA polymerase II and SRB proteins (Figure 4A).
SRB7, SRB8 and SRB9 coeluted with the other SRB proteins, RNA
polymerase II and transcriptional activity. Thus, all nine SRB genes
identified through our genetic selection encode components of the RNA
polymerase II holoenzyme.
The most highly purified RNA polymerase II holoenzyme preparation
was subjected to SDS-PAGE and silver-stained (Figure 4B). The SRB proteins
were assigned to protein bands based on Western blot analysis. RNA
polymerase II and general transcription factor subunits were assigned to
protein bands based on their mobility and, in some cases, on Western blot
analysis. From this analysis, many of the known components of the
holoenzyme can be accounted for, although a number of polypeptides remain
unidentified. Some of these components may be encoded by genes that have
been identified through other genetic screens (Berger et al., 1992; Amakasu et
al., 1993; Pina et al., 1993; Fassler et al., 1991).
SRB proteins are components of the mediator of activation
A subcomplex of RNA polymerase II, named the mediator of activation, can
be dissociated from a preparation of RNA polymerase II holoenzyme using
anti-CTD monoclonal antibodies (Kim et al., 1994). Purified mediator
contains SRB2, SRB4, SRB5, SRB6, SUG1, GAL11, the general transcription
factor TFIIF, and as yet unidentified subunits (Kim et al., 1994). Since all nine
SRB proteins are components of the holoenzyme, and genetic analysis
suggests that the SRB proteins are involved in a similar process in
transcription, we investigated whether SRB7, SRB8, SRB9, and SRB10 are also
part of a mediator preparation.
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Figure 4. All SRBs are components of an RNA polymerase II holoenzyme.
(A) RNA polymerase II holoenzyme was purified as described (Koleske et al.,
1994). Holoenzyme loaded onto a Mono S column, the last chromatographic
step in the purification procedure, was eluted with a 0.1 - 1.0 M gradient of
potassium acetate. The onput (OP) and flow-through (FT) and a portion of
every other fraction eluting between 0.1 and 0.9 M potassium acetate were
analyzed for holoenzyme activity (top panel). These samples were also
analyzed by Western blot for the presence of RNA polymerase II and SRB
proteins. The Western blot for SRB11 was done with an RNA polymerase II
holoenzyme purified independently from cells with an epitope-tagged SRB11
protein; the purification and transcriptional properties of this holoenzyme
were identical to the holoenzyme lacking the epitope tag (Liao et al., 1995).
(B) Polypeptide composition of RNA polymerase II holoenzyme. One
microgram of purified holoenzyme was subjected to SDS-PAGE and stained
with silver. Proteins in the holoenzyme preparation that correspond in size
to subunits of RNA polymerase II, SRB proteins, and general transcription
factors are indicated. The numbers used for the subunits of transcription
factors TFIIF and TFIIH are from previous reports (Henry et al., 1992; Feaver
et al., 1993). The sizes of protein molecular weight standards are indicated in
kD.
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The mediator of activation was purified from commercial baker's yeast
as described (Kim et al., 1994). The chromatographic behavior, yield and
transcriptional activities of the mediator preparation were similar to those
reported. Figure 5 shows the results of transcription and Western blot
analysis of fractions from the last chromatographic step in the purification.
Fractions containing the mediator stimulated increases in basal and in
activated transcription, as previously described (Kim et al., 1994). Western
blot analysis with specific antisera against SRB proteins showed that SRB2,
SRB4, SRB5, SRB6, SRB7, SRB8, SRB9 and SRB10 proteins all coeluted with
the mediator activity. Our lack of anti-SRB11 antibodies prevented us from
assaying the presence of SRB11 in the mediator, but evidence that SRB11 is a
component of the holoenzyme and binds to directly to SRB10 (Liao et al.,
1995) argues that SRB11 is also a component of the mediator. Thus, all nine
of the SRB proteins, together with SUG1, GAL11 and TFIIF, can be dissociated
as a complex from the RNA polymerase II holoenzyme to produce the
mediator of activation.
Acidic activator VP16 coimmunoprecipitates with RNA polymerase II
holoenzyme
Two observations suggest that some acidic activators may contact the RNA
polymerase II holoenzyme directly. Both forms of RNA polymerase II
holoenzyme described thus far are able to respond to activators in
reconstituted in vitro transcription systems (Koleske and Young, 1994; Kim et
al., 1994). One form of RNA polymerase II holoenzyme contains TFIIB and
TFIIH, two factors that have been shown to interact with the VP16 activation
domain (Lin et al., 1991; Goodrich et al., 1993; Xiao et al., 1994). To investigate
whether the holoenzyme can bind to the acidic activation domain of the
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Figure 5. SRBs are components of the mediator of activation.
(A) In vitro transcription templates used for assaying mediator activity.
(B) A mediator preparation was loaded onto a MonoQ column, the last
column in the purification procedure, and eluted with a 0.4-0.8 M gradient of
potassium acetate. Each column fraction was assayed for mediator activity
using a reconstituted transcription system with purified general transcription
factors, core RNA polymerase II and recombinant GAL4-VP16. Mediator
activity, defined by activator-responsive transcription and increased basal
transcription, was found to peak in fraction 25 (top panel). This and nearby
fractions were then analyzed by Western blot for the presence of SRB
proteins.
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activator VP16, we immunoprecipitated the RNA polymerase II holoenzyme
from a crude yeast protein preparation in the presence of wild type and
mutant VP16 activator proteins. The herpes simplex virus transactivator
VP16 has been extensively characterized, and analysis of VP16 mutants
suggests the presence of two activation subdomains within the highly acidic
C-terminal 78 amino acids (Triezenberg et al., 1988; Regier et al., 1993). The
VP16A456FP442 mutant is defective in transcriptional activation; one
subdomain of transcriptional activation is deleted (aa 457-490), and the second
subdomain (aa 413-456) contains a single amino acid substitution abolishing
residual transcriptional activation activity (Phe-442 to Pro-442) (Cress and
Triezenberg, 1991; Regier et al., 1993).
RNA polymerase II holoenzyme was immunoprecipitated from a
crude yeast protein preparation supplemented with recombinant GST-VP16
or GST-VP16A456FP442 using affinity-purified anti-SRB5 polyclonal antibodies.
Western blot analysis of the input, supernatant, wash and pellet show that
the pellet contains components of the RNA polymerase II holoenzyme,
including the pol II subunit RPB1, SRB proteins, and TFIIB (Figure 6, IP 1 and
IP 2). A polyclonal control antibody directed against a human TGFO receptor
did not immunoprecipitate any RNA polymerase II holoenzyme components
(Figure 6, IP 3). TBP, which is not a component of purified holoenzymes,
could not be detected in any of the pellets, arguing against non-specific
aggregation of proteins in the immunoprecipitation (Figure 6, IP 1 and IP 2
pellets). As an additional control, SSA1, a yeast HSP70 protein, also fails to be
immunoprecipitated. Thus, holoenzyme components are specifically
coprecipitated with SRB5 from crude yeast proteins under these conditions.
The results also show that GST-VP16 is coprecipitated with the holoenzyme,
whereas GST-VP16A456FP442 is not (Figure 6, IP 1 and IP 2 pellets). We
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Figure 6. Coimmunoprecipitation of the VP16 activator with the RNA
polymerase II holoenzyme.
IP 1, IP 2, and IP 3 represent three separate immunoprecipitation experiments.
A yeast whole cell extract was subjected to an ammonium sulfate cut,
fractionated by step elution from BioRex 70 and DEAE-Sephacel
(Experimental procedures), and immunoprecipitations were carried out with
anti-SRB5 antibodies (IP 1 and IP 2), or a control antibody, anti-hTGF-RII (IP
3). Recombinant GST-VP16 was added to the input of IP 1 and IP 3, while
recombinant GST-VP16A456FP442 was added to the input of IP 2. 1/50 of the
input (I) and supernatant (S), and 1/5 of the last wash (W) and pellet (P) were
subjected to SDS-PAGE and analyzed by Western blot using specific
antibodies.
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estimate that the concentration of VP16 proteins was similar to that of
holoenzyme components in the crude yeast protein preparation, and that the
ratio of GST-VP16 to holoenzyme molecules in the immunoprecipitate was
approximately 1:10.
A VP16 column selectively retains the RNA polymerase II holoenzyme
together with TBP
To confirm that the holoenzyme interacts specifically with GST-VP16, the
same crude protein preparation used in the immunoprecipitation
experiments was passed over GST-VP16 or GST-VP16A456FP442 columns. The
columns were washed extensively and GST-fusion and associated proteins
were eluted with glutathione. Components of the RNA polymerase II
holoenzyme bound to GST-VP16 but not to GST-VP16A456FP442 (Figure 7).
Consistent with previous reports, TBP also specifically bound to the GST-
VP16 (Stringer et al., 1990; Ingles et al., 1991). SSA1 protein did not bind to
either column, arguing against non-specific protein aggregation on the GST-
VP16 column. Thus, both immunoprecipitation experiments and column
chromatography support the conclusion that the RNA polymerase II
holoenzyme interacts with the activation domain of VP16.
A VP16 column retains the mediator of activation
We investigated whether the mediator subcomplex interacts with VP16 and,
if so, whether the interaction involves both VP16 activation subdomains. A
mediator preparation was passed over columns containing GST-VP16, GST-
VP16A456, or GST-VP16A456FP 44 2. The columns were washed extensively and
GST-fusion and associated proteins were eluted with glutathione. The onput,
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Figure 7. RNA polymerase II holoenzyme and TBP bind a VP16 activator
column.
The DEAE-Sephacel fraction described in Figure 6 was loaded onto GST-VP16
and GST-VP16A456FP442 glutathione-agarose columns. After washing, the
columns were eluted with glutathione. 1/200 of the load (L) and the
flowthrough (FT), and 1/10 of the last wash (W) and the eluate (E) were
subjected to SDS-PAGE and analyzed by Western blot.
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flowthrough, wash and eluate fractions from the three columns were
subjected to Western blot analysis (Figure 8A). Components of the mediator
were bound most effectively by GST-VP16. In contrast, there was limited
binding of the mediator to GST-VP16A456 , and no apparent binding to GST-
VP16A456FP442. Figure 8B shows that the mediator preparation lacks RPB1,
confirming that it contains little or no contaminating holoenzyme. These
results indicate that the VP16 activator binds to the mediator. Furthermore,
both of the activation subdomains of VP16 contribute to maximal binding of
the mediator.
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Figure 8. Mediator of activation binds to VP16 activator column.
(A) Mediator of activation (peak fractions from heparin column) was loaded
onto GST-VP16, GST-VPA 456, and GST-VP16A456FP442 glutathione-agarose
columns. After washing, the columns were eluted with glutathione. 1/150 of
the load (L) and the flowthrough (FT), and 1/60 of the last wash (W) and the
eluate (E) were subjected to SDS-PAGE and analyzed by Western blot.
(B) Mediator of activation (peak fractions from heparin column) and pure
RNA polymerase II holoenzyme (Koleske et al., 1994) were analysed by
Western blot for the presence of the largest subunit of RNA polymerase II
(RPB1) and for SRB2 and SRB7 proteins. The lanes contained 0.8 gg and 0.32
ptg of RNA polymerase II holoenzyme, and 2.5 Rg and 1 Rg of mediator of
activation, respectively.
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Discussion
The genetic and biochemical analysis reported here provides a more complete
description of the RNA polymerase I holoenzyme. The products of all nine
SRB genes described thus far are components of the holoenzyme. All nine
SRB proteins can be dissociated from the holoenzyme in a subcomplex which
functions in basal and activated transcription and has been termed the
mediator of activation. The ability of holoenzymes to respond to activators
suggests a model in which the holoenzyme is recruited to the initiation
complex through direct interactions with activator proteins. Indeed, we find
that the VP16 activator can bind to the holoenzyme. Since VP16 can bind the
mediator, this subcomplex is among the components of the holoenzyme that
interact with VP16.
SRB components and the RNA polymerase II holoenzyme
The nine SRB genes were identified through a selection for genes whose
products are involved in RNA polymerase II transcription in vivo.
Suppressing alleles of the SRB genes were isolated by their ability to suppress
the cold-sensitive phenotype of yeast cells that contain RNA polymerase II
molecules with truncated CTDs. The isolation of the SRB2, SRB4, SRB5 and
SRB6 genes and the biochemical analysis of their protein products originally
led to the discovery of the RNA polymerase II holoenzyme (Koleske and
Young, 1994). Two additional SRB genes, SRB1O and SRB11, were recently
described; they encode kinase and cyclin-like polypeptides that are tightly
associated with the holoenzyme and appear to have roles in CTD
phosphorylation (Liao et al., 1995). Analysis of all 75 independent suppressor
isolates obtained in the genetic selection has led to the identification and
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characterization of three additional SRB genes. We have summarized the
data for the nine SRB genes and proteins in Table I.
Biochemical studies have shown that all nine SRB proteins are
integral components of the RNA polymerase II holoenzyme. The SRB
proteins copurify with RNA polymerase II, TFIIB, TFIIF, and TFIIH in
conventional chromatography (Figure 4A; Koleske and Young, 1994). All
SRB proteins tested (SRB2, 4, 5, 6, 7, 10 and 11) and other components of the
holoenzyme have been shown to co-immunoprecipitate with SRB5 (Figure
6A; Koleske and Young, 1994; Liao et al., 1995). Furthermore, when we purify
for any of these SRB proteins, all of the SRB protein detected by Western
analysis copurifies with the holoenzyme (Koleske and Young, 1994; Liao et al.,
1995; Hengartner and Koleske, unpublished).
A model depicting the RNA polymerase II holoenzyme is shown in
Figure 9. This complex consists of RNA polymerase II, the general
transcription factors TFIIB and TFIIH, and the mediator of activation. The
mediator of activation contains the nine SRB proteins, TFIIF, GAL11 and
SUG1 (Figure 5; Kim et al., 1994). In cell lysates, the SRB proteins are only
found tightly associated with the holoenzyme; the SRB-containing mediator
of activation can be dissociated from the holoenzyme by anti-CTD
monoclonal antibodies, indicating that the interaction of these antibodies
with the RNA polymerase II CTD disrupts interactions between the CTD and
the mediator subcomplex.
Several lines of evidence suggest that the RNA polymerase I
holoenzyme is the form of the enzyme involved in transcription initiation in
vivo. Genetic analysis has indicated that the CTD and SRB gene products
have roles in transcription initiation and are essential for normal yeast cell
growth. Using temperature-sensitive mutants, we have found that SRB4 and
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Figure 9. Model for interactions among activators, TFIID, and the RNA
polymerase II holoenzyme.
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SRB6 are necessary for transcription of most, if not all, genes transcribed by
RNA polymerase II in vivo (Thompson and Young, 1995). Since the vast
majority of SRB protein in cell extracts is tightly associated with the RNA
polymerase II holoenzyme, these results suggest that the holoenzyme is
employed at most pol II promoters in vivo.
What roles do the SRB proteins have in the holoenzyme? Some of the
SRB proteins are likely to contribute to interactions between RNA
polymerase II and general transcription factors. For instance, SRB2 and SRB5
are essential for transcription in unfractionated in vitro systems, where they
have roles in stable preinitiation complex formation (Koleske et al., 1992;
Thompson et al., 1993). Both SRB2 and SRB5 can bind to TBP in vitro
(Koleske et al., 1992; Thompson et al., 1993), raising the possibility that they
contribute to the stability of holoenzyme-TBP interactions at the promoter.
The mediator subcomplex appears to act as a contact point for at least some
transcriptional regulatory proteins and these regulators may bind directly to
specific SRB proteins. The SRB-containing subcomplex may also function as
a signal processor in the response to transcriptional regulators. SRB10 and
SRB11 form a cyclin-dependent kinase that has a role in CTD
phosphorylation (Liao et al., 1995). The role of CTD phosphorylation in
transcription is not yet clear, but it may serve to disrupt interactions between
RNA polymerase II and general factors, which may be necessary for promoter
clearance.
Initiation complex formation with the holoenzyme
The identification of a yeast RNA polymerase II holoenzyme suggests a
model for initiation complex formation in which the holoenzyme is the form
of RNA polymerase recruited to promoters. Activators are believed to
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influence the rate of transcription of an adjacent gene in part by interacting
with components of the initiation apparatus and affecting stable initiation
complex formation. Figure 9 depicts a model that posits interactions between
activators and TFIID and between activators and components of the
holoenzyme. These interactions could occur sequentially or simultaneously.
The portion of the model that depicts interactions between activators
and TFIID has been proposed by others and is supported by several lines of
evidence. Activator proteins can stimulate transcription in vitro in reactions
directed by the TFIID multisubunit complex but they do not stimulate
transcription reactions directed by recombinant TBP alone (Pugh and Tjian,
1990). Reconstitution of activated transcription in vitro can be accomplished
by reconstituting TFIID using recombinant TBP and TBP-Associated Factors
(TAFs) (Dynlacht et al., 1991; Tanese et al., 1991; Zhou et al., 1992; Chen et al.,
1994). These and other results support the idea that activators interact with
the TAF subunits of TFIID. A recent report, however, indicates that TFIID
may not be sufficient to confer a response to an acidic activator in vitro in
highly purified systems (Kretschmar et al., 1994). It is possible that TFIID is
necessary but not sufficient for a response to some activators.
The portion of the model in Figure 9 that depicts interactions between
activators and the RNA polymerase II holoenzyme is supported by the
following lines of evidence. The RNA polymerase II holoenzyme contains
components necessary and sufficient for responding to transcriptional
activators in a reconstituted system, apparently in the absence of TAFs
(Koleske and Young, 1994; Kim et al., 1994). Genetic evidence suggests that
GAL11 and SUG1, two components of the mediator, may interact with certain
activators (Nishizawa et al., 1990; Swaffield et al., 1992). We have shown that
VP16 can bind to the mediator subcomplex of the holoenzyme. Thus, the
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activator VP16 has been shown to interact in vitro with three components of
the RNA polymerase II holoenzyme: the mediator subcomplex, TFIIB (Lin et
al., 1991; Goodrich et al., 1993) and TFIIH (Xiao et al., 1994).
The complexity of the transcription initiation complex suggests that
there are numerous molecular mechanisms involved in transcriptional
regulation. Precise identification of the interactions that regulatory proteins
have with components of the holoenzyme should lead to a better
understanding of the mechanisms that regulate transcription initiation.
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Experimental Procedures
Genetic manipulations
Yeast strains and plasmids are listed in tables 2 and 3, respectively. Details of
strain and plasmid constructions are available upon request. Yeast media was
prepared as described (Thompson et al., 1993). Yeast transformations were
done using a lithium acetate procedure (Schiestl and Gietz, 1989). Plasmid
shuffle techniques were performed as described (Boeke et al., 1987) using 5-
fluoro-orotic acid (5-FOA) as a selective agent against URA3 plasmids.
Plasmids were recovered from yeast as described by Hoffman and Winston
(1987).
Extragenic suppressors of the cold-sensitive phenotype of Z551 were
isolated as previously described (Nonet and Young, 1989, Thompson et al., 1993).
Dominant and recessive suppressors were identified by mating to Z26
(Thompson et al., 1993), selecting against the presence of pRP112 (Nonet et al.,
1987) using 5-FOA and assaying growth at 12 0C on YEPD. Diploids able to grow at
12 0C contained a dominant suppressor. Diploids unable to grow at 12 0C
contained a recessive suppressor.
Yeast strains of the opposite mating type of approximately half of the
dominant suppressors and half of the recessive suppressors were generated by
inducing a mating type switch by expression of the HO gene placed on a plasmid
under the control of a galactose inducible promoter. Random spore analysis of
the dominantly suppressing mutations was used to determine if two
independent isolates were likely to contain mutations in the same gene.
Haploids were mated to each other, each containing the CTD truncation
mutation rpblAl04 and an independently isolated SRB mutation, to form
diploids. These diploids were sporulated on plates and a small quantity of spores
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scraped off and shaken overnight at 30 0C in 0.5 mL 30 mM b-mercaptoethanol
and 100 ng/mL Zymolase 100 T (ICN). 0.5 mL of 1.5% NP-40 and 0.4 g glass beads
were added and the mixture incubated on ice for 15 min. The suspension was
then vortexed 3 min, incubated on ice 5 min, vortexed 2 min, and the glass beads
allowed to settle for 10 min at room temperature. The supernatant was
removed, spun 2 min, the pellet washed once in water, then resuspended in
water and a portion plated onto YEPD. Approximately fifty of the haploid
offsprings were assayed for their ability to grow at 12 0C. If all haploids were able
to grow at 12 0C then the two SRB isolates were assumed to contain mutations in
the same gene. Genetic complementation of the recessive alleles involved
mating haploids to each other, each containing the CTD truncation mutation
rpblAl04 and an independently isolated srb mutation, to form diploids and
assessing the ability of these diploids to grow at 12 0C. Diploids able to grow at
12 0C were assumed to contain srb mutations in the same gene. Genomic clones
of each complementation group were used to confirm the identity of each
member of the complementation group and to identify additional members.
Cells containing the CTD truncation mutation rpblAl04 and a recessive srb allele
were unable to grow at 12 0C and on pyruvate media when transformed with the
corresponding wild-type SRB allele.
Deletions of SRB7, SRB8 and SRB9 were created by a single step disruption
method (Rothstein, 1991). Z558 was transformed with the desired DNA
fragment and plated on SC-Ura media (Thompson et al., 1993). Southern
analysis was used to confirm that a single copy of the desired SRB gene had been
deleted. The diploid was sporulated and tetrads dissected (>20) on YEPD plates
and scored for nutritional auxotrophies and growth at a variety of temperatures.
Z697 was created by transformation with the srb7A1::URA3hisG fragment from
pCH46. Two spores from each tetrad were viable and these spores were uracil
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auxotrophs, indicating that SRB7 is essential. Z698 was created by transformation
with the srb8Al::URA3hisG fragment from pSL315 and Z699 was created by
transformation with the srb9A1::URA3hisG fragment from pCH66. In each case
segregants scored 2:2 for uracil prototrophy and all uracil prototrophs exhibited
mild cold-sensitive, temperature-sensitive, and slow growth phenotypes,
indicating that SRB8 and SRB9 deletion strains are conditionally viable. srb8Al
and srb9Al strains are also flocculent as are the suppressing isolates of SRB8 and
SRB9. Strains containing unmarked deletions of SRB8 and SRB9 were created by
selecting for the excision of the URA3 gene by growth on 5-FOA (Alani et al.,
1987).
DNA methods
DNA manipulations were performed according to Sambrook et al. (1989). Site-
directed mutagenesis was performed as described in Kunkel et al. (1987). PCR
amplifications to produce pCH45 (srb7Al), pSL315 (srb8AI), and pSL307 (SRB8 in
pET-3a) were performed with Taq DNA polymerase (Perkin Elmer) in 100 gL of
buffer (provided by the manufacturer) supplemented with 200 mM dNTP for a
total of 25 cycles. Primer concentrations were 0.5 mM with 50 ng of DNA and
cycling was at 94 0C (1.0 min), 50 0C (1.0 min) and 72"C (2.5 min).
Cloning and sequence analysis
Genomic clones of SRB7 (pCH2), SRB8 (pSL301), and SRB9 (pCH47) were
isolated as previously described (Liao et al., 1995) by transformation and
complementation of Z694, Z695, and Z696 respectively. When necessary, the
wild-type genes were further localized by subcloning fragments of the
genomic inserts and repeating the screen. The clones with the smallest
inserts were sequenced. pCH36 was created from pCH7 in vivo by
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transforming Z694 with linearized pCH7 lacking SRB7 coding DNA and
isolating the plasmid from a Ura+ transformant which had repaired the
plasmid with the mutant srb7-1 sequences from the chromosome (Rothstein,
1991). SRB7 and SRB9 were completely sequenced on each strand using
genomic DNA from pCH7 and pCH47, respectively. Unidirectional deletions
were constructed using the Erase-a-Base system (Promega) and double
stranded sequencing with dideoxynucleotides and Sequenase (US
Biochemical) was carried out as described by the manufacturer using T3 and
T7 promoter primers. Gaps in the sequence were filled in by sequencing with
internal oligonucleotide primers. Sequence comparison analysis was
performed at the National Center for Biotechnology Information using the
BLAST network service (Altschul et al., 1990).
The srb7-1 mutant allele obtained by plasmid gap repair in vivo
contained a single-point missense mutation changing alanine 21 to threonine
(Fig. 1B). Unlike their wild-type counterparts, plasmids containing this
mutation did not prevent growth at 12 C when transformed into yeast cells
containing the CTD truncation mutation rpblA104 and srb7-1(Z694),
indicating that the correct gene was cloned. Similar results were obtained for
the srb8-1 and srb9-1 mutant alleles obtained by plasmid gap repair in vivo.
The conditional phenotypes associated with CTD truncations are
suppressed both by srb8-1 or by complete deletion of SRB8 (Z695 vs. Z701).
Similarly, the conditional phenotypes associated with CTD truncations are
suppressed both by srb9-1 or by complete deletion of SRB9 (Z696 vs. Z703).
The mutations in srb8-1 or srb9-1 are thus likely to have at least partially
destroyed gene function, since cells containing either the suppressor or the
deletion alleles exhibit very similar phenotypes.
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The cloned genes were physically mapped using the prime lambda
clone grid filters of the yeast genome (provided by L. Riles and M. Olson,
Washington University).
Purification of recombinant proteins
Recombinant SRB proteins were purified for generating polyclonal antibodies
in rabbits. SRB7 and a portion of SRB8 (amino acids 868 to 1226) were
purified from the bacterial strain BL21(DE3) pLysS (Studier and Moffatt, 1986)
carrying the plasmids pCH34 and pSL307, respectively, in the same manner
SRB2 was purified (Koleske et al., 1992). A portion of SRB9 (amino acids 45 to
501) was purified as a fusion to glutathione-S-transferase from DH5a carrying
pCH64 according to the method of Smith and Johnson (1988).
GST-VP16, GST-VP16A456, and GST-VP16A456FP442 recombinant
proteins were purified from DH5x carrying pGVP, pGVPA456, and
pGVPA456-FP442 (provided by Michael Green), respectively, as described
(Smith and Johnson, 1988).
Mediator purification and assay
Mediator was purified essentially as described (Kim et al., 1994). In vitro
transcription assay for mediator activity was performed as described (Sayre et
al., 1992) with modifications (Liao et al., 1995). GAL4-VP16, TBP, TFIIB, and
TFIIE were prepared as described (Liao et al., 1995). TFIIF and TFIIH were
prepared as described (Sayre et al., 1992). RNA polymerase II was prepared as
described (Edwards et al., 1990).
Western blot analysis
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Western blotting was performed by standard methods (Harlow and Lane,
1989). RPB1 was detected via the CTD with 8WG16 monoclonal antibody
ascites fluid (Promega). Polyclonal rabbit anti-SRB2, anti-GST-SRB4, anti-
SRB5, anti-GST-SRB6, anti-SRB7, anti-SRB8 (aa 868 to 1226), anti-GST-SRB9
(aa 45 to 501), and anti-SRB10 (aa 1 to 271) antiserum were used to detect the
SRBs. TBP, TFIIB, SSA1, and GST were detected using specific rabbit
polyclonal antiserum. In all cases, bands were visualized by secondary
probing with alkaline phosphatase conjugated secondary antibodies
(Promega).
DEAE-400 fraction preparation
2 kg of dry yeast (Red Star) were disrupted essentially as described (Thompson
et al., 1993), except that the disruption buffer was 1.2 M ammonium sulfate,
160 mM HEPES-KOH pH 7.6, 4 mM DTT, 40 mM EDTA, 2 mM PMSF, 4 mM
benzamidine, 2 gM pepstatin A, 0.6 gM leupeptin, and 2 gg/mL chymostatin.
After the initial centrifugation, 1/100 volume of 10% Polymin P pH 7.0 was
added to the supernatant. The supernatant was incubated 10 min. at 40C and
then spun for 20 minutes at 5,000 rpm in a SorvallTM H6000A rotor. Solid
ammonium sulfate was added to 35% saturation, and the solution was
incubated for 30 minutes. The suspension was centrifuged for 1 hr at 13000
rpm in a GSA rotor. The pellet was resuspended in 9.5 L of Buffer A (20 mM
HEPES-KOH pH 7.6, 1 mM EDTA, 20% glycerol, 1 mM DTT, 0.5 mM PMSF, 1
mM benzamidine, 0.5 gM pepstatin A, 0.15 gM leupeptin and 1 gg/mL
chymostatin) to a conductivity equal to Buffer A-150 mM potassium acetate.
The resuspended pellet was centrifuged for 20 minutes at 5,000 rpm in a
H6000A rotor. The supernatant (6.14 g) was incubated for 1.5 hours with 500 g
of damp BioRex 70 pre-equilibrated in Buffer A-150 mM potassium acetate.
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The resin was collected by filtration, washed with 3 L of Buffer A-150 mM
potassium acetate, and packed into a column (5 cm width). The column was
eluted with Buffer A-600 mM potassium acetate at a flow rate of 8 mL/min.
The eluate (0.6 g, 165 mL) was diluted with 500 mL of Buffer B ( 20 mM Tris-
acetate pH 7.8, 1 mM EDTA, 20% glycerol, 0.01% NP-40, 1 mM DTT and the
same protease inhibitors as in Buffer A). The diluted eluate was centrifuged
for 10 minutes at 10,000 rpm in a GSA rotor. The supernatant was loaded
onto a column (5 cm width) containing 100 mL of DEAE-Sephacel pre-
equilibrated with Buffer B-200 mM potassium acetate at a flow rate of 8
mL/min. The column was washed with 200 mL of Buffer B-200 mM
potassium acetate and eluted with Buffer B-400 mM potassium acetate. The
eluate contained 150 mg of protein in 60 mL.
Immunoprecipitation
0.1 mL of the DEAE-400 fraction was dialyzed against Modified Transcription
Buffer (50 mM Hepes-KOH pH7.3, 100 mM potassium acetate, 25 mM MgAc,
5 mM EGTA, 1 gM DTT, 10% glycerol, 0.01% NP40, 1 mM PMSF, 2 mM
benzamidine, 2 iM pepstatin A, 0.6 pM leupeptin and 2 tg/mL chymostatin)
and subsequently diluted to 0.4 mL with Modified Transcription Buffer. lgg
of either affinity purified anti-SRB5 antibodies or purified anti-human TGF-
RII peptide (aa 30 to 44) IgG, and 1lg of recombinant GST-VP16 or GST-
VP16A456FP442 were added to the input. Immunoprecipitation was carried out
essentially as described (Harlow and Lane, 1989). 30 gL Anti-rabbit antibody
linked to dynabeads (Dynal) were used as the secondary reagent in the
immunoprecipitation.
Affinity chromatography
141
1 mL of the DEAE-400 fraction (for holoenzyme binding experiments) or 1 mL
of the mediator preparation (peak fractions from the heparin column) was
dialyzed for 2 hours against Modified Transcription Buffer. The GST-VP16,
GST-VP16A4 56 , and GST-VP16A456FP442 affinity columns were prepared by
immobilizing GST fusion proteins on glutathione-agarose beads as described
(Smith and Johnson, 1988). The columns contained 200 gL matrix and
contained approximately 300 pg of GST fusion proteins. The columns were
equilibrated with 6 mL Modified Transcription Buffer (minus DTT), loaded 3
times over with 0.2 mL of dialyzed DEAE-400 fraction (for holoenzyme
binding experiments) or 0.37 ml of the dialyzed mediator preparation (0.5
mg/mL), washed with 6 mL of Modified Transcription Buffer (minus DTT),
and eluted with buffer containing 50 mM Tris-Cl pH 7.5, 0.1 mM DTT and 5
mM glutathione, eluting both GST-fusion proteins and interacting proteins.
Figures
The figures were prepared from digital replicas of primary data scanned using
a UMAX UC840 Max Vision digital scanner.
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Table 2. Yeast Strains
Strain Alias Genotype
Z694 S242 Mata ura3-52 his3A200 leu2-3,112 rpb1A187::HIS3
Z695 S358 Mata ura3-52 his3A200 leu2-3,112 rpblA187::HIS3
Z696 S363 Mata ura3-52 his3A200 leu2-3,112 rpblAl87::HIS3
Z697 CHY102 Mata /Matca ura3-52/ura3-52 his3A200/his3A200
srb7A1::URA3hisG/SRB7
Z698 SLY35 Mata /Mata ura3-52/ura3-52 his3A200/his3A200
srb8Al::URA3hisG/SRB8
Z699 CHY105 Mata /Mata ura3-52/ura3-52 his3A200/his3A200
srb9Al:: URA3hisG/SRB9
Z700 SLY61 Mata ura3-52 his3A200 leu2-3,112 rpblA187::HIS.
[pRP114 (LEU2 CEN RPB1)]
Z701 SLY76 Mata ura3-52 his3A200 leu2-3,112 rpblA187::HIS
[pC6 (LEU2 CEN rpblA04)]
Z702 CHY113 Mata ura3-52 his3A200 leu2-3,112 rpb1A187::HISZ
[pRP114 (LEU2 CEN RPBI)]
Z703 CHY116 Mat a ura3-52 his3A200 leu2-3,112 rpb1A187::HIS.
[pC6U (URA3 CEN rpblA04)]
srb7-1 [pC6 (LEU2 CEN rpblA104)]
srb8-1 [pC6 (LEU2 CEN rpblA04)]
srb9-1 [pC6 (LEU2 CEN rpblA104)]
leu2-3,112/leu2-3,112
leu2-3,112/leu2-3,112
leu2-3,112/leu2-3,112
3 srb8Al::hisG
3 srb8Al::hisG
3 srb9Al::hisG
3 srb9Al::hisG
------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------
143
Table 3. Plasmids
Plasmid Description
SRB7
pCH2 SRB7 (6.7 kb) URA3 CEN
pCH7 SRB7 (2.0 kb) URA3 CEN
pCH36 srb7-1 URA3 CEN
pCH34 SRB7 in pET-3a (Studier and Moffat, 1986)
pCH46 srb7Al::URA3hisG in pSP72 (Promega)
SRB8
pSL301 SRB8 (9.0 kb) URA3 CEN
pSL311 SRB8 (6.0 kb) URA3 CEN
pSL307 SRB8 (encoding aa 868 to 1226) in pET-3a (Studier and Moffat, 1986)
pSL315 srb8Al::URA3hisG in pBSIISK(+) (Stratagene)
pSL316 srb8-1 URA3 CEN
SRB9
pCH47 SRB9 (7.3 kb) URA3 CEN
pCH64 SRB9 (encoding aa 45 to 501) in pGEX-1 (Smith and Johnson, 1988)
pCH66 srb9Al::URA3hisG in pSP72 (Promega)
pJZ995 srb9-1 URA3 CEN
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Chapter 3
Temporal regulation of RNA polymerase II by SrblO and Kin28 cyclin-
dependent kinases
151
Summary
Two cyclin-dependent kinases have been identified in yeast and mammalian
RNA polymerase II transcription initiation complexes. We find that the two
yeast kinases are indistinguishable in their ability to phosphorylate the RNA
polymerase II CTD, yet in living cells one kinase is a positive regulator and
the other a negative regulator. This paradox is resolved by the observation
that the negative regulator, SrblO, is uniquely capable of phosphorylating the
CTD prior to formation of the initiation complex on promoter DNA, with
consequent inhibition of transcription. In contrast, the TFIIH kinase
phosphorylates the CTD only after the transcription apparatus is associated
with promoter DNA. These results reveal that the timing of CTD
phosphorylation can account for the positive and negative functions of the
two kinases and provide a model for SrblO-dependent repression of genes
involved in cell type specificity, meiosis, and sugar utilization.
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Introduction
Cyclin-dependent kinases (CDKs), originally described as cell cycle regulators,
also have roles in transcription (reviewed in Dynlacht, 1997). Two distinct
cyclin-dependent kinases are associated with eukaryotic RNA polymerase II
transcription initiation complexes (Liao et al., 1995; Maldonado et al., 1996;
Pan et al., 1997; Scully et al., 1997). The yeast kinase Kin28, and it's
mammalian homologue Cdk7, are subunits of the general transcription factor
TFIIH, which phosphorylates RNA polymerase II subsequent to formation of
the pre-initiation complex (PIC) on promoter DNA (Feaver et al., 1994; Roy et
al., 1994; Serizawa et al., 1995; Shiekhattar et al., 1995). Yeast Srb1O, and it's
mammalian homolog Cdk8, are subunits of the RNA polymerase II
holoenzyme, but their functions are not yet understood (Liao et al., 1995;
Maldonado et al., 1996; Pan et al., 1997; Scully et al., 1997).
The C-terminal domain (CTD) of the large subunit of eukaryotic RNA
polymerase II (pol II) contains a repeated heptapeptide which is
phosphorylated in a portion of pol II molecules in the cell (Cadena and
Dahmus, 1987; Kolodziej, et al., 1990; reviewed in Dahmus, 1996). Several
lines of evidence indicate that PIC formation involves RNA polymerase II
molecules with unphosphorylated CTDs, and that these molecules become
phosphorylated during or after the transition to active elongation. The form
of pol II found in holoenzymes lacks phosphate on its CTD (Koleske and
Young, 1994; Kim et al., 1994). The unphosphorylated form of pol II
preferentially assembles into a PIC reconstituted with purified transcription
factors (Bartholomew et al., 1986; Laybourn and Dahmus, 1990; Lu et al., 1991;
Chesnut et al., 1992; Usheva et al., 1992; Kang et al., 1993; Maxon et al., 1994).
Since the phosphorylated CTD has a role in recruiting the mRNA capping
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enzyme to the nascent transcript, and mRNA capping occurs soon after
promoter clearance (Coppola et al., 1983; Cho et al., 1997; McCracken et al.,
1997a; McCracken et al., 1997b; Yue et al., 1997), CTD phosphorylation most
likely occurs during the transition from transcription initiation to elongation.
pol II molecules in the midst of elongation contain CTDs which are highly
phosphorylated (Bartholomew et al., 1986; Cadena and Dahmus, 1987; Weeks
et al., 1993; O'Brien et al., 1994).
The TFIIH kinase is apparently responsible for CTD phosphorylation
subsequent to PIC formation (Laybourn and Dahmus, 1990; Ohkuma and
Roeder, 1994; Akoulitchev et al., 1995; reviewed in Dahmus, 1996). Consistent
with such a role, TFIIH has been found as one of two CTD kinases stimulated
by the viral transactivator Tat (Parada and Roeder, 1996; Garcia-Martinez et
al., 1997; Cujec et al., 1997). The HIV-1 Tat protein enhances transcription
elongation by interacting with either TFIIH or P-TEFb CTD kinases to
stimulate CTD phosphorylation (reviewed in Jones, 1997; Yankulov and
Bentley, 1998). Loss-of-function mutations in the yeast TFIIH kinase subunit
cause a general defect on class II transcription in vivo (Cismowski et al., 1995;
Valay et al., 1995), confirming the positive role in transcription inferred from
in vitro studies.
RNA polymerase II holoenzymes have been purified from yeast and
mammalian cells which contain a second CDK implicated in CTD
phosphorylation. Genes encoding the Srb10 kinase, and its cyclin partner
Srbll, were initially identified in a yeast genetic screen designed to reveal
factors involved in CTD function; subsequent analysis revealed that their
protein products copurify with the other SRB proteins in the RNA
polymerase II holoenzyme (Nonet and Young, 1989; Liao et al., 1995).
Holoenzymes with a catalytically inactive Srb10 subunit have substantially
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reduced CTD kinase activity, suggesting that Srb1O is a CTD kinase (Liao et al.,
1995), but this has yet to be directly demonstrated. Mammalian Cdk8 and
cyclin C are apparently homologues of Srb1O and Srbll, as they share strong
sequence similarity and are both found in mammalian holoenzymes
(Maldonado et al., 1996; Pan et al., 1997; Scully et al., 1997; D. Chao and R.
Young, unpublished data).
While the function of the TFIIH kinase has been thoroughly studied,
the function of Srb1O is poorly understood. It is clear, however, that yeast
Kin28 and Srb1O CDKs are not functionally redundant. Substantial genetic
and biochemical evidence indicates that Kin28 plays an essential, general and
positive role in transcription. In contrast, the evidence suggests that Srb1O is
essential for regulation of a subset of genes which are involved in cell type
specificity (Wahi and Johnson, 1995), meiosis (Surosky et al., 1994), and sugar
utilization (Kuchin et al., 1995). How Srb1O contributes to the regulation of
these important genes is not yet clear.
Here we describe evidence that the two holoenzyme CDKs are
indistinguishable in their ability to phosphorylate the CTD, yet in living cells
Kin28 functions as a positive regulator and Srb1O as a negative regulator. The
different regulatory consequences appear to be due to the fact that the Srb1O
kinase is able to phosphorylate the CTD prior to holoenzyme binding to
promoter DNA, with consequent inhibition of transcription. In contrast,
Kin28 is active only after PIC formation, and plays a positive role through
CTD phosphorylation. These results support a novel model for
transcriptional regulation in which the negative and positive roles of the two
kinases, which act on the same substrate, are a consequence of the time at
which they are activated. This model describes how Srb1O contributes to
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repression of yeast genes involved in cell type specificity, meiosis, and sugar
utilization.
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Results
SrblO is a negative regulator of transcription in vivo
The SrblO gene was identified in a genetic screen designed to reveal genes
whose products interact functionally with the RNA polymerase II carboxy-
terminal domain (CTD) (Liao et al., 1995). Cells containing a CTD truncation
mutation exhibit conditional lethality, and extragenic suppressors (SRBs)
were identified which restore the ability of these cells to grow at the
nonpermissive temperature (reviewed in Koleske and Young, 1995). We
have found that the suppressing phenotype of the srbl0-1 allele, the original
recessive suppressor obtained in the selection, can be duplicated by altering a
single amino acid residue in Srb1O which is critical for its kinase function
(srbIO-3; SrblO(D290A)) or by deleting the entire SRB1O gene (srbIOAI) (Figure
1 A). The observation that loss-of-function mutations in SRB10 can restore
viability to yeast cells with a CTD truncation indicates that the Srb1O kinase
normally has a negative role in transcription in vivo.
The effect of SRB10 mutations on yeast cells with a spectrum of CTD
truncation mutations (Figure 1B) supports a negative role for Srb1O in
transcription. We previously demonstrated that progressive truncation of
the RNA polymerase II CTD produced cells with increasingly severe growth
phenotypes, and that these phenotypes were due to functional defects rather
than reduced stability of the pol II molecules (Nonet et al., 1987; Scafe et al.,
1990). The phenotypes exhibited by each of eighteen different strains, which
differ only in pol II CTD length, were classified into three categories:
nonviable (N) strains which failed to grow under any condition, conditional
lethal (C) strains which were cold sensitive, and viable (V) strains which
exhibited essentially wild-type growth phenotypes. The wild-type SRB10 gene
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Figure 1. SrblO is a negative regulator in vivo.
(A) Loss-of-function mutations in SRB1O rescue the conditional lethality of a
CTD truncation mutant. Strains with a truncated CTD (11 heptapeptide
repeats) are inviable when grown at 12 0C. Three different loss-of-function
mutations in the SRB1O gene restore viability to the CTD truncation strain.
srbIO-1, the original SRB suppressor, is a C-terminal truncation of the kinase,
srblOA1 is a deletion of the entire Srb1O coding sequence and srblO-3 is an
engineered point mutation (D290A) which renders the kinase catalytically
inactive. CTD repeat length is indicated on the left, growth temperature on
the right and SRB1O genotypes across the top.
(B) SRB1O loss-of-function alleles suppress growth defects across a spectrum
of CTD truncation mutations. The effect of loss-of-function mutations in
SRB2, SRB4, and SRB10 was investigated in strains containing progressively
truncated CTDs. The number of CTD repeats is shown on the horizontal axis,
and the plasmid carrying each CTD truncation allele is indicated (i.e. pN51).
The growth phenotypes exhibited by each CTD truncation mutant in the
presence of wild-type SRB genes or with mutations in SRB2, SRB4 or SRB1O
is shown. Non-viable (N) cells are indicated by a dashed line, conditional (C)
cells that are inviable at 12'C but can grow at 24'C are indicated with a thin
line, and viable (V) cells that exhibit wild-type growth characteristics under all
conditions tested are indicated by a heavy line. The loss of Srb1O increases the
viability of CTD truncation mutants, whereas the loss of Srb2 or Srb4
decreases the viability of the CTD mutants.
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was replaced with the srblO-1 or the srb1OA1 allele, and the growth
phenotypes of these cells were examined. The results, summarized in Figure
1B, demonstrate that the loss of Srb1O function restores full viability to CTD-
mutants which exhibited conditional lethal phenotypes in the presence of
wild-type Srb1O kinase activity. In addition, the loss of Srb1O function rescues
N15 cells, which were inviable with wild-type Srb10. Thus, the loss of this
putative CTD kinase increases the viability of cells whose pol II molecules
have shortened CTDs. In contrast, the loss of Srb2 or Srb4, both positive
acting transcription factors, decreases the viability of these cells (Figure 1B).
These results provide strong evidence that Srb1O is a negative regulator of
transcription in vivo.
An artificial holoenzyme recruitment assay (Barberis et al., 1995; Farrell
et al., 1996; reviewed in Ptashne and Gann, 1997) provides another in vivo
test of the hypothesis that Srb1O is a negative regulator. Tethering of a
holoenzyme component (such as Gall, Srb2, etc.) to a sequence specific DNA-
binding domain (LexA) is sufficient to activate transcription from a promoter
containing the appropriate upstream element, as the tethered holoenzyme
component apparently recruits the remaining transcription apparatus to the
promoter. If the kinase activity of Srb1O has a negative function in vivo, a
mutation which eliminates kinase activity but does not alter the ability of the
protein to interact with the holoenzyme should be a better artificial activator
than its wild-type counterpart because it would recruit holoenzyme as
efficiently as its wild-type counterpart, but would have no inhibitory effect on
transcription (Figure 2A). Strains were constructed which contain the LexA
DNA binding domain fused with either the wild-type Srb1O sequence or the
SrblO(D290A) sequence. The D290A mutation renders Srb1O protein
catalytically inactive but fully capable of being incorporated into the
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Figure 2. Artificial recruitment of holoenzyme with LexA-Srb fusion
proteins.
(A) Diagram of the experimental concept. If Srb1O is a negative regulator of
the transcription initiation complex, then a LexA-SrblO fusion protein should
recruit the transcription apparatus, yet repress transcription. In contrast, a
LexA-SrblO(D290A) fusion protein, in which the kinase is catalyticaly
inactive, should recruit the apparatus and produce levels of transcription
similar to those observed with Srb proteins which have positive roles in the
holoenzyme.
(B) A wild-type strain containing the LexA-lacZ reporter plasmid pSH18-34
was transformed with plasmids expressing LexA alone, or LexA fused to Srb6,
SrblO, or SrblO(D290A) as indicated. The specific activity of $-galactosidase is
expressed in nmoles of o-nitrophenol produced/min/mg of total protein
assayed. As predicted by the model in (A), the LexA-SrblO protein is a very
poor artificial activator whereas the LexA-SrblO(D290A) fusion protein is a
good activator. The LexA-SrblO(D290A) fusion activates as well as LexA-
fusions with Srb proteins which have positive functions; LexA-Srb6 is shown
as an example. The Srb1O protein is active in vivo when fused to LexA; the
LexA-SrblO expression plasmid complements all phenotypes associated with a
srblOA strain (data not shown). Western blots of whole cell extracts probed
with x-LexA antibodies show that LexA-SrblO, LexA-SrblO(D290A), and LexA-
SRB6 are all expressed at similar levels.
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holoenzyme (Liao et al., 1995). The results of the experiment (Figure 2B)
demonstrate that LexA-Srb1O has substantially less activity in artificial
recruitment than LexA-SrblO(D290A). This result supports the model that
the Srb1O kinase is a negative regulator of transcription in vivo.
CTD Phosphorylation by Srb1O and Kin28 CDKs
Although two CDKs have been identified in yeast and mammalian
holoenzyme preparations (Liao et al., 1995; Maldonado et al., 1996; Pan et al.,
1997; Scully et al., 1997), only the TFIIH kinases have been demonstrated to
phosphorylate the CTD directly (Feaver et al., 1991; Lu et al., 1992; Serizawa et
al., 1992). The Srb1O kinase has been proposed to be a CTD kinase based upon
genetic evidence for a interaction with the CTD and evidence that
holoenzyme preparations lacking Srb1O activity have substantially reduced
CTD kinase activity (Liao et al., 1995). We tested whether purified SrblO has
CTD kinase activity and, if so, how it compares to Kin28 CTD kinase activity.
Epitope-tagged recombinant Srb10/Srb11 and Kin28/Ccll cyclin-dependent
kinases were expressed in a baculovirus expression system and purified in a
one-step affinity purification (Figure 3). Catalytically inactive recombinant
SrblO(D290A)/Srbl1 and Kin28(D147A)/Ccll cyclin-dependent kinases were
also produced and purified as controls. Both Srb1O/Srb1l and Kin28/Ccll
were found to be capable of phosphorylating recombinant glutathione-S-
transferase-CTD (GST-CTD) (Figure 4A). The recombinant kinase-cyclin pairs
phosphorylated rGST-CTD and pure yeast RNA polymerase II with similar
efficiencies (data not shown). Neither kinase could phosphorylate GST alone,
calf thymus histone H1, the other kinase-cyclin pair, or general transcription
factors (GTFs) (Figure 4A and data not shown). The activity of Srb1O/Srb11
and Kin28/Ccll could be directly attributed to the highly purified kinases,
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Figure 3. Purification of recombinant SrblO/Srbll and Kin28/Ccll cyclin-
dependent kinases (CDKs).
(A) Scheme for production and purification of recombinant holoenzyme
CDKs from Sf21 cells co-infected with baculovirus encoding a kinase (SrblO or
Kin28) and the corresponding cyclin partner (Srbll or Ccli, respectively).
FLAG-epitope tagged recombinant Srb1O/Srb11 and Kin28/Ccll and their
inactive mutant derivatives, Srb1OD29 A/Srb11 and Kin28 D147A/Ccll were
purified in a single step from whole cell extracts of baculovirus infected insect
cells using an anti-FLAG affinity column.
(B) Purity of recombinant kinase-cyclin pairs. Onput (OP), Flowthrough (FT),
Wash (W) and Eluate (E) fractions of the anti-FLAG affinity column were
subjected to SDS-PAGE electrophoresis followed by Coomassie (upper panel)
or silver staining (lower panel). The identities of the kinase and cyclin
subunits and position of the molecular weight markers (MW) in kiloDaltons
is shown.
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Figure 4. Recombinant CDKs are indistinguishable in CTD phosphorylation
activity.
(A) Holoenzyme associated CDKs phosphorylate the CTD, but not histone H1
in vitro. Recombinant GST, GST-CTD, or calf thymus H1 substrates were
incubated with pure recombinant CDK/cyclin pairs in the presence of 'y.32P-
ATP, separated by SDS-PAGE and visualized by autoradiography. Label is
transferred only to the GST-CTD fusion and not to GST or histone H1, a well
studied kinase substrate.
(B) Purified mutant recombinant CDKs exhibit no kinase activity. Wild-type
and mutant CDKs were incubated with GST-CTD in the presence of y-32 P-ATP
as in panel A. The inactive CDK/cyclin pairs contained a point mutation at a
highly conserved aspartate residue critical for catalytic activity. The absence of
a labeled product in the mutant CDK/cyclin preparations suggests the
observed activity is not due to a contaminating kinase.
(C) Phosphoamino acid analysis of in vitro phosphorylated CTD.
Recombinant GST-CTD was incubated with recombinant CDK/cyclin pairs in
the presence of y-32 P-ATP. After SDS-PAGE and transfer to a PVDF
membrane, the labeled CTD band was cut out and subjected to acid hydrolysis.
The phosphoamino acids were separated by two-dimensional thin layer
electrophoresis. Amino acid standards were visualized by ninhydrin and
their mobilities shown on the left, while the labeled phosphoamino acids
were visualized by autoradiography as shown in the middle and right panel.
Serine is the primary phosphoacceptor on the GST-CTD substrate for both
SrblO/Srbi1 and Kin28/Ccll kinases.
(D) Holoenzyme CDKs show identical specificity for synthetic CTD peptide
substrates. Synthetic peptides consisting of three heptapeptide consensus
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repeats, or mutant variations thereof, were used as substrates for recombinant
holoenzyme CDKs. The wild-type (WT) heptapeptide consensus sequence as
well as the amino acid numbering used in describing various mutants is
shown at the bottom of the figure. After SDS-PAGE, the phosphorylated
peptides were visualized by autoradiography. The Ser 5 to Ala mutant peptide
was unable to serve as a substrate for either CDK, strongly suggesting that Ser 5
is the primary substrate labeled by the CDKs.
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since the catalytically inactive CDK mutant kinases were unable to
phosphorylate GST-CTD at any level (Figure 4B). These results demonstrate
that Srb1O and Kin28 CDKs are both capable of phosphorylating the CTD.
Genetic evidence presented here and elsewhere (Cismowski et al., 1995;
Valay et al, 1995) indicate that Kin28 and Srb1O contribute positive and
negative functions, respectively, to transcription in vivo. We investigated
the possibility that differential phosphorylation of the CTD by the two CDKs
might account for their different functions. The amino acid residues of the
CTD phosphorylated in vitro by the two CDKs were identified by two
dimensional thin layer chromatography. The results demonstrate that both
Srb1O and Kin28 phosphorylate serine residues (Figure 4C).
To investigate further the substrate specificity of the two CTD kinases,
a battery of synthetic peptides were used as substrates to determine which
amino acid residues in the heptapeptide consensus repeat are critical for CTD
phosphorylation (Figure 4D). The results show that the activities of Srb10 and
Kin28 on these peptide substrates are indistinguishable. Substitution of Ser 2,
Thr 4 or Ser7 with alanine did not significantly affect the ability of the peptide
to act as a substrate for either kinase. In contrast, substitution of Ser 5 with
alanine led to a dramatic loss in peptide phosphorylation, suggesting that Ser 5
is the principal phosphoacceptor in the heptapeptide repeat. Substitutions of
Tyrp, Pro3 or Pro6 reduced phosphorylation of the synthetic peptides, probably
due to the effects such alterations have on their structure. These results
indicate that Srb1O and Kin28 CDKs are indistinguishable in substrate
specificity and activity in these CTD phosphorylation assays.
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Srb1O Dependent Inhibition of Transcription In Vitro
The existence of two CDKs in the holoenzyme with similar biochemical
specificity and activity, yet opposite in vivo function, led us to entertain the
possibility that the timing of CTD phosphorylation in the holoenzyme could
determine whether the event had a negative or a positive consequence.
Although both kinases are capable of CTD phosphorylation as purified,
recombinant kinase-cyclin pairs, it is possible that they can function only at
certain times when assembled in the holoenzyme. We therefore considered a
temporal model for the action of these kinases, in which Srb1O is uniquely
capable of CTD phosphorylation prior to initiation complex formation by the
holoenzyme, thereby repressing transcription. In contrast, Kin28, when
assembled into the holoenzyme, is capable of CTD phosphorylation only after
preinitiation complex formation, when such activity would not interfere
with transcription.
This temporal model predicts that holoenzymes with catalytically
active Srb1O should be transcriptionally inhibited when the kinase functions
prior to association with template DNA. RNA polymerase II holoenzymes
containing Kin28 and either wild-type Srb1O or catalytically inactive
SrblO(D290A) were purified in parallel and assayed for kinase and
transcriptional activities (Figure 5). The two purified holoenzymes contained
comparable amounts of Rpbl, Srb2, Srb4, Srb5, Srb1O and Kin28 (Figure 5A).
To determine whether Srb1O kinase activity can inhibit transcription by acting
prior to PIC formation, we performed an in vitro transcription experiment in
which both wild-type and mutant Srb1O containing holoenzymes were
preincubated with ATP prior to addition of template DNA, additional GTFs
and nucleoside triphosphates (NTPs) (Figure 5B). Preincubation with ATP
produced a significant inhibition of transcription with the wild-type
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Figure 5. Catalytically active Srb10 can inhibit transcription by RNA
polymerase II holoenzyme in vitro.
(A) Purified holoenzymes contain similar amounts of Rpbl, Srb2, Srb4, Srb5
and the kinases Srb10 and Kin28. Wild-type and Srb10 (D290A) mutant
holoenzymes were purified in parallel and analyzed by western blot.
Monoclonal antibodies specific to unphosphorylated CTD (a-P- CTD; 8WG16)
were used to detect Rpbl.
(B) Holoenzymes containing either wild-type Srb10 kinase (lanes 1-2) or
catalytically inactive SrblO(D290A) kinase (lanes 3-4) were preincubated with
or without ATP prior to PIC formation and analyzed as diagrammed. Only
holoenzymes containing functional Srb10 are inhibited for transcription
when kinases are allowed to function before PIC formation (compare lanes 2
and 4). In vitro transcription is performed in the presence of c-32 P-UTP
resulting in internal labeling of a 400 nucleotide transcript derived from a G-
less cassette driven by the CYCI promoter. The state of CTD phosphorylation
after ATP preincubation was monitored by western analysis using
monoclonal antibodies specific to unphosphorylated (ct-P- CTD; 8WG16) or
Ser-phosphorylated CTD (c-P+ CTD; H5). CTD phosphorylation occurs
during preincubation only in holoenzymes containing functional Srb10
kinase (compare lanes 2 and 4). Control experiments indicate that the Srb10
CTD kinase activity is largely restricted to the holoenzyme in which it resides
(data not shown). Srb4 is probed as a loading control.
(C) Changes in mAb reactivity to RPB1 is due to phosphorylation.
Holoenzyme containing functional Srb10 was incubated with ATP (lanes 1-2).
The signal obtained when the phosphorylated preparation is probed with
mAb 8WG16 (u.-P- CTD) is reduced and the mobility of RPB1 is retarded (lane
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3). The same preparation then reacts with the phospho-serine CTD specific
H5 mAb (c-P+ CTD). Subsequent treatment of the sample with protein
phosphatase eliminates the H5 reactive band and restores 8WG16 reactivity
and mobility to that seen prior to ATP incubation (compare lanes 1 and 4).
This indicates the mAbs are accurately probing the phosphorylation state of
the CTD.
(D) Srb1O kinase does not affect transcription post PIC formation.
Holoenzymes containing either wild-type Srb1O kinase (WT) or catalytically
inactive SrblO(D290A) kinase, preincubated with template DNA and GTFs
prior to addition of NTPs, exhibit identical transcriptional activity (top panel).
The state of CTD phosphorylation after transcription was monitored with the
phospho-serine specific H5 mAb (cc-P+ CTD). Both wild-type and
srblO(D290A) containing holoenzymes are able to phosphorylate the CTD.
Srb4 is probed as a loading control (bottom panel).
174
holoenzyme, but not with the holoenzyme lacking Srb1O catalytic activity
(Figure 5B; compare lanes 2 and 4). These data show that transcription by
RNA polymerase II holoenzyme is inhibited when the Srb1O kinase is
allowed to function prior to PIC formation.
pol II CTD phosphorylation was monitored in the holoenzymes that
were subjected to preincubation with and without ATP (Figure 5B). CTD
phosphorylation occurred only in holoenzymes containing catalytically active
Srb1O (Figure 5B, compare lanes 2 and 4). Kin28 is apparently not active in the
holoenzyme prior to PIC formation, because the Srb1O mutant holoenzyme
exhibits essentially no CTD phosphorylation activity during the
preincubation. The SrblO-dependent phosphorylation of the CTD was highly
efficient; most of the pol II molecules in the wild-type holoenzyme became
phosphorylated in this reaction (Figure 5B, compare lanes 1 and 2). A control
experiment confirmed the specificity of the antibodies used to detect
unphosphorylated and phosphorylated CTDs (Figure 5C). Thus, Srb10-
dependent CTD phosphorylation is coincident with repression of
transcription, a result consistent with previous evidence that formation of a
functional preinitiation complex is impaired if the pol II molecules contain
phosphorylated CTDs (Lu et al., 1991; Chesnut et al., 1992; Usheva et al., 1992;
Kang et al., 1993; Maxon et al., 1994).
The temporal model also predicts that RNA polymerase II
holoenzymes which are allowed to bind template DNA prior to addition of
nucleoside triphosphates should not be transcriptionally inhibited by Srb1O
activity. The experiment shown in Figure 5D shows that the wild-type and
Srb1O mutant holoenzymes are in fact equally active in transcription under
these conditions, confirming the prediction. The state of CTD
phosphorylation was also assayed after the transcription reaction, revealing
175
that CTD phosphorylation occurs in RNA polymerase II molecules from
holoenzymes with or without functional SrblO, albeit the levels are three-fold
less in holoenzymes lacking catalytically active Srb1O kinase. These results
indicate that SrblO-independent CTD phosphorylation occurs during the in
vitro transcription reaction, as would be expected from the action of Kin28.
We and others have found that Srb1O is critical for regulation of a
subset of genes in yeast cells, including those involved in cell type specificity
(Wahi and Johnson, 1995), meiosis (Surosky et al., 1994), and sugar utilization
(Liao et al., 1995; Kuchin et al., 1995). SrblO is not a general repressor of
transcription, as a variety of genes are expressed normally in SrblO mutant
cells (Surosky et al., 1994, Liao et al., 1995), and the levels of active
holoenzyme are similar in wild-type and Srb1O mutant cells (S.S.K. and R.Y.,
unpublished). The observation that Srb1O is not a general repressor of
protein-coding genes suggests that in living cells, where there is abundant
ATP, Srb1O activity in holoenzymes must be inhibited in order to prevent
constitutive inactivation of the general transcription initiation apparatus. To
test this idea, we produced nuclear extracts from wild-type and SrblO(D290A)
mutant strains and investigated whether the wild-type extract showed an
ATP-dependent inhibition of transcription prior to PIC formation. We
previously showed that the transcriptional activity in these extracts is entirely
dependent on components of the Srb/mediator complex (Koleske et al., 1992;
Thompson et al., 1993), which are tightly associated with pol II holoenzymes
(Koleske and Young, 1994). The results, shown in Figure 6, demonstrate that
transcription in nuclear extracts is not inhibited by preincubation with ATP,
suggesting that these extracts contain an SrblO inhibitory activity which is lost
during holoenzyme purification.
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Figure 6. Nuclear extracts show no SrblO-dependent inhibition of
transcription by RNA polymerase II holoenzyme.
Nuclear extracts from cells containing either wild-type Srb1O kinase or
catalytically inactive SrblO(D290A) kinase were preincubated with or without
ATP prior to PIC formation, as diagrammed (the experimental design is
identical to that in Figure 5B). In vitro transcription is performed in the
presence of oC- 32 P-UTP resulting in internal labeling of a 400 nucleotide
transcript derived from a G-less cassette driven by the CYCI promoter. No
inhibition of transcription was observed after ATP preincubation with either
extract.
178
Discussion
Yeast and mammalian RNA polymerase II holoenzymes have been described
which contain two cyclin-dependent kinases. Previous studies established
that Kin28 is a CTD kinase with a positive role in transcription, that of
producing a phosphorylated form of the enzyme which is associated with
active elongation. Genetic and biochemical evidence described here reveals
that the Srb1O kinase is a CTD kinase with a negative role in transcription.
Srb1O is uniquely capable of phosphorylating the CTD in purified
holoenzymes prior to template binding, and this phosphorylation inhibits
subsequent transcription by the holoenzyme. Srb1O does not appear to inhibit
transcription after formation of a stable preinitiation complex. Thus, the
transcription initiation apparatus can be regulated positively or negatively via
modification of the CTD, depending on the timing of the phosphorylation
event (Figure 7).
In arriving at this temporal model, we first examined the two most
obvious models which could account for differential regulation by the two
CDKs. It was possible that the Srb1O and Kin28 kinases could act on other
substrates in the transcription initiation apparatus, but we did not detect
phosphorylation of general transcription factors or histones, nor did we find
that either kinase could phosphorylate the other. It was also possible that the
two kinases phosphorylated different residues on the CTD, but our
experiments indicate that they exhibit very similar substrate recognition and
modification behaviors. The one clear difference in behavior was the unique
ability of Srb1O to phosphorylate the pol II CTD prior to initiation complex
formation when a component of the holoenzyme. We conclude that the
temporal regulation of transcription by CDKs is an instance where a specific
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Figure 7. Model for temporal function of holoenzyme CDKs in transcription
initiation.
The two holoenzyme cyclin-dependent kinases are CTD kinases which
function at different times. SrblO-dependent CTD phosphorylation can occur
prior to stable preinitiation complex (PIC) formation at a subset of promoters,
presumably activated by factors associated with these promoters, with
consequent inhibition of transcription. The Kin28 kinase functions after
stable PIC formation at promoters generally, producing the
hyperphosphorylated form of pol II associated with productive elongation.
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phosphorylation event, carried out at different times, can produce opposite
regulatory effects in the cell.
Negative Regulation by Srb1O in vivo
Progressive truncation of the RNA polymerase II CTD produces cells with
increasingly severe growth phenotypes (Nonet et al., 1987). The greater the
truncation of the CTD, the larger the number of genes affected, accounting for
the increasingly severe growth phenotypes (Scafe et al., 1990). The SRB genes
were originally identified as suppressors of defects due to CTD truncation. A
subset of these genes, for example those encoding Srb4 and Srb6, are essential
for expression of most protein-coding genes (Thompson and Young, 1995). In
contrast, Srb8, Srb9, Srb1O and Srb11 are not essential for expression of protein
coding genes generally, but are critical for normal regulation of a subset of
genes (Surosky et al., 1994; Kuchin et al., 1995; Liao et al., 1995; Wahi and
Johnson, 1995).
Genetic and biochemical evidence indicates that Srb2, Srb4, Srb5 and
Srb6 all contribute positively to holoenzyme function (Koleske and Young,
1995; Hengartner et al., 1995). For example, mutations which reduce the
function of the Srb2, Srb4, Srb5, Srb6 or Srb7 proteins cause reduced cell
viability, and this is exacerbated in cells with CTD truncation mutations
(Koleske at al., 1992; Thompson et al., 1993; Hengartner et al., 1995). In
contrast, mutations which eliminate Srb1O or Srb11 function actually restore
viability to cells with CTD truncation mutations. This, and additional genetic
evidence, indicates that Srb1O is a negative regulator of transcription. Highly
repressed genes such as SPO13, GALl, SUC2, PHO5, and MFA2 are
derepressed in strains lacking Srb1O activity (Kuchin et al., 1995; Liao et al.,
1995; Wahi and Johnson, 1995; S.-M. L. and R. Y., unpublished). Since Srb1O
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represses only a subset of genes, there must be a mechanism to activate the
kinase solely at these genes. We suggest that promoter specific factors repress
transcription at these genes by stimulating an otherwise quiescent Srb1O prior
to stable association of the holoenzyme with promoter DNA (Figure 7).
Phosphorylation of CTD by Srb1O and Kin28
Previous studies demonstrated that the kinase activity of purified TFIIH
could phosphorylate the CTD (Feaver et al., 1991; Lu et al., 1992; Serizawa et
al., 1992). Previous reports also indicated that SrblO is involved in CTD
phosphorylation, as the SRB10 gene was identified in genetic selection for
suppressors of a CTD truncation defect, and holoenzymes with catalytically
inactive Srb1O protein have markedly reduced CTD phosphorylation activity
(Liao et al., 1995). The use of highly purified recombinant forms of the two
yeast CDKs allowed us to demonstrate that they phosphorylate the CTD, to
identify the residues of the heptapeptide which are modified, and to compare
and contrast their activities. SrblO/Srbll and Kin28/Ccll phosphorylate the
CTD with similar efficiency and are indistinguishable in their specificity
towards recombinant full length CTD or synthetic heptapeptide repeats, down
to the specific residue they modify, Ser5 . These results suggest that the
positive and negative regulatory functions of the two CDKs are not due to
differences in substrate specificity.
Temporal Regulation via CTD Phosphorylation
The form of pol II found in RNA polymerase II holoenzyme preparations
lacks phosphate on its CTD (Koleske and Young, 1994; Kim et al.. 1994).
Several experimental observations led us to postulate that the timing of CTD
phosphorylation in the holoenzyme determines whether the event has a
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negative or a positive consequence. The two holoenzyme CDKs have very
similar biochemical specificity and activity, yet opposite in vivo function. In
an assay designed to measure transcriptional activity subsequent to template
binding, wild-type and SrblO(D290) mutant holoenzymes are
indistinguishable. However, previous studies have shown that the
phosphorylation state of the CTD affects PIC formation; formation of such a
complex is impaired if the pol II molecules contain phosphorylated CTDs (Lu
et al., 1991; Chesnut et al., 1992; Usheva et al., 1992; Kang et al., 1993; Maxon et
al., 1994). If one of the holoenzyme kinases phosphorylates the CTD prior to
template association, it could inhibit subsequent transcription.
We carried out an experiment designed to identify an effect of kinase
activity in the holoenzyme prior to pre-initiation complex (PIC) formation on
template DNA. This experiment revealed that CTD phosphorylation and
transcription inhibition does occur when holoenzymes are provided with
ATP prior to template association, but only if Srb1O is catalytically active. In
contrast, Kin28 kinase activity in these holoenzymes is not evident prior to
template association, but is evident later in the transcription reaction. Thus,
the positive and negative roles of the two kinases can be attributed to the time
at which they act during the process of transcription initiation. In this model,
SrblO-dependent CTD phosphorylation prior to stable PIC formation at
specific promoters inhibits transcription initiation, accounting for the
negative regulatory activity observed for Srb1O in vivo. In contrast, Kin28
phosphorylation of the pol II CTD subsequent to PIC formation has a positive
role, that of producing the phosphorylated RNA polymerase II molecule
which recruits mRNA capping enzyme and which is associated with efficient
elongation of the nascent transcript (Cho et al., 1997; McCracken et al., 1997a;
McCracken et al., 1997b; Yue et al., 1997).
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Regulation of CDKs
Cyclin-dependent kinases were first described as cell cycle regulators. These
kinases are themselves regulated in a temporal fashion through pairing with
various cyclins, through phosphorylation events which can have positive or
negative effects, and through interactions with CDK inhibitors. The two
holoenzyme CDKs are paired with cyclin molecules, but are not typically
activated, since holoenzyme preparations contain RNA polymerase II
molecules with unphosphorylated CTDs. Furthermore, our experiments
suggest that Srb1O kinase activity is inhibited in nuclear extracts. The future
identification of this CDK regulator should reveal important new insights
into the molecular mechanisms involved in regulation of cell type specificity,
meiosis, sugar utilization and other important cellular processes under the
control of Srb1O.
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Experimental Procedures
Genetic Analysis
To examine the ability of various SRB10 alleles to suppress the conditional
phenotypes caused by a truncated CTD (rpbA104), yeast strains Z768 and Z769
(Table 1) were transformed with plasmids containing SRB1O (pRY2973), srblO-
1 (pRY7091), srblOAl (pRY2966), and srblO-3 (pRY7096). Growth conditions
were assayed as described (Nonet et al., 1987).
Growth phenotype analysis of yeast cells containing CTD truncation
mutations was performed as described (Nonet et al., 1987). The various
SRB1O background strains used were N418 (SRB10), Z741 (srblOAl) and Z735
(srblO-1) (Table 1). The viability of cells containing CTD truncations in those
backgrounds were assayed by plasmid shuffle, and surviving strains were
tested for cold sensitivity.
In Vivo Recruitment Assays
f-galactosidase assays were performed as described (Rose and Botstein, 1983).
The strains are derivatives of Z719 transformed with the reporter pSH18-34
and the appropriate LexA fusion. To make the LexA fusions, SRB10, srbl0-3,
and SRB6 open reading frames were subcloned into the LexA fusion plasmid
pEG202 (Ausubel et al., 1997).
Recombinant CDK/cyclin Production and Purification from Insect Cells
Recombinant CDK/cyclin pairs were produced using a baculovirus expression
system. For expression of CDKs, genes for Srb1O and Kin28 were amplified by
polymerase chain reactions (PCR) and cloned into baculoviral transfer vectors
pSK277 or pSK278 (Koh et al., 1997) to produce recombinants with FLAG
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epitope-tag at their N-termini. For expression of cyclins, genes for Srb11 and
Ccli were amplified by PCR and cloned into baculoviral transfer vectors
pBacPAK8 or pBacPAK9 (Clontech). PCRs were performed with Vent DNA
polymerase (New England Biolabs). All the PCR clones were verified by DNA
sequencing. Mutant CDK clones, SrblO(D290A) and Kin28(D147A), were
produced by site-directed in vitro mutagenesis (Kunkel et al., 1987) using
oligonucleotides CAAAACCTAAAGCACCAATTTT and
CCTTGCTAGACCGAAAGCTGCTACTTTTATCTG, respectively. All
mutations were verified by DNA sequencing.
Recombinant baculoviruses were generated from the recombinant
transfer plasmids containing CDKs or cyclins by cotransfection of the plasmids
with wild-type viral DNA as recommended by the manufacturer (Clontech).
Spodoptera frugiperda (Sf21) cells were coinfected with recombinant
baculoviruses expressing CDKs and their cyclin partners at a multiplicity of
infection (m.o.i.) of 5-10. The cells from 200 mL of culture (approx. 3 x 108)
were collected 60-72 hr post-infection and lysed by sonication. The lysates
were then clarified by centrifuging for 3 hr at 100,000 x g yielding 20-40 mg of
total protein in 10 mL. CDK/cyclin pairs were purified from the lysates as
described (Koh et al., 1997) using 1 mL of anti-FLAG M2 affinity gel and 73
gg/mL of FLAG peptide in the elution buffer. Typical yields were 0.2-0.4 % of
total protein from cell lysate.
Kinase Assay
Kinase assays were performed using 1 Rg of protein substrate (GST,
recombinant GST-CTD, or calf thymus histone H1) or 15 gg of synthetic CTD
peptide substrate with 100 ng of pure recombinant CDK/cyclin pairs in 15 gl
reaction containing 20 mM Hepes-KOH, pH 7.3, 10% glycerol, 2.5 mM EGTA,
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15 mM magnesium acetate, 1 mM DTT, 100 mM potassium acetate, 200 tM
ATP, 10 pCi [y-32P] ATP (NEN, 6000 Ci/mmol, 10 mCi/ml), a mixture of
phosphatase inhibitors (1 mM NaN 3, 1 mM NaF, 0.4 mM NaVO3 , 0.4 mM
Na3VO 4), a cocktail of protease inhibitors (0.5 mM PMSF, 1 mM benzamidine,
1 gM pepstatin, 0.3 gM leupeptin and 1 [tg/ml chymostatin) and 0.5 mg/ml of
acetylated BSA. Reactions were assembled on ice and initiated with the
addition of ATP. After 60 min at 250C , the reactions were terminated by
adding 15 gl of Stop Buffer (2X SDS-PAGE loading buffer supplemented with
100 mM Tris-HCl, pH 6.8, and 40 mM EDTA) and then resolved by 4-20%
acrylamide gradient SDS-PAGE. The dried gels were exposed directly to
autoradiographic films.
Kinase substrates GST and GST-CTD were purified from bacteria as
described (Thompson et al., 1993) and purified calf thymus histone H1,
purchased (Boehringer Mannheim). Triple CTD heptapeptide consensus
repeats were synthesized (Research Genetics) and were provided in the form
H-YSPTSPSYSPTSPSYSPTSPS-Amide. CTD peptide variants where one or
more amino acids of the consensus sequence have been systematically
replaced by alanine were also synthesized by Research Genetics.
Phosphoamino Acid Analysis
Using GST-CTD as a substrate, a kinase reaction was performed. After SDS-
PAGE, the samples were transferred to a PVDF membrane and the labelled
phosphorylated GST-CTD band, localized and cut out after a short film
exposure. Two-dimensional electrophoretic analysis of phosphoamino acid
content was performed subsequent to acid hydrolysis as described in Coligan
et al. (1997). The phospholabelled phosphoamino acids were visualized by
autoradiography.
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Nuclear Extract Transcription
Nuclear extracts from Z719 and Z690 were prepared according to Lue et al.
(1991) with the modifications described by Liao et al. (1991), yielding a final
protein concentration of 85 and 75 mg/ml, respectively. In vitro transcription
was carried out essentially as described (Liao et al., 1991). Each reaction
contained 90 pg of Z719 protein or 120 jig of Z690 protein with 250 ng of
template.
Transcription and Western Blot Analysis
Holoenzyme was purified according to Liao et al. (1995). In vitro transcription
reactions were performed essentially as described (Gadbois et al., 1997) with
the following modifications. Preincubations (19g1 total) contained all
reaction components except TBP, TFIIE, TFIIB, nucleotides and DNA
template; ATP containing reactions were brought to a final ATP
concentration of 1mM with 100 mM stock (Pharmacia). After a fifteen
minute preincubation at room temperature, GTFs (3 ptl) and NTP mix (4 jil; 5
mM ATP, CTP, 0.156 mM UTP, 0.25 mM 3'-O-Me GTP and 10 RCi [x- 32P] UTP
3000 Ci/mmole ) containing 100ng DNA template (pGALA) were added for a
final reaction volume of 26 jil. After allowing transcription to proceed for 30
minutes at room temperature, reactions were stopped by addition of 125 pl
stop buffer (10 mM Tris-HCl, pH 7.5, 20 mM EDTA, 2 M ammonium acetate,
and 10 jig/ml glycogen) and 150 g1 isopropanol. Samples were placed on dry
ice for 10 min., microcentrifuged at 14K RPM for 10 min., pellets resuspended
in 6 ji formamide loading dyes and electrophoresed on a 4% Urea-containing
denaturing polyacrylamide gel. Gels were dried and exposed to Kodak X-AR
film at -80'C with an intensifying screen.
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Samples for western blot analysis were fractionated on 5% SDS-PAGE
gels and transferred according to standard procedures. 8WG16 monoclonal
antibody (Babco) and Srb4 rabbit anti-serum were used at 1:1000, H5
monoclonal antibody (Babco) was used at 1:250. HRP-conjugated anti-mouse
(Pierce) and anti-rabbit (Amersham) secondary antibodies were used at 1:2000.
Detection was performed by ECL according to the manufacturers directions
(Amersham).
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Table 1. Yeast Strains
Strain Alias Genotype Reference
------------------------------------------------------------ 
------
Z768 SLY67 Mata ura3-52 his3A200 leu2-3,-112
[L14 (LEU2 CEN RPB1)]
Z769 SLY69 Mata ura3-52 his3A200 leu2-3,-112
[C6 (LEU2 CEN rpblAl04)]
N418 Mata ura3-52 his3 A200 leu2-3,-112
[pRP112 (URA3 CEN RPB1)]
Z741 SLY37 Mata ura3-52 his3.A200 leu2-3,-112
[pRP112 (URA3 CEN RPB1)]
Z735 SLY26 Mata ura3-52 his3A200 leu2-3,-112
[pRP112 (URA3 CEN RPBI)]
Z687 SLY7 Mata ura3-52 his3A200 leu2-3,-112
Z690 SLY96 Mata ura3-52 his3A200 leu2-3,-112
rpblA187::HIS3 srblOAl::hisG
rpblA187::HIS3 srblO.A1::hisG
rpb1A187::HIS3 SRB10
rpb1A187::HIS3 srbIOAl::hisG
rpblA187::HIS3 srblO-1::hisG
RPB1 srblOAl::hisG
RPB1 srblO-3::hisG
Z719 SLY3 Mata ura3-52 his3A200 leu2-3,-112 RPBI SRB10
This study
This study
Nonet et al., 1989
This study
This study
Liao et al., 1995
Liao et al., 1995
Liao et al., 1995
--------------------------------------------------------------------------------------
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Chapter 4
Genome-wide survey of genes regulated by transcriptional cyclin-dependent
kinases SRB10 and KIN28
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Summary
Eukaryotic transcription of protein encoding genes is initiated by the
regulated assembly of an RNA polymerase II preinitiation complex (PIC) at
the promoter DNA. This PIC, made up of a variety of protein complexes such
as RNA polymerase II holoenzyme, general transcription factors and
chromatin modifying complexes, contains two cyclin-dependent kinases
(CDKs). Studies usingS. cerevisiae have led to a model wherein the two
CDKs, Srb1O and Kin28, both phosphorylate the RNA polymerase II carboxy-
terminal domain (CTD) at different times in the PIC formation to act as a
negative and positive regulator of transcription, respectively. While
transcription of most protein-coding genes seems to require the function of
Kin28, Srb1O has been proposed to negatively regulate only a subset of genes.
Genome-wide expression analysis was used to identify the genes whose
transcription depends on the functions of the RNA polymerase II core
enzyme and of the two cyclin-dependent CTD kinases in yeast. Kin28
function was found to be generally required throughout the genome, while
Srb1O was found to function negatively at a small subset of genes. Analysis of
this subset of genes revealed a novel mechanism for coordinate regulation of
specific sets of genes when cells encounter limiting nutrients. It also allowed
us to uncover a negative role for Srb1O in a yeast developmental pathway and
suggests that the ultimate targets of signal transduction pathways can be
identified within the initiation apparatus.
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Introduction
Much of biological regulation occurs at the level of transcription initiation.
Genes contain promoter sequences which are bound by transcriptional
activators and repressors (Struhl, 1995; Ptashne and Gann, 1997). Activators
recruit the transcription initiation machinery, which for protein-coding genes
consists of RNA polymerase II and at least 50 additional components
(Orphanides et al., 1996; Roeder, 1996; Greenblatt, 1997; Hampsey, 1998; Myer
and Young, 1998). The transcription initiation machinery includes factors
which bind to DNA, cyclin-dependent kinases which regulate polymerase
activity, and acetylases and other enzymes which modify chromatin (Burley
and Roeder, 1996; Kingston et al., 1996; Roth and Allis, 1996; Steger and
Workman, 1996; Tsukiyama and Wu, 1997; Hengartner et al., 1998; Struhl,
1998).
Our understanding of eukaryotic gene expression remains limited in
several ways. The complete set of transcriptional regulators has yet to be
identified. How these regulators interact with and regulate components of
the transcriptional machinery is not yet clear. The functions of just a fraction
of the components of the transcriptional machinery are understood, and then
only with respect to a small set of genes. Cells must adjust genome
expression to accommodate changes in their environment and in their
programs of growth control and development, but precisely how coordinate
remodeling of genome expression is accomplished for signal transduction
pathways or for the cell cycle clock has yet to be learned.
Genome-wide expression monitoring has recently become feasible with
the description of complete genome sequences and through the development
of cDNA and high-density oligonucleotide array technology (Lockhart et al,
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1996; Chee et al., 1996; DeRisi et al., 1997; Lashkari et al., 1997; Wodicka et al.,
1997). Expression profiling has been used to examine differences in gene
expression when yeast are grown in various media (Wodicka et al., 1997) and
has revealed how yeast genome expression is remodeled during the metabolic
shift from fermentation to respiration (DeRisi et al., 1997), during the cell
cycle (Cho et al., 1998), and during sporulation (Chu et al., 1998). Expression
profiling is also being used to improve our understanding of various aspects
of human biology and disease (DeRisi et al., 1996; Schena et al., 1996), and to
facilitate drug development (Gray et al., 1998). The data generated with
genome-wide expression monitoring technology describes the level of each
mRNA species in a population, but this data alone does not always produce
significant new biological insights. Our knowledge of genome-wide
transcriptional regulation is incomplete, making it difficult to understand
how such genome-wide expression signatures transpire.
We are exploring the ability of genome-wide expression analysis to
provide insights into the transcriptional regulatory functions of the two yeast
cyclin-dependent kinases (CDK) found in the transcription preinitiation
complex, Kin28 and Srb10. Since those CDKs have been suggested to play an
important role in regulation of gene expression, it becomes important to
determine the extent to which each gene in the genome depends on their
function. We describe here the mRNA population of yeast cells and the
expression requirement of this population on Rpbl, a core RNA polymerase
II subunit, and on Srb10 and Kin28 CDKs. While Rpbl and Kin28 are
generally required for protein-coding gene expression, Srbl0 negatively
regulates a small subset of genes. The insight provided by these results, is
followed up with the observation that Srb10 itself is regulated when cells
encounter limiting nutrients, and that it is a negative regulator of
201
pseudohyphal growth, a dimorphic developmental pathway in S. cerevisiae
under conditions of nutrients limitation. Our results reveal that the
transcriptional CDKs can add an additional level of combinatorial control on
eukaryotic gene expression in vivo.
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Results
Features of the study
The study described here was designed to assess the requirement for the two
cyclin-dependent kinases that are components of the RNA polymerase II
transcriptional machinery. This was accomplished by using high density
oligonucleotide arrays (HDAs) (Wodicka et al., 1997) to determine the effects
of mutations in these components genome-wide. Databases supporting all
aspects of this study can be found on the World Wide Web at
http: / /www.wi.mit.edu/young/expression.html.
The yeast transcriptome
Knowledge of the levels of all detectable mRNA species in yeast is useful for
evaluating the degree to which these levels depend on any one component of
the transcription apparatus. To obtain this information and to assess the
reproducibility of the HDA technology, RNA was harvested from two
independent wild type cultures and compared using two sets of HDAs on two
separate days. The HDAs used here can score mRNA levels for up to 6181
genes. Of the 5460 genes whose mRNA levels were accurately determined
and compared in both experiments, 99% of the mRNAs differed no more
than 1.7 fold, and only 35 transcripts (0.65%) showed more than a two-fold
change (Figure 1). In order to prevent these minimal variations from
influencing the results, all experiments were performed in duplicate. The
levels determined for the 5460 transcripts in wild type yeast cells and
additional information derived from this experiment can be found under
"Yeast mRNA population" on the Web site. The SAGE method has
previously been used to determine values for 4465 transcripts, the result of
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Figure 1. Reproducibility of the HDA technology.
RNA was harvested from two independent wild type colonies and the two
RNA preparations were hybridized to two different HDAs on two separate
days. The results were plotted on a histogram in which the ratio of levels of
each mRNA measured from the two independent experiments (fold change)
was plotted against the number of genes whose mRNAs have been counted
in that category. For 99% of all genes scored, the expression values produced
for each gene in the two experiments were within 1.7-fold. The genes whose
expression values scored outside this narrow range in the two experiments
tended to be genes whose expression levels are near the lower limits of
detection (0.1 mRNA molecules/cell). Thus, the technology generates highly
reproducible results.
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which has been termed the yeast transcriptome (Velculescu et al., 1996). The
sensitivity of the HDA technology permitted a determination of the levels of
many additional gene products, and revealed that transcripts from 80% of
expressed yeast genes exist at steady state levels of 0.1 to 2 molecules/cell.
Dependence of genome expression on components of the transcriptional
machinery
At any one promoter, the transcriptional machinery might include the RNA
polymerase II core enzyme, the general transcription factors (GTFs), the core
Srb/mediator complex, the Srb1O CDK complex, the Swi/Snf complex, and the
SAGA complex, among others (Figure 2). Besides the Srb1O CDK complex, a
second cyclin-dependent kinase (CDK), named Kin28, can be found as part of
the general transcription factor TFIIH. The kinase subunit of each of the two
transcriptional CDK was investigated for its role in genome-wide gene
expression through the use of mutations which affect either the function or
the physical presence of the subunit (Table 1). As a control, we also analyzed
the mutated allele rpbl-1 (Nonet et al., 1987), a temperature sensitive (ts)
mutation in RPB1, a critical component of the RNA polymerase II core
enzyme. For the essential CDK Kin28, a temperature-sensitive (ts) mutations
was valuable because it allowed us to examine the effects on gene expression
at any point after inactivating the factor. For the non-essential CDK Srb10, we
used a point mutation which knocked out the catalytic kinase function. In
each experiment, a mutant cell and its isogenic wild-type counterpart are
grown to mid-log phase, the two populations are harvested, RNA is prepared,
and hybridization to HDAs is carried out, all in duplicate.
RNA Polymerase 11 Holoenzyme
Nucleosome
Gene-specific
regulators
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Figure 2. Model of RNA polymerase II transcription machinery.
The machinery depicted here encompasses over 85 polypeptides in 10 (sub)
complexes: core RNA polymerase II (RNAPII) consists of 12 subunits, TFIIH 9
subunits, TFIIE 2 subunits, TFIIF 3 subunits, TFIID 14 subunits, core
SRB/mediator more than 16 subunits, Swi/Snf complex 11 subunits, Srb1O
kinase complex 4 subunits and SAGA 13 subunits (see Web site for more
details). As detailed in Table 1, Rpbl, a subunit of the core RNA polymerase II
complex, Srb1O, a subunit of the Srb1O CDK complex, and Kin28, a subunit of
the TFIIH complex, were choosen for analysis of genome-wide transcription
dependence.
Table 1. Transcriptional Machinery
Complex and Subunit Features Fraction of genes dependent
on subunit function
RNA Polymerase II
Rpb1 Largest subunit, mRNA catalysis, contains CTD 100%
General Transcription Factors
TFIIH (Kin28) CTD kinase 87%*
Srb CDK complex
Srb1O CTD kinase, negative regulator 3%
* Kin28 results were essentially identical to Rpbl, but because of the stringency applied by the fit algorithm, a
minimal estimate is produced.
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Dependence on core RNA polymerase II
To determine the genome-wide dependence of gene expression on core RNA
polymerase II, RNA was isolated from an rpbl-1 temperature sensitive (ts)
cell and its wild type counterpart 45 minutes after a shift to the
nonpermissive temperature and was hybridized to HDAs. Because rpbl-1
cells shut down transcription of protein-coding genes immediately after a
temperature shift, these cells have been used by us and other investigators to
determine the half-life of various yeast mRNAs (Nonet et al., 1987; Herrick et
al., 1990). The 45 minute time point was used for the analysis of all ts
mutants in this study because it is sufficiently long to detect a significant (i.e. a
two-fold or more) loss of mRNA levels for 94% of detectable gene products
without any loss of rRNA (Nonet et al., 1987). In addition, the 45 minute
time point is short enough to minimize the potentially complicating effects of
cell cycle arrest and cell death.
The results of genome wide expression analysis of the rpbl-1 mutant as
compared to an isogenic wild type strain are shown in a grid format in Figure
3A. The grid shows the change in mRNA level for each gene, beginning with
the left-most gene on chromosome I and proceeding in a linear fashion, left
to right, through chromosome I, then II, then III, etc., until the last gene on
the right arm of chromosome XVI is reached at the lower right hand corner.
5735 genes were scored in this analysis. The vast majority of mRNAs are
reduced more than two-fold in the mutant cells relative to wild type cells, and
this reduction provides an apparent half-life for each of the mRNA species
(see Yeast mRNA Population on the Web site). The value determined with
this approach is an approximation, but is useful for comparative purposes.
Comparison of this data with that obtained for the kin28ts-3 allele identifies
the set of genes whose expression is equivalently dependent on RNA
A RPB1
B KIN28
-4
Fold Change
-2 +2
Fold Change
-2 +2 +4
C SRB10
-4
Fold Change
-2 +2 +4
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Figure 3. Genome-wide expression data for RPB1, KIN28 and SRB10.
Data reflecting the change in mRNA levels when a mutant is compared to its
isogenic wild type counterpart is presented in a grid format. In the grid, the
upper left grid square represents the left-most gene on chromosome I, and the
squares to its right represent adjacent genes, proceeding in a linear fashion
through chromosome I, then II, then III, etc., until the last gene on the right
arm of chromosome XVI is reached at the bottom of the grid. The results are
shown for (A) Rpbl, (B) Kin28 and (C) Srb1O.
213
polymerase II and Kin28. There is a set of genes whose mRNAs are not
significantly reduced in the mutant cells. These consist of genes that have
stable messages as well as genes whose mRNA levels are slightly elevated in
the mutant cells relative to wild-type.
In this latter group are many known heat shock or stress response
genes (e.g. SSA4, SSA3, HSP26, HSP30, HSP42 and SSL2), plus additional ORFs
of unknown but perhaps related function. Another group had recently
reported that the same temperature-sensitive mutant in Kin28 did not
significantly affect activated transcription of the heat shock induced gene,
SSA4, and the copper induced gene, CUPI (Lee and Lis, 1998). At the time,
these results were interpreted to suggest that transcription activation at these
genes might be independent of the TFIIH kinase. However, subsequent
studies could not reproduce these results and found instead that CUPI and
SSA4 induction required Kin28 function (H. Causton and R. Young,
unpublished). Previous studies in yeast cells had indicated that heat shock
responsive genes are maximally transcribed approximately 15 min. after the
temperature shift, after which a rapid reduction of heat shock mRNA levels
occurs (Werner-Washburne et al., 1989; Miller et al., 1982). Careful time
course analysis of SSA4 induction in vivo has revealed that transcriptional
induction required Rpbl and Kin28, but that the mRNA became highly stable
when transcription was inhibited during or immediately after heat shock
(Causton and Young, unpublished results). This increased mRNA stability,
combined with the measurement of mRNA at a single time point of 45 min
after the temperature shift, explains the apparent Rpbl and Kin28
"independence" seen for heat shock gene transcription.
Dependence on Kin28 CDK
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The general transcription factors are necessary to reconstitute promoter-
dependent transcription in vitro with core RNA polymerase II. These factors
include TFIID, TFIIB, TFIIF, TFIIE and TFIIH. Among these factors, TFIIH is
of particular interest because it has been found to be dispensable for
transcription in vitro under certain conditions (Parvin et al., 1992; Serizawa et
al., 1993; Timmers 1994). Kin28, a CDK subunit of TFIIH, is an RNA
polymerase II CTD kinase which is involved in the transition from initiation
to elongation (Dahmus, 1996). Analysis of kin28 ts mutants suggested that
most protein coding genes did require the function of KIN28 in vivo
(Cismowski et al., 1995; Valay et al., 1995). Genome-wide expression analysis
provides a more rigorous test of the model that expression of all protein-
coding genes is dependent on Kin28. The analysis was carried out on a Kin28
ts cell and its isogenic wild type counterpart using the same experimental
protocol used for the Rpb1 ts mutant. The reduction in mRNA levels
observed in ts mutants soon after a temperature shift (i.e., 45 minutes) is
likely a consequence of primary effects due to factor inactivation. A longer
time would be required to produce most secondary effects since indirect effects
involve a substantial and sequential reduction in both transcription and
translation products. Nonetheless, the results obtained in this type of
experiment must be regarded as the sum of primary and secondary effects.
To identify the set of genes whose change in expression is most likely a
direct consequence of the loss of function of the ts Kin28, we compare data
sets from the ts inactivation of Kin28 and Rpb1 mutants and look for
transcripts with equivalent decay kinetics (see Experimental procedures and
Data Analysis on the Web site for details). The results reveal that Kin28 is
generally required for expression of protein coding genes (Figure 3B). Of the
5405 genes whose mRNA expression levels could be compared (i.e. those that
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had a greater than two-fold decrease in the experiment with Rpb1 ts and were
scored in the Kin28 ts experiment), 87% showed a decrease that closely fit the
decrease observed in the Rpb1 ts experiment. While the remaining 13% of
the genes did not closely fit the Rpb1 decay rates, they nonetheless
consistently decreased in the Kin28 ts experiment, and are thought to require
Kin28 as well. The stringent standard applied in the data comparison, the
experimental error, and the strain background difference between the Rpb1 ts
and Kin28 ts strains, must all have contributed to the difference observed.
Our results thus indicate that genome-wide gene expression generally
requires Kin28. However, without knowing the exact nature of the Kin28 ts
mutation, we can not distinguish between a general requirement for the
Kin28 protein, the Kin28 kinase activity or the TFIIH multisubunit complex.
Dependence on Srb10 CDK complex
Srb10 is a cyclin dependent kinase which is part of a holoenzyme subcomplex
containing Srb8, 9, 10 and 11 proteins (Liao et al., 1995; Hengartner et al., 1995).
Srb10 and its associated proteins have been proposed to form a negative
regulatory complex which functions through phosphorylation of the RNA
polymerase II CTD (Hengartner et al., 1998). To determine how gene
expression depends on Srb10, RNA was isolated from an Srb10 point mutant
which lacks catalytic activity and the expression profile was compared to that
of its wild type counterpart. The results are shown in a grid format in Figure
3C. Of the 5626 genes which were scored, 173 gene products showed 2-fold or
greater increases in mRNA levels in the mutant relative to the wild type.
This indicates that Srb10 is normally a negative regulator of these 173 genes
(approximately 3% of the genome).
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Coordinate negative regulation of nutrient starvation response genes via
Srb1O
The analysis revealed that Srb1O is a negative regulator of 173 genes. It
is notable that nearly half of these genes are derepressed during the nutrient
deprivation which occurs during the diauxic shift (DeRisi et al., 1997) (Figure
4). Yeast cells undergo a diauxic shift as nutrients are depleted in culture, and
a variety of genes which enable the cell to survive nutrient-limiting
conditions are derepressed (Johnston and Carlson, 1992; Yin et al., 1996).
These include genes involved in dimorphic morphology (nutrient starved
cells alter their morphology to permit foraging for nutrients) and stress
responses (starved cells are apparently better able to survive nutrient
deprivation when stress proteins are elevated). Srb1O in wild type cells most
likely plays a role in repressing this set of genes when cells are in exponential
growth on glucose, but no longer performs this function as cells enter the
diauxic shift. Coordinate regulation of this set of genes could be accomplished
by eliminating the function of Srb1O as cells enter the diauxic shift.
To determine whether Srb1O is physically lost from cells as they enter
the diauxic shift, cells containing an epitope-tagged Srb1O protein were grown
in YPD media and sampled at various times during the growth curve (Figure
4C). Cell lysates were prepared from each sample and the levels of Srb1O were
assayed by Western blot. The data in Figure 4C shows that Srb1O levels
become sharply reduced (approx. 4-fold) as cells enter the diauxic phase of
growth. This result is consistent with evidence that the levels of Srbll, the
cyclin partner of Srb10, are reduced when cells are exposed to the limiting
nutrient environment in sporulation media (Cooper et al., 1997). It may also
explain why a form of yeast holoenzyme purified from commercially
available yeast cells lacks the SrblO/Srbll kinase/cyclin pair (Li et al., 1995;
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Myers et al., 1998), as these cells are typically harvested past mid-log phase (or
even near stationary phase). In contrast to what was seen for SrblO, a survey
of epitope-tagged Srb5 levels showed no marked decrease as cells encountered
the diauxic shift; instead, the protein levels remained relatively constant
even as the cells neared stationary phase (data not shown). In addition to
Srb5, Srb4 protein levels have also been shown to remain unaffected by the
cellular growth state (Walker et al., 1997). These results argue against a
general decrease of holoenzyme levels as cells move from logarithmic growth
to stationary phase and indicate that the nutrient starvation response is
mediated, in part, through the physical loss of the Srb1O CDK from the
holoenzyme. This novel mechanism provides an example of how coordinate
regulation of gene expression can be accomplished through regulation of
components of the general initiation machinery.
Srb1O is a negative regulator of a yeast developmental program
When nutrients become limiting on solid media, S. cerevisiae cells
undergo a developmental transition from a single cell form to a filamentous
pseudohyphal form, allowing better nutrient foraging. In diploid cells, this
dimorphic form is called pseudohyphal growth and can readily be observed as
a difference in colony morphology, as filamentous growth extends beyond the
perimeter of the colony. Filamentous growth is accompanied by agar
penetration, and in haploid cells, the dimorphic growth is referred to as
invasive growth. A strain's invasive growth can be observed by washing the
top portion of the colony off the plate surface and examining the remaining
cells embedded in the agar. FLO 11, which encodes a cell wall protein which is
highly expressed in pseudohyphal cells, is expressed at 15-fold higher levels
when Srb1O function is lost (Figure 4A). The dramatic increase in the
A Gene Description Fold Up
FLOl Flocculence cell wall protein 102
SIP18 Induced by osmotic stress 74
YBR116C Induced by diauxic shift 61
YMR107W Induced by diauxic shift 32
ALD3 Induced by diauxic shift 28
HSP26 Induced by osmotic stress, diauxic shift 26
GRE1 Induced by osmotic stress, diauxic shift 25
YER150W Induced by diauxic shift 24
HSP12 Induced by numerous stresses 18
RCK1 Serine/threonine protein kinase 18
FLO11 Flocculence 15
RTA1 Involved in 7-aminocholesterol resistance 15
YDR070C Induced by diauxic shift 13
YBR147W Induced by diauxic shift 10
CTTl Induced by osmotic stress, diauxic shift 10
YDL204W Induced by diauxic shift 10
TKL2 Induced by diauxic shift 10
YGRO43C Induced by diauxic shift 9
YNL194C Induced by diauxic shift 9
SOL4 Induced by diauxic shift 8
CYC7 Induced by numerous stresses, diauxic shift 8
PUT4 Proline permease, nitrogen induced 8
YKL187C Induced by diauxic shift 8
NCA3 Life-span determination 8
YML128C Induced by diauxic shift 8
GPH1 Induced by diauxic shift 8
POTI Induced by diauxic shift 7
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Figure 4. SRB10 CDK represses genes elevated during response to nutrient
starvation.
(A) Subset of 173 genes whose expression is derepressed in cells lacking Srb1O
kinase activity.
(B) Venn diagram showing the number of genes which are derepressed
during the nutrient deprivation which occurs during the diauxic shift and the
fraction of these which are derepressed in cells lacking Srb1O kinase activity.
(C) Srb1O protein is depleted from cells as they enter the diauxic shift. The
graph shows the growth curve of a yeast strain allowed to grow near the
stationary phase (21 hours). At specified time points, aliquots from a culture
were measured for cell density and equal amounts of cells were harvested for
Western blot analysis. Western blots against epitope-tagged SrblOp and a
control protein Tub2p (p-tubulin) show that Srb1O levels decrease
substantially as cells enter the diauxic shift (9 to 10 hours).
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expression of FLO 1 and other genes whose products are involved in the
dimorphic shift led us to determine whether the absence of Srb1O function
would affect two key features of filamentous pseudohyphal growth: filament
formation and agar invasion.
To assay filament formation, both copies of the SRBLO gene were
deleted from a diploid strain which is generally used to assay this phenotype,
and colony morphology was examined under the microscope. The results in
Figure 5A demonstrate that the complete loss of Srb1O causes cells to grow
preferentially in a pseudohyphal form. While Srb1O negatively regulates
pseudohyphal growth, other layers of repression must also exist since no
pseudohyphal growth was detected on nitrogen rich media in the absence of
Srb1O (data not shown).
To assay agar invasion we used haploid cells derived from two
different yeast strains: 11278b and S288C. 11278b, like most feral yeast strains,
is able to form pseudohyphae and haploid invasion while the laboratory
strain S288C does not, due to a naturally occurring mutation in the FLO8 gene
(Liu et al., 1996). The SRB1O gene was deleted in both strains and cells that
were embedded in the agar could be seen after washing off the surface cells
from the yeast plate (Figure 5B). In the S288C strain background, loss of Srb1O
now allowed the cells to dig lightly into the agar while the loss of Srb1O in the
X1278b background promoted an agar superinvasive behavior. Thus, Srb1O
negatively regulates two characteristic components of the pseudohyphal
developmental pathway. This example demonstrates how expression
analysis is useful for predicting unexpected phenotypes. More importantly,
specific signal transduction pathways control the dimorphic shift (Madhani
A
SRB1O/SRB10 srb1 OA/srb1 OA
B
Total Cells
Superinvasive growth
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Figure 5. SRB1O CDK acts negatively on the filamentous pseudohyphal
growth developmental pathway in haploid and diploid yeast cells.
(A) Diploid cells lacking Srb1O kinase activity exhibit increased pseudohyphal
filament growth upon nitrogen starvation. Diploid strains PHY584
(SRB1O/SRBIO) and CHY134 (srb1OA/srb1OA) were streaked and grown on
SLAD plates at 30'C. Individual colonies were photographed at 5 days.
(B) Haploid cells lacking Srb1O kinase activity exhibit increased invasive
growth. 11278b derived haploid strains (Dig+ control, 10560-5B), (Dig-
control, CSY251), (SRB10, CHY131) and (srblOA, CHY130), as well as S288C
derived haploid strains (SRB1O, Z718) and (srblOA, Z723) were patched on a
YPD plate and incubated at 300 C for 3 days, then at room temperature 3 more
days. The cells were first washed off the agar surface with deionized water
and later by gently surface rubbing with a gloved finger. The plate was
photographed before washing (total growth), after moderate water washing
(invasive growth) and after mechanical rubbing of plate surface
(superinvasive growth).
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and Fink, 1998), and these results suggest that one of the ultimate targets of
these pathways is the Srb1O kinase.
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Discussion
Using HDA technology, we have characterized the mRNA population of
yeast cells and the gene expression requirement for an essential component of
the core RNA polymerase II, Rpbl, and two cyclin-dependent kinases (CDK)
found in the transcription preinitiation complex, Kin28 and SrblO. The
insights obtained from this analysis include the following. While the
essential requirement of RPB1 for genome-wide expression was expected, the
general requirement for KIN28 suggests that TFIIH is generally recruited and
functions at promoters of protein-coding genes. The distinct expression
signature obtained when the Srb1O kinase is inactivated, reveals the
coordinate negative regulation of functionally related genes, as exemplified by
the regulation of SrblOp levels under growth limiting amounts of nutrient
and the role of this kinase in the various responses to nutrient deprivation.
The results obtained here about the effect of these CDKs in genome-wide gene
expression has confirmed and united a variety of unlinked original
observations about their role in vivo and in vitro.
Transcriptome
We have estimated the number of mRNA molecules present for all genes in
a single wild type haploid cell using HDA data (see Yeast mRNA Population
on the Web site). This is a more accurate representation of the transcriptome
than that previously determined because it is better able to score mRNA
species which are expressed at very low levels (5460 genes were scored using
HDAs, whereas 4465 genes were scored with SAGE). It is particularly valuable
to have information on transcripts from genes expressed at low levels because
many of the regulatory components of the cell are expressed at low levels.
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Core RNA polymerase II
Because Rpbl is generally required for expression of protein-coding genes, and
it is associated tightly and exclusively with RNA polymerase II (Koleske and
Young, 1994; Kim et al., 1994; Myers et al., 1998), we can infer that RNA
polymerase II is generally required for transcription. This agrees, of
course,with previous studies describing a rapid decrease of the bulk of poly-
A+ RNA levels upon loss of RPB1 function (Nonet et al., 1987; Cormack and
Struhl, 1992; Thompson et al., 1995).
Kin28 CDK and the TFIIH complex
Assuming that the function of Kin28 is restricted to TFIIH, the data obtained
with the Kin28 mutant demonstrates that TFIIH is a generally required factor.
This requirement for Kin28 in transcription is consistent with prior
observations of a rapid decrease of overall mRNA levels upon a shift to
restrictive temperatuer with the kin28ts-3 mutant allele used here (Valay et
al., 1995) or an unrelated kin28 ts allele (Cismowski et al., 1995). The use of a
mutant of that specifically knocked out the kinase function would allow us to
narrow down the Kin28 function required for transcription.
In contrast to our results, a recent report has suggested that the same
Kin28 mutant does not affect activated transcription of the heat genes such as
SSA4 and CUP1 (Lee and Lis, 1998). However, a number of problems tarnish
these results. First, the temperature used to inactivate Kin28 was lower than
suggested (Valay et al., 1995), raising the distinct possibility of an incomplete
inactivation of Kin28 function. Second, levels of mRNA were assayed at a
single time point after Kin28 inactivation, a source of possible error as
explained in the Results section. Indeed, when a time course experiment was
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performed at the proper restrictive temperature, a clear requirement for
Kin28 was found for both SSA4 and CUP1 induction (H. Causton and R.
Young, unpublished).
SrblO CDK complex
The function of the Srb1O CDK complex can be defined by the kinase itself,
since loss-of-function mutations in any of the four components of this
complex produce identical phenotypes (Hengartner et al., 1995; Carlson, 1998).
The Srb1O kinase is a negative regulator of a substantial fraction of genes
which are repressed when cells grow vegetatively in rich media and are
induced as cells experience nutrient deprivation. These results complete and
confirm the description of the negative function of SrblO inferred from
amassed genetic and biochemical evidence (Hengartner et al., 1998). The
genes regulated by Srb1O include those which are critical for the
morphological change which permits foraging for nutrients and stress
responses. Since SrblOp levels are reduced as cells enter the diauxic shift, a
simple mechanism for derepression of this set of genes can be proposed: Srb1O
in wild type cells is responsible for repressing this set of genes when cells are
in exponential growth on glucose, but due to reduced protein levels, no
longer can perform this function as cells enter the diauxic shift. The idea that
Srb1O is part of a nutrient sensing pathway is also consistent with the finding
that it negatively regulates SPO13, GAL1 and SUC2. The first is a gene
activated upon yeast sporulation, one of the possible responses to nutrient
limitation, the other two genes are sugar utilization genes that are subject to
glucose-repression (Surosky et al., 1994; Liao and Young, unpublished;
Kuchin et al., 1995). What mechanism restricts the negative activity of Srb1O
to only a subset of genes is as yet not known, but we have suggested that
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promoter specific factors at these genes stimulate an otherwise quiescent
Srb1O to hinder formation of pre-initiation complex through early CTD
phosphorylation (Hengartner et al., 1998). The identification of such factors
and of the promoter elements that recruit them is currently under way.
The results described here reveal that a layer of regulation is available
to the cell in addition to that provided by gene-specific regulators: the
expression of specific sets of genes can be regulated by affecting the availability
or function of a specific component of the RNA polymerase II holoenzyme,
TFIID and other general transcription initiation factors. A good example of
such a mechanism of regulation involves the modification of core RNA
polymerase II structural composition by alteration of the incorporation of
subunits in response to stress signals. Rpb4 and Rpb7 form a dissociable
subcomplex that has been implicated in the stress response and in the
initiation of transcription (Dezelee et al., 1976; Woychik and Young, 1989;
Edwards et al., 1991; Choder and Young, 1993). While Rpb4 and Rpb7 are
present only in substoichiometric amounts during the exponential phase of
yeast growth, they are found as stoichiometric subunits of core RNA
polymerase II under suboptimal conditions such as the stationary phase of
cell growth (Choder and Young, 1993). Another example of regulation of core
RNA polymerase II by post-translational modifications of it's subunits is
illustrated by the reversible phosphorylation of the carboxy-terminal domain
(CTD) of Rpbl (reviewed in Dahmus, 1996). While core RNA polymerase II
with unphosphorylated CTD are needed for efficient assembly onto a
promoter to initiate transcription, mRNA elongation efficiency and
processing is correlated with a heavily phosphorylated CTD. Future surveys
might determine whether the regulation of other RNA polymerase II
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holoenzyme components is critical to the coordination of genome-wide gene
expression regulation in response to extracellular and intracellular signals.
Distinct requirements for other components of transcriptional machinery
A more extended genome-wide analysis has been performed by F.C. Holstege
et al. (1998), that included not only the three components described here
(Rpbl, Kin28 and Srb1O) but also components of the Srb/mediator complex
(Srb4, Srb5 and Med6), Swi/Snf complex (Swi2), SAGA complex (Gcn5 and
TAF 1117), and the two general transcription factors TFIID (TAF11145 and
TAF 1117) and TFIIE (Tfal) (refer to the following world wide web site for
additional details: http://www.wi.mit.edu/young/expression.html). In
addition to the Rpbl subunit of core RNA polymerase II and the Kin28
subunit of the general transcription factor TFIIH, the Srb4 subunit of the
Srb/mediator complex was also generally required for transcription of protein
coding genes. In contrast, Tfal, a subunit of TFIIE, and Taf17, a subunit of
both the SAGA complex and TFIID, were found to be required for more than
half, but not all genes. Most other components investigated were necessary
for transcription of less than a fifth of the genome (Srb5, Med6, Srb1O, Swi2,
Tafl45, Gcn5). In this latter group, the evidence indicates that Srb5, Med6, and
Taf145 have predominantly positive roles, Srb1O has an almost exclusively
negative role, and Swi2 and Gcn5 can have either a positive or a negative role
in gene expression. These data suggest that coordinate regulation of large sets
of genes could be accomplished by affecting the function of specific
components of the transcriptional machinery. If this is the case, then it
would be expected that functional relationships exist among some genes
within these sets, as has been observed with TAF11145 (Holstege et al., 1998)
and Srb10. It also raises the possibility that the ultimate targets of certain
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signal transduction pathways could be identified by comparing genome
expression signatures from these experiments and those which modify the
cellular environment.
Development of a genome control map
The results described here support the feasibility of dissecting the regulatory
circuitry of the yeast genome by using genome-wide expression analysis on
cells with mutations in the transcription apparatus. The set of yeast genes
whose expression depends on the functions of key components of the
transcriptional machinery has been identified (Holstege et al., 1998). The
genome-wide expression signatures produced by lesions in specific
components of the transcription apparatus are quite distinct, making it
possible to envision a genome control map. Such a map would identify all
the components of the transcriptional machinery which have roles at any
particular promoter and the contribution which specific components make to
coordinate regulation of genes. The map will facilitate modeling of the
molecular mechanisms which regulate gene expression and implicate
components of the transcription apparatus in functional interactions with
gene-specific regulators.
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Experimental Procedures
High-density oligonuleotide array (HDA) technology
Affymetrix GeneChip high-density oligonucleotide arrays (HDAs) were used
in this study. The yeast genome HDAs are described in detail in Wodicka et al.
(1997). The arrays can detect as few as 0.1 mRNA molecules/cell; the dynamic
range over which detection is accurate is approximately 0.1 - 100 mRNA
molecules /cell.
With the Genechip arrays, the entire yeast genome is covered by four
HDAs. In total, 6181 ORFs are present within this set. Each gene is represented on
the HDA by 20 25-mer oligos that match the sequence of the message (perfect
match oligos) and 20 oligos that are identical but differ by one base (mismatch
oligos). mRNA levels are calculated by subtracting the signal of a mismatch
from its perfect match partner and averaging the difference for each oligo pair
representing a given gene. Based on various criteria that assay the consistency of
behavior of each perfect match and mismatched oligomer pair, a Present or
Absent call is also returned for each mRNA.
Genome-wide survey
Two independent experiments were performed for each wild type versus
mutant comparison. For any experiment involving a comparison between a
mutant and its isogenic wild type counterpart, the HDAs used were from the
same lot number.
Expression profiles were determined by growing yeast cultures to mid-log
phase, isolating total RNA, spiking in known amounts of control RNA for
normalization and isolating poly A+ RNA. This was used to generate double
stranded complementary DNA (dscDNA) that in turn was used to generate
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biotin labeled copy RNA (cRNA; the oligo used for dscDNA synthesis contains a
T7 RNA polymerase promoter). 1-3 gg of poly A+ RNA thus resulted in
synthesis of approximately 60 gg cRNA. This was fragmented and hybridized to
the oligonucleotide arrays, arrays were washed, stained, washed and scanned.
All steps subsequent to poly A+ RNA purification were carried out exactly as
described in the Affymetrix product information supplied with the Genechips
(the leaflets are part numbers 700187 Rev 1 and 700163 Rev 1 5/98).
HDA result analysis
Individual mRNA levels were scored if the computer algorithm analyzing the
scanned results (Wodicka et al., 1997) returned a "Present" call in both the two
wild type and the two mutant expression profiles for that gene or if the
expression levels of that gene changed in the same direction and the amplitude
of the change was greater than background levels in both wild type and mutant
comparisons.
For all genes scored, the fold change was calculated by dividing the mutant
value by the wild type value. The reported fold changes are the average of the
two independent experiments. For the grid representation comparing the
change in mRNA levels between mutant and wild type strains (Figure 3), a 2-fold
change was called if it satisfied the following two conditions: a given mRNA
level had to change more than two-fold in both comparisons, and the change in
the values was above background values in both comparisons.
For comparing the dependence of gene expression on Kin28 and Rpbl,
the fold change in genes scored in the rpbl-I and the kin28ts-3 experiments
were compared. Transcripts whose levels dropped less than 2-fold in the
rpbl-1 experiment were not included in the analysis because the decay rates
were not sufficient to provide a meaningful comparison. A gene was
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determined to be equivalently dependent on Rpbl and Kin28 if it satisfied two
conditions: the gene's mRNA level dropped more than two-fold in the
kin28ts-3 experiment, and the fold decrease in the kin28ts-3 experiment was
two-fold within that seen in the rpbl-1 experiment.
Cell Harvesting
Freshly streaked colonies were used to inoculate a pair of 10 ml YPD culture
grown overnight at 30'C. After dilution to an O.D-600 of 0.05 in 200 ml pre-
warmed YPD culture, the cells were grown an additional 4-8 hours to an
O.D. 600 of 0.5.
For temperature shift experiments, the culture were diluted 1:2 with
pre-warmed YPD so that the final temperature of the mix would be correct
(e.g., to shift 200 ml of culture from 30'C to a final temperature of 37*C, 200 ml
of YPD pre-warmed to 44'C were added). Cultures were then incubated at the
restrictive temperature for exactly 45 minutes.
The cells were harvested as quickly as possible by centrifugation for 3
min at 3500 rpm in a GSA rotor, resuspended in 6 ml ice-cold ddH20 and
respun 2.5 min at 2600 rpm in a Sorvall HICOOB rotor. The resulting pellet
was frozen in liquid nitrogen for at least 2 minutes and stored at -80'C. The
steps from the harvesting to the frozen pellet took approximately 15 min.
The wild type and mutant strains used for the RPB1, KIN28 and SRB10
gene analysis were , Z579 and Z460, GF1047 and GF2092, and Z579 and Z690,
respectively. The rpbl-1 ts, the kin28ts-3 and the srbIO-3 mutants have all
been described (Nonet et al., 1987; Valay et al., 1995; Liao et al., 1995). Z460,
Z579 and Z690 are all S288C derived. It is unclear whether GF1047 and GF2092
were also S288C derived.
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RNA preparation
Total RNA was prepared using a hot acidic phenol RNA preparation
procedure (Ausubel et al., 1997). Total RNA was resuspended in DEPC-treated
water to a final concentration of 15 mg/ml, snap-frozen and stored at -80*C.
We verified that the yield of total RNA obtained from wild type and mutant
cells was very similar. Equivalent amounts of total RNA from each strain
were used isolate mRNA since stable RNAs such as rRNA and tRNA account
for approximately 96% of total RNA. mRNA was prepared using an
OligotexTM resin (Qiagen Inc.) and was resuspended to a final concentration of
0.5 mg/ml. For strains where no general loss of mRNA was expected, 1 mg of
total RNA was used. Otherwise 2 or 3 mg of total RNA were used. For each
mg of total RNA, 5 gl of poly A+ control RNA (see below) was added.
Poly A+ control RNA
PolyA tagged lys, phe, thr, trp and dap T7/T3 IVT expression constructs were
obtained from the ATCC (#'s87482, 87483, 87484, 87485, 87486, respectively).
The polyA tagged RNA was generated with NotI digested template DNA and
Ambion's Megascript T3 IVT kit according to their instructions. Transcripts
were purified using the Qiagen RNeasy kit. An undiluted stock of these
controls was prepared by mixing the various transcripts: 133 gg lys, 58.5 g
phe, 24.5 xg dap, 8.8 pg thr, 3.3 gg trp in 225 k1 DEPC water. This was aliquoted
in 22.5 [ 1 amounts. A diluted stock was made by adding 477.5 pl DEPC water
to the undiluted stock and this was again aliquoted. The diluted stock was
spiked into the total RNA, 5 R1 per mg total RNA. The final amounts of the
controls in the total RNA were then: 4 trp, 13.3 thr, 40 dap, 133.3 phe, 400 lys
(pmol/mg). By using theses same controls in every experiment all
experiments can be normalized to equivalent amounts of total RNA.
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Srb1O epitope surveying
An SRB1O epitope-tagged culture (CHY159) grown at 30 0C overnight in YPD
was diluted to an O.D. 600 of 0.2 in YPD and grown further for 2-3 hours. 50
O.D. 600 of cells were harvested every 1-2 hours for whole cell extract (WCE)
preparation, washed twice with 1 ml ddH 20, flash frozen and stored at -70 0 C
until needed. Frozen cells were resuspend in 350 gl of lysis buffer (50 mM
Hepes-KOH pH7.6, 5 mM EDTA, 5 mM EGTA, 50 mM of neutralized
ammonium sulfate, 10% glycerol, 1x Protease inhibitors) and added to 400 gl
of glass beads. The cells were lysed using a combination of bead beating and
freeze thawing: frozen in liquid nitrogen for 1 min, thawed at 37*C for
another and vortexed for 30 sec. This procedure was repeated 4 times. The
supernatant was collected, the remaining beads were washed with 100 gl of
lysis buffer (+ 5 gl of 100 mM DTT), and the wash was combined with the
supernatant. After spinning in a microfuge at 14,000 rpm for 20 min at 4*C,
the supernatant (WCE) was flash frozen and stored at -70'C until needed.
Yields ranged from 3.7 to 2.3 mg/ml of total protein. WCE (30 gg) samples for
western blot analysis were fractionated on 4-20% SDS-PAGE gradient gels and
transferred according to standard procedures. Tub2 rabbit anti-serum was
used at 1:3500, anti-HA mouse ascites fluid was used at 1:1000. HRP-
conjugated anti-mouse (Pierce) and anti-rabbit (Amersham) secondary
antibodies were used at 1:2000. Detection was performed by ECL according to
the manufacturers directions (Amersham).
CHY159 was obtained by PCR epitope-tagging the genomic copy of
SRB1O in Z22 to introduce a N-ternimal His 6-HA3 tag (Schneider et al., 1995).
Pseudohyphal and invasive growth assay
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Pseudohyphal growth of the diploid strains was assayed as described (Gimeno
et al., 1992) using synthetic low ammonia dextrose media (SLAD). CHY134
was created by deletion of SRB10 using a single step disruption method. In
short, L5978 was transformed with a 5.1 kb srblOA::HIS3 DNA fragment
(SalI/NotI double digestion of pRY2969) and plated on SC-His media.
Southern analysis was used to confirm that a single copy of SRB1O had been
deleted. The resulting heterozygous diploid (CHY126) was sporulated and
tetrads dissected on YEPD plates and scored for nutritional auxotrophies and
colony morphology. Mating of 2 srblOA::HIS3 haploids (CHY129 and CHY130)
produced CHY134, a strain homozygous for the srblOA. All strains described
as derived from 11278b are congenic to each other (Gimeno et al., 1992).
Haploid invasive growth was assayed as described (Roberts and Fink,
1994). Haploid strains CHY131 (11278b, SRB1O) and CHY130 (X1278b, srblOA)
were both obtained from tetrad dissection of SRB10/srblOA heterozygote,
CHY126.
Figures
The figures were prepared from digital replicas of primary data scanned using
a UMAX UC840 Max Vision digital scanner.
Additional information
A variety of additional detailed information on experimental procedures,
genetic reagents, HDA technology and data analysis can be found on the
world wide web at http://www.wi.mit.edu/young/expression.html in the
section titled Study Design.
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Table 2. Yeast Strains
Strain source Genotype
CHY126 this study Mata/Mata ura3-52/ura3-52 LEU2/leu2::hisG his3::hisG/his3::hisG TRP1/trpl
SRB10/srblOA::HIS3
CHY129 this study Mata ura3-52 his3::hisG trpl srblOA::HIS3
CHY130 this study Mata ura3-52 leu2::hisG his3::hisG srblOA::HIS3
CHY131 this study Mata ura3-52 leu2::hisG his3::hisG
CHY134 this study Mata/Mata ura3-52/ura3-52 LEU2/leu2::hisG his3::hisG/his3::hisG TRP1/trpl
srbl OA::HIS3/srblOA::HIS3
CHY159 this study Matca ura3-52 leu2-3,112 his3 A200 His6 -HA3 -SRB10
CSY251 Fink lab Mat a ura3-52 leu2::hisG TRP1 his3::hisG invl::LEU2+lacZ (dig- strain)
GF1047 Faye lab Mata ura3 leu2 trpl lys2
GF2092 Faye lab Mata ura3 leu2 trpl lys2 kin28-ts3
L5978 Fink lab MataiMata ura3-52/ura3-52 LEU2/leu2::hisG his3::hisG/his3::hisG TRP1/trpl
PHY584 Fink lab Mata/Mata ura3-52/ura3-52 LEU2/leu2::hisG HIS3/his3::hisG TRP1/trp1
srblOA::HIS3/srbIOA::HIS3
Z22 Young lab Mata ura3-52 leu2-3,112 his3A200
Z460 Young lab Mata ura3-52 leu2-3,112 his3A200 his4-912 lys 2 -1 28 rpblA187::HIS3
[pRP1-1U (URA3 CEN rpbl-1)]
Z579 Young lab Mata ura3-52 leu2-3,112 his3A200 srb4A2::HIS3 [RY2884 (LEU2 CEN SRB4)]
Z690 Young lab Mata ura3-52 leu2-3,112 his3A200 srbl0-3::hisG
Z718 Young lab Mata ura3-52 leu2-3,112 his3A200
Z723 Young lab Mata ura3-52 leu2-3,112 his3A200 srblOA1::HIS3
10560-5B Fink lab Mata ura3-52 leu2::hisG trpl::hisG (dig+ strain)
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